Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,A1BG,Alpha-1B-glycoprotein,23501,41,7.44 [1.37-40.56],0.0202984874429972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AAMDC,Mth938 domain-containing protein,22859,42,1.40 [0.82-2.39],0.2161898606107639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AARSD1,Alanyl-tRNA editing protein Aarsd1,26762,58,1.77 [1.22-2.57],0.0027883605115387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABCA2,ATP-binding cassette sub-family A member 2,22720,41,1.45 [0.69-3.06],0.324916836593198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABHD14B,Protein ABHD14B,26617,58,1.45 [0.99-2.13],0.0571917287504392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABL1,Tyrosine-protein kinase ABL1,26762,58,1.39 [1.01-1.90],0.0418855188001348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABO,Histo-blood group ABO system transferase,23469,40,0.97 [0.79-1.19],0.7816521939979801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABRAXAS2,BRISC complex subunit Abraxas 2,22720,41,1.25 [0.81-1.94],0.3205027342445843
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",26244,55,1.41 [1.09-1.81],0.0083131872839164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23016,42,1.00 [0.66-1.50],0.9906603184823034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",23456,41,1.16 [0.85-1.59],0.3557433579928579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACAN,Aggrecan core protein,26653,56,0.84 [0.36-1.95],0.6821875443095838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE,Angiotensin-converting enzyme,23469,40,1.59 [0.50-5.00],0.4310346252380481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE2,Angiotensin-converting enzyme 2,26386,58,1.51 [1.03-2.20],0.033841715028889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACHE,Acetylcholinesterase,22952,38,1.08 [0.41-2.80],0.8796950915421918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOT13,Acyl-coenzyme A thioesterase 13,23331,41,1.15 [0.88-1.49],0.2959384418458899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,26888,57,1.29 [0.87-1.90],0.2011141291315159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP1,Low molecular weight phosphotyrosine protein phosphatase,22791,40,1.35 [0.73-2.49],0.3358506551964403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP5,Tartrate-resistant acid phosphatase type 5,27014,59,1.75 [1.08-2.85],0.0235054403854865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP6,Lysophosphatidic acid phosphatase type 6,27059,59,1.20 [0.82-1.73],0.3477458503875966
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACRBP,Acrosin-binding protein,23323,40,1.14 [0.56-2.36],0.7132666031894686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACRV1,Acrosomal protein SP-10,22791,40,1.02 [0.43-2.41],0.9573753623080252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACSL1,Long-chain-fatty-acid--CoA ligase 1,22720,41,1.48 [0.85-2.59],0.166916053275309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTA2,"Actin, aortic smooth muscle",26386,58,1.17 [0.72-1.90],0.5153174973092987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN2,Alpha-actinin-2,22720,41,1.19 [0.72-1.98],0.493134988362487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN4,Alpha-actinin-4,26345,55,0.76 [0.32-1.81],0.5366365534451552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACVRL1,Serine/threonine-protein kinase receptor R3,26662,58,2.41 [1.02-5.74],0.0459272946307253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACY1,Aminoacylase-1,26888,57,1.11 [0.76-1.62],0.5971586471331947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,22720,41,1.55 [0.96-2.50],0.0702253440297168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACYP1,Acylphosphatase-1,22863,38,1.18 [0.74-1.88],0.4879219654728329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA,Adenosine deaminase,27167,58,2.38 [1.40-4.06],0.0013900678291635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA2,Adenosine deaminase 2,26709,59,2.39 [1.47-3.88],0.0004095537438841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,22791,40,2.29 [1.43-3.65],0.0005129617161231
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,26386,58,0.84 [0.39-1.80],0.6501256480966409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,26703,58,0.77 [0.40-1.49],0.441073900063724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,27167,58,0.62 [0.35-1.10],0.1048459120618953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,27076,59,1.73 [0.77-3.90],0.1856104675921077
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,23331,41,1.77 [0.71-4.38],0.2205024540045336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,22791,40,2.30 [1.39-3.81],0.0012495502004126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,27215,59,2.35 [0.84-6.55],0.1030406306761931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,26762,58,1.02 [0.60-1.73],0.9434579884677848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,26386,58,1.04 [0.50-2.16],0.9117502788428428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,22791,40,1.93 [0.96-3.91],0.065560242841851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,26973,57,0.96 [0.57-1.62],0.8691493995072777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL2,ADAMTS-like protein 2,23449,42,3.02 [1.43-6.40],0.003845388139332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL4,ADAMTS-like protein 4,22859,42,1.82 [0.52-6.41],0.3510463182163987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL5,ADAMTS-like protein 5,23456,41,0.81 [0.37-1.76],0.5875162711842307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,26244,55,1.15 [0.69-1.90],0.5911415012799566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADD1,Alpha-adducin,22952,38,1.25 [0.81-1.94],0.3098549796601179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRB3,Adhesion G protein-coupled receptor B3,26662,58,1.80 [0.92-3.50],0.0843489152311923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRD1,Adhesion G-protein coupled receptor D1,22952,38,1.08 [0.46-2.51],0.859100701275816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE1,Adhesion G protein-coupled receptor E1,23331,41,1.17 [0.69-1.97],0.5685132109595487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE2,Adhesion G protein-coupled receptor E2,27019,58,1.30 [0.57-2.99],0.5312288016433786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE5,Adhesion G protein-coupled receptor E5,27084,59,1.47 [0.70-3.07],0.3056007601872457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRF5,Adhesion G protein-coupled receptor F5,23456,41,2.20 [0.84-5.75],0.1080572833781007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG1,Adhesion G-protein coupled receptor G1,26762,58,1.42 [1.09-1.87],0.0104377486356166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG2,Adhesion G-protein coupled receptor G2,26888,57,0.78 [0.33-1.88],0.5827292080342512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRV1,Adhesion G-protein coupled receptor V1,22691,40,1.20 [0.84-1.71],0.3151861694635202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADH1B,All-trans-retinol dehydrogenase,22952,38,1.05 [0.70-1.57],0.8217126098242168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,26386,58,0.88 [0.66-1.17],0.3921718966824689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADIPOQ,Adiponectin,23501,41,1.10 [0.71-1.72],0.6649406825474615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADM,Pro-adrenomedullin,27107,59,2.36 [0.96-5.78],0.0602039081487078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADRA2A,Alpha-2A adrenergic receptor,22720,41,0.97 [0.62-1.50],0.8773046510516546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFAP1,Actin filament-associated protein 1,22952,38,1.02 [0.70-1.47],0.9263500649173978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFM,Afamin,23501,41,1.26 [0.26-6.04],0.77103800845967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFP,Alpha-fetoprotein,26624,58,1.08 [0.77-1.52],0.6680620200853913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGBL2,Cytosolic carboxypeptidase 2,22691,40,0.99 [0.70-1.40],0.9698809925878088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGER,Advanced glycosylation end product-specific receptor,26843,58,0.96 [0.55-1.67],0.8751450179601806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGR2,Anterior gradient protein 2 homolog,25993,57,1.08 [0.87-1.36],0.4809488153843234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGR3,Anterior gradient protein 3,26197,54,1.23 [0.84-1.80],0.2975646096005588
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRN,Agrin,27019,58,2.05 [1.12-3.75],0.0203402849452404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRP,Agouti-related protein,27167,58,1.37 [0.88-2.14],0.1635973332650155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGT,Angiotensinogen,23469,40,0.75 [0.27-2.13],0.5923846894484439
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGXT,Serine--pyruvate aminotransferase,26888,57,1.17 [0.87-1.56],0.3023466899739692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHCY,Adenosylhomocysteinase,26888,57,1.14 [0.81-1.59],0.4552139740072334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHNAK,Neuroblast differentiation-associated protein AHNAK,22859,42,2.03 [0.98-4.22],0.0564354210205778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHNAK2,Protein AHNAK2,22859,42,1.02 [0.36-2.85],0.9745763067811593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,23323,40,0.96 [0.61-1.54],0.8765849070098374
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSG,Alpha-2-HS-glycoprotein,23469,40,1.10 [0.36-3.41],0.864879755339785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSP,Alpha-hemoglobin-stabilizing protein,26853,58,1.13 [0.87-1.47],0.3469849252733402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIDA,"Axin interactor, dorsalization-associated protein",22801,38,1.02 [0.71-1.47],0.91259881021665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIF1,Allograft inflammatory factor 1,26244,55,1.48 [0.98-2.24],0.0656079149637863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIF1L,Allograft inflammatory factor 1-like,22859,42,1.12 [0.69-1.82],0.6400559209504266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",26713,58,1.14 [0.92-1.42],0.2228783238970842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AK1,Adenylate kinase isoenzyme 1,26888,57,1.44 [1.04-2.01],0.0291001851265744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AK2,"Adenylate kinase 2, mitochondrial",23402,42,1.04 [0.79-1.37],0.7946848421421382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKAP12,A-kinase anchor protein 12,22952,38,0.40 [0.08-1.90],0.2476668162063068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1B1,Aldo-keto reductase family 1 member B1,26244,55,1.24 [0.92-1.68],0.1552470771963561
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1B10,Aldo-keto reductase family 1 member B10,22801,38,1.73 [1.25-2.40],0.0010274455396682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1C4,Aldo-keto reductase family 1 member C4,26386,58,1.01 [0.67-1.53],0.9642272210131784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR7L,Aflatoxin B1 aldehyde reductase member 4,22791,40,1.58 [1.18-2.13],0.0024103217263762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT1S1,Proline-rich AKT1 substrate 1,26221,58,1.18 [0.83-1.67],0.349269060770598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT2,RAC-beta serine/threonine-protein kinase,23420,41,1.02 [0.81-1.30],0.851297804305574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT3,RAC-gamma serine/threonine-protein kinase,26119,55,1.24 [0.82-1.89],0.3065357028821497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALCAM,CD166 antigen,27215,59,2.12 [0.67-6.72],0.2016340038214635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH1A1,Retinal dehydrogenase 1,26892,58,1.37 [0.93-2.00],0.1088678729650371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH2,"Aldehyde dehydrogenase, mitochondrial",23323,40,1.24 [0.79-1.94],0.3554148890644056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",26798,59,1.25 [0.95-1.64],0.109316844619996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",23420,41,1.06 [0.57-1.97],0.8540641338841466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALMS1,Alstrom syndrome protein 1,23016,42,1.18 [0.71-1.97],0.5153815541723192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALPI,Intestinal-type alkaline phosphatase,22791,40,1.18 [0.92-1.50],0.1914469435232828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALPP,"Alkaline phosphatase, placental type",26762,58,1.08 [0.86-1.35],0.5027977194582776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBN,Ameloblastin,26345,55,0.96 [0.42-2.20],0.9173628922642478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBP,Protein AMBP,27070,59,4.07 [1.40-11.81],0.0097197295820972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,23449,42,0.97 [0.31-3.06],0.9626446484647924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMFR,E3 ubiquitin-protein ligase AMFR,26221,58,0.84 [0.56-1.25],0.3870723902608411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMIGO1,Amphoterin-induced protein 1,22801,38,1.38 [0.89-2.13],0.1489138285433043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMIGO2,Amphoterin-induced protein 2,26762,58,3.05 [1.10-8.41],0.0316117510737796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMN,Protein amnionless,26345,55,0.95 [0.58-1.58],0.8557843015485215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMOT,Angiomotin,22952,38,0.98 [0.44-2.17],0.9616843726033316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMOTL2,Angiomotin-like protein 2,23246,40,1.11 [0.61-2.02],0.7316929632634073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMPD3,AMP deaminase 3,23402,42,1.24 [0.84-1.84],0.2747683507497996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,21965,37,0.70 [0.36-1.39],0.309352927733904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY2A,Pancreatic alpha-amylase,25820,55,0.57 [0.34-0.93],0.0254369388684531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY2B,Alpha-amylase 2B,25054,55,0.55 [0.34-0.92],0.021324630343205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANG,Angiogenin,26796,59,0.89 [0.45-1.76],0.7366005285738572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT1,Angiopoietin-1,26794,58,1.05 [0.80-1.39],0.7133418949955398
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT2,Angiopoietin-2,27107,59,2.33 [1.33-4.07],0.0030391155552726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL1,Angiopoietin-related protein 1,26526,55,1.94 [0.85-4.40],0.114755129738774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL2,Angiopoietin-related protein 2,26935,58,2.12 [1.22-3.67],0.0075584312912779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL3,Angiopoietin-related protein 3,26882,59,1.52 [0.82-2.84],0.1841411708346316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL4,Angiopoietin-related protein 4,26976,58,1.11 [0.66-1.87],0.6916659039071322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL7,Angiopoietin-related protein 7,27107,59,0.79 [0.42-1.48],0.4644900482614525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANK2,Ankyrin-2,22720,41,1.17 [0.84-1.65],0.3550577869856975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,22791,40,1.41 [0.98-2.03],0.066020785018606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKRA2,Ankyrin repeat family A protein 2,22605,39,0.98 [0.57-1.69],0.9424064390690752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKRD54,Ankyrin repeat domain-containing protein 54,26244,55,1.59 [1.24-2.05],0.0003002041058133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,22859,42,1.32 [0.78-2.23],0.2996795019928469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANPEP,Aminopeptidase N,26925,59,1.93 [0.94-3.96],0.0745550865390054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA1,Annexin A1,22819,38,1.16 [0.59-2.26],0.6719620564808183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA10,Annexin A10,26221,58,1.19 [0.93-1.51],0.1658401432050326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA11,Annexin A11,26799,59,1.07 [0.76-1.52],0.6839163193418316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA2,Annexin A2,22509,42,1.52 [1.17-1.99],0.0018657487876052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA3,Annexin A3,27076,59,1.36 [0.99-1.88],0.0574680181669006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA4,Annexin A4,26749,57,1.19 [0.87-1.62],0.2885258293697027
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA5,Annexin A5,26143,58,0.97 [0.44-2.15],0.9393346382557864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AOC1,Amiloride-sensitive amine oxidase [copper-containing],26345,55,0.72 [0.42-1.22],0.224569742657209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AOC3,Membrane primary amine oxidase,26974,59,1.94 [0.91-4.17],0.0875801555357193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP1G2,AP-1 complex subunit gamma-like 2,23323,40,1.30 [0.91-1.85],0.1520299650663512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP2B1,AP-2 complex subunit beta,22801,38,1.10 [0.59-2.05],0.7554454954712233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP3B1,AP-3 complex subunit beta-1,23331,41,1.27 [0.87-1.84],0.2215418666149075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP3S2,AP-3 complex subunit sigma-2,23402,42,1.22 [0.67-2.20],0.5171216711406075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,26762,58,1.69 [1.15-2.48],0.0079551257890814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APCS,Serum amyloid P-component,23287,41,1.95 [0.81-4.69],0.1380725728064164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,27013,59,1.48 [1.05-2.08],0.0238346807609056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APLP1,Amyloid-like protein 1,26888,57,0.65 [0.41-1.03],0.0673969534222749
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA1,Apolipoprotein A-I,23501,41,0.55 [0.16-1.94],0.3505872305444191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA2,Apolipoprotein A-II,23469,40,0.91 [0.49-1.70],0.7758688110090695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA4,Apolipoprotein A-IV,23501,41,0.80 [0.33-1.95],0.6270717647489162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOB,Apolipoprotein B-100,23469,40,0.88 [0.24-3.29],0.8549442946045388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOBR,Apolipoprotein B receptor,22859,42,1.09 [0.53-2.23],0.8105413689488038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOC1,Apolipoprotein C-I,23450,41,0.86 [0.36-2.08],0.741570494111165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOD,Apolipoprotein D,22422,41,0.61 [0.24-1.51],0.282835435209516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOE,Apolipoprotein E,23501,41,0.88 [0.54-1.43],0.5989408612285059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOF,Apolipoprotein F,23469,40,0.61 [0.30-1.26],0.180071932210537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOH,Beta-2-glycoprotein 1,26892,58,0.52 [0.27-1.02],0.0564439326668751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOL1,Apolipoprotein L1,23469,40,0.90 [0.55-1.48],0.6725579256403804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOM,Apolipoprotein M,26928,59,0.72 [0.31-1.67],0.4379501486459577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APP,Amyloid-beta precursor protein,26856,58,1.33 [0.95-1.87],0.0934017675067928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APPL2,DCC-interacting protein 13-beta,22952,38,1.10 [0.83-1.46],0.5219812399905954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APRT,Adenine phosphoribosyltransferase,26665,57,1.29 [0.78-2.13],0.3200614381441949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARAF,Serine/threonine-protein kinase A-Raf,23016,42,1.35 [0.95-1.92],0.093764486298339
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AREG,Amphiregulin,26762,58,1.66 [1.09-2.54],0.018257159430352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARF6,ADP-ribosylation factor 6,23331,41,1.06 [0.80-1.40],0.6972546418300583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARFIP1,Arfaptin-1,23420,41,1.14 [0.75-1.75],0.537207847821866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARG1,Arginase-1,26737,58,1.23 [0.80-1.89],0.3493856030433725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARG2,"Arginase-2, mitochondrial",23323,40,0.92 [0.45-1.89],0.8202631690399397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP1,Rho GTPase-activating protein 1,26244,55,1.02 [0.60-1.73],0.9312152981934804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP25,Rho GTPase-activating protein 25,26244,55,1.10 [0.74-1.65],0.6246465140304682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP30,Rho GTPase-activating protein 30,23016,42,1.21 [0.60-2.46],0.5948603068031958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP45,Rho GTPase-activating protein 45,22952,38,1.16 [0.80-1.70],0.4312899335428587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP5,Rho GTPase-activating protein 5,22605,39,1.24 [0.89-1.72],0.2003194694395442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF1,Rho guanine nucleotide exchange factor 1,23402,42,1.20 [0.87-1.67],0.2682370564692617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF10,Rho guanine nucleotide exchange factor 10,23420,41,1.08 [0.79-1.48],0.6147383595676561
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF12,Rho guanine nucleotide exchange factor 12,26837,59,1.04 [0.83-1.30],0.7261450143407224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF5,Rho guanine nucleotide exchange factor 5,22691,40,1.11 [0.75-1.64],0.5910572313220452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARID3A,AT-rich interactive domain-containing protein 3A,22691,40,0.95 [0.44-2.06],0.899319744673705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARID4B,AT-rich interactive domain-containing protein 4B,26221,58,0.73 [0.38-1.42],0.3554937029609945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARL13B,ADP-ribosylation factor-like protein 13B,22720,41,0.85 [0.54-1.35],0.4962149523985316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,22720,41,1.23 [0.60-2.54],0.5679465896234474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARMCX2,Armadillo repeat-containing X-linked protein 2,22691,40,1.01 [0.63-1.63],0.9513513278069832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARNT,Aryl hydrocarbon receptor nuclear translocator,26345,55,1.15 [0.61-2.14],0.6690716193549224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,22720,41,1.20 [0.77-1.88],0.418320586135305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARSA,Arylsulfatase A,26892,58,1.18 [0.71-1.96],0.5115880143617926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARSB,Arylsulfatase B,26762,58,1.58 [1.06-2.35],0.0244184662769442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ART3,Ecto-ADP-ribosyltransferase 3,26974,59,0.58 [0.29-1.15],0.1167813686881028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ART5,Ecto-ADP-ribosyltransferase 5,22691,40,0.83 [0.46-1.48],0.5258464109135899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARTN,Artemin,26345,55,0.86 [0.47-1.56],0.622982228645444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASAH1,Acid ceramidase,23232,42,1.04 [0.55-1.95],0.9046250531582491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASAH2,Neutral ceramidase,26703,58,0.71 [0.50-1.01],0.0543616483402712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASGR1,Asialoglycoprotein receptor 1,26703,58,2.02 [0.96-4.25],0.06411847905662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASGR2,Asialoglycoprotein receptor 2,23469,40,1.97 [0.66-5.85],0.2236667055037836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASPN,Asporin,23456,41,0.42 [0.13-1.35],0.1429111315429309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASPSCR1,Tether containing UBX domain for GLUT4,23420,41,1.13 [0.73-1.75],0.5783349544281615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASRGL1,Isoaspartyl peptidase/L-asparaginase,22859,42,1.02 [0.76-1.36],0.9048113150140852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASS1,Argininosuccinate synthase,22720,41,1.06 [0.73-1.55],0.7524998771616006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATF2,Cyclic AMP-dependent transcription factor ATF-2,26221,58,0.65 [0.39-1.10],0.1112503703999884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATF4,Cyclic AMP-dependent transcription factor ATF-4,22605,39,0.74 [0.28-1.98],0.5517654771429377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATG16L1,Autophagy-related protein 16-1,23331,41,1.23 [0.87-1.74],0.2500311616673737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATG4A,Cysteine protease ATG4A,26244,55,1.52 [1.06-2.18],0.0236856869496255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATOX1,Copper transport protein ATOX1,26973,57,1.01 [0.72-1.41],0.95025895802013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,22720,41,0.99 [0.53-1.84],0.968513836314169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,22720,41,1.95 [1.27-2.99],0.0021788731180993
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,22720,41,1.17 [0.59-2.33],0.6494064257485419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B4,Protein ATP1B4,22605,39,0.46 [0.19-1.11],0.0849724680879188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP2B4,Plasma membrane calcium-transporting ATPase 4,22720,41,1.11 [0.72-1.72],0.6334162108091196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5F1D,"ATP synthase subunit delta, mitochondrial",22720,41,0.80 [0.40-1.57],0.5114485642959867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5IF1,"ATPase inhibitor, mitochondrial",27019,58,1.06 [0.86-1.31],0.566159932155132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5PO,"ATP synthase subunit O, mitochondrial",26221,58,0.59 [0.33-1.07],0.0846598832460484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6AP2,Renin receptor,26244,55,1.37 [0.86-2.16],0.1824403037256276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1D,V-type proton ATPase subunit D,26762,58,1.57 [0.88-2.81],0.1241750378152331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1F,V-type proton ATPase subunit F,26171,58,0.82 [0.57-1.19],0.3045087924004213
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1G1,V-type proton ATPase subunit G 1,22859,42,1.24 [0.84-1.85],0.2784862604608391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1G2,V-type proton ATPase subunit G 2,22720,41,1.16 [0.89-1.50],0.2777108538838098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATRAID,All-trans retinoic acid-induced differentiation factor,23331,41,1.69 [1.10-2.58],0.0159392578550352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATRN,"Attractin, Isoform 2",23501,41,4.15 [0.70-24.50],0.116464249341143
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN10,Ataxin-10,26221,58,1.07 [0.77-1.47],0.7013297996594617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN2,Ataxin-2,22691,40,1.07 [0.84-1.36],0.5990662646346538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN2L,Ataxin-2-like protein,23420,41,1.41 [0.84-2.37],0.1992630715228975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN3,Ataxin-3,23402,42,1.30 [0.83-2.05],0.2531350876677349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AXIN1,Axin-1,26837,59,1.05 [0.82-1.33],0.718539767497328
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AXL,Tyrosine-protein kinase receptor UFO,26974,59,1.30 [0.57-2.96],0.5352199100224455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AZI2,5-azacytidine-induced protein 2,23420,41,1.35 [0.81-2.23],0.2472024538020876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AZU1,Azurocidin,26026,57,1.16 [0.88-1.51],0.2929228550183834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B2M,Beta-2-microglobulin,23501,41,1.64 [1.10-2.44],0.0161519709432444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,22720,41,0.78 [0.16-3.76],0.7590017165010644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",22859,42,1.46 [0.64-3.32],0.3658364603059205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GALT1,"Beta-1,4-galactosyltransferase 1",27019,58,1.66 [0.72-3.78],0.2320127669898854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GAT1,"Beta-1,4-glucuronyltransferase 1",26892,58,1.31 [0.50-3.44],0.5784969866043593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BABAM1,BRISC and BRCA1-A complex member 1,22791,40,1.47 [0.63-3.44],0.371920551091401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BACH1,Transcription regulator protein BACH1,26837,59,1.14 [0.83-1.55],0.4236101611760443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG3,BAG family molecular chaperone regulator 3,26662,58,0.76 [0.45-1.30],0.3153595819666909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG4,BAG family molecular chaperone regulator 4,22791,40,1.47 [0.86-2.51],0.1579470141064926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG6,Large proline-rich protein BAG6,26386,58,1.44 [0.75-2.74],0.2725167671397984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,26244,55,1.56 [1.15-2.11],0.0042196502730283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAMBI,BMP and activin membrane-bound inhibitor homolog,26244,55,1.82 [0.90-3.68],0.0938417784969465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BANK1,B-cell scaffold protein with ankyrin repeats,26837,59,1.00 [0.80-1.24],0.9864951357158406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAP18,Chromatin complexes subunit BAP18,23402,42,1.31 [0.94-1.83],0.1152136302081173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BATF,Basic leucine zipper transcriptional factor ATF-like,22801,38,1.24 [0.95-1.60],0.1092210592999005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAX,Apoptosis regulator BAX,26181,58,1.17 [0.90-1.52],0.2403677466591169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAM,Basal cell adhesion molecule,26892,58,1.24 [0.48-3.24],0.6557530335418897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAN,Brevican core protein,26703,58,0.45 [0.23-0.87],0.018152105711765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",23456,41,1.65 [0.73-3.71],0.2248743288248157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",22691,40,1.13 [0.69-1.85],0.6155597730819865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCHE,Cholinesterase,23038,39,0.90 [0.30-2.66],0.8453215725443601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2,Apoptosis regulator Bcl-2,23331,41,1.21 [0.79-1.86],0.3776854848823882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L1,Bcl-2-like protein 1,23402,42,1.03 [0.77-1.39],0.8216188708788972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",26837,59,0.75 [0.47-1.19],0.2225038050759543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L15,Bcl-2-like protein 15,22791,40,1.15 [0.72-1.84],0.5593927947772944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7A,B-cell CLL/lymphoma 7 protein family member A,22605,39,0.81 [0.47-1.40],0.4470263184496825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7B,B-cell CLL/lymphoma 7 protein family member B,23323,40,1.09 [0.56-2.09],0.8058077003685333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCR,Breakpoint cluster region protein,26837,59,1.03 [0.80-1.33],0.8068066574178444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BDNF,Brain-derived neurotrophic factor,23449,42,1.02 [0.72-1.45],0.9115604604022088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BECN1,Beclin-1,22859,42,1.31 [0.83-2.08],0.2502040411894765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BEX3,Protein BEX3,22605,39,1.05 [0.57-1.94],0.8830310175366638
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BGLAP,Osteocalcin,23449,42,1.38 [0.99-1.91],0.0563807672919829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BGN,Biglycan,26198,55,0.88 [0.72-1.08],0.2109904415596496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BHLHE40,Class E basic helix-loop-helix protein 40,22691,40,0.85 [0.53-1.36],0.4972273440134646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,22720,41,1.15 [0.35-3.79],0.8178755671310141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BID,BH3-interacting domain death agonist,26837,59,1.24 [0.90-1.71],0.1809060662311337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BIN2,Bridging integrator 2,26892,58,1.04 [0.81-1.34],0.7579549323416103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BIRC2,Baculoviral IAP repeat-containing protein 2,26244,55,1.08 [0.74-1.58],0.692617653101069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLMH,Bleomycin hydrolase,27215,59,1.62 [0.87-3.00],0.125680014263919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLNK,B-cell linker protein,22791,40,1.47 [0.83-2.61],0.187764847588814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,22691,40,1.03 [0.68-1.54],0.9013280712186916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,23402,42,1.29 [0.64-2.61],0.4733221879954237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLVRB,Flavin reductase,26892,58,1.28 [0.94-1.75],0.1209564458900707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP10,Bone morphogenetic protein 10,22952,38,0.56 [0.20-1.58],0.2722542270174976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP4,Bone morphogenetic protein 4,26662,58,0.84 [0.49-1.44],0.5160054630899991
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP6,Bone morphogenetic protein 6,26344,58,1.17 [0.66-2.07],0.5839574783610807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMPER,BMP-binding endothelial regulator protein,22952,38,2.32 [0.88-6.14],0.0894325477893736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,23456,41,1.21 [0.53-2.80],0.6508123658617523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,22791,40,2.36 [1.46-3.83],0.0004726054727932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOC,Brother of CDO,26386,58,0.83 [0.30-2.26],0.7110730122860263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOLA1,BolA-like protein 1,22691,40,1.22 [0.75-1.98],0.4260125032397811
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOLA2_BOLA2B,BolA-like protein 2,22859,42,1.21 [0.71-2.07],0.4915439291669762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFA2,BPI fold-containing family A member 2,22008,41,0.84 [0.63-1.11],0.2107635554377646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFB1,BPI fold-containing family B member 1,26818,58,1.39 [0.95-2.04],0.0879789635409121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFB2,BPI fold-containing family B member 2,23410,41,1.42 [0.99-2.03],0.0565383780107179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRAP,BRCA1-associated protein,23129,41,1.01 [0.77-1.33],0.952774552766208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD1,Bromodomain-containing protein 1,23016,42,0.65 [0.22-1.93],0.4420768359295099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD2,Bromodomain-containing protein 2,22691,40,0.76 [0.28-2.10],0.5989438585673477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD3,Bromodomain-containing protein 3,22720,41,1.35 [0.91-2.02],0.1373505761323662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRDT,Bromodomain testis-specific protein,22720,41,1.07 [0.47-2.45],0.8666330218868858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRK1,Protein BRICK1,26221,58,1.20 [0.71-2.02],0.4894132402858041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRME1,Break repair meiotic recombinase recruitment factor 1,22691,40,0.75 [0.32-1.77],0.5101201903243148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRSK2,Serine/threonine-protein kinase BRSK2,23420,41,1.51 [0.78-2.90],0.2212690320304368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSG,Basigin,27123,58,3.21 [1.06-9.78],0.0397378655212593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSND,Barttin,22605,39,1.84 [1.29-2.61],0.0006821000289129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,27122,59,2.89 [1.26-6.60],0.0119012991056503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST2,Bone marrow stromal antigen 2,27122,59,1.57 [1.14-2.16],0.0052788864090838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTC,Probetacellulin,26244,55,1.29 [1.00-1.67],0.0500592366376406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTD,Biotinidase,23501,41,1.30 [0.30-5.64],0.7234457185899508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTLA,B- and T-lymphocyte attenuator,22605,39,0.90 [0.59-1.36],0.6164561636602885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN1A1,Butyrophilin subfamily 1 member A1,23279,40,1.16 [0.58-2.30],0.6745495214065345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN2A1,Butyrophilin subfamily 2 member A1,27019,58,1.83 [0.79-4.26],0.1599271953667168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN3A2,Butyrophilin subfamily 3 member A2,26837,59,1.97 [1.29-3.01],0.0016308082728514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTNL10,Butyrophilin-like protein 10,22605,39,1.95 [1.43-2.65],2.331135879523231e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C19orf12,Protein C19orf12,26221,58,1.22 [0.91-1.65],0.187774224037953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1GALT1C1,C1GALT1-specific chaperone 1,22720,41,1.72 [0.86-3.44],0.1259874824825062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QA,Complement C1q subcomponent subunit A,27030,58,3.32 [1.24-8.90],0.0173168359469833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",23420,41,0.93 [0.59-1.47],0.7530759548835909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QL2,Complement C1q-like protein 2,22791,40,0.84 [0.42-1.72],0.6401222233942634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,26974,59,1.69 [1.03-2.76],0.0369216209891323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,22952,38,1.31 [0.57-3.02],0.5309149792536236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,23420,41,0.87 [0.33-2.25],0.768900466074867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,22904,38,0.77 [0.42-1.40],0.3912248977063927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1R,Complement C1r subcomponent,23501,41,2.23 [0.90-5.51],0.0821103334680327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1RL,Complement C1r subcomponent-like protein,23465,41,3.87 [0.82-18.21],0.0864534954791141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1S,Complement C1s subcomponent,23501,41,7.61 [2.41-23.99],0.0005365475277298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2,Complement C2,26928,59,1.57 [0.53-4.67],0.4167559641583505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2CD2L,Phospholipid transfer protein C2CD2L,26171,58,1.50 [1.01-2.21],0.0420691042670891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2orf69,UPF0565 protein C2orf69,22801,38,0.85 [0.47-1.54],0.6010476082058684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C3,Complement C3,22286,39,1.59 [0.98-2.57],0.0599027500524057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C4BPB,C4b-binding protein beta chain,26973,57,1.60 [0.92-2.78],0.0942834851285696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C5,Complement C5,23501,41,4.48 [1.12-17.94],0.0338453449206771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7,Complement component C7,22934,41,3.83 [1.52-9.65],0.0044080844720989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7orf50,Uncharacterized protein C7orf50,23402,42,1.62 [0.70-3.76],0.2581340222401551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C8B,Complement component C8 beta chain,23501,41,1.81 [0.67-4.91],0.2433591581590146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C9,Complement component C9,23469,40,0.73 [0.41-1.29],0.280257942207025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C9orf40,Uncharacterized protein C9orf40,23331,41,1.25 [0.89-1.76],0.1949723433026769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA1,Carbonic anhydrase 1,26258,59,1.21 [0.85-1.73],0.2962862213948409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA11,Carbonic anhydrase-related protein 11,26244,55,0.73 [0.31-1.74],0.4811379152880345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA12,Carbonic anhydrase 12,26762,58,2.19 [1.18-4.06],0.0130730440053268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA13,Carbonic anhydrase 13,26603,55,1.05 [0.83-1.32],0.6852143400102173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA14,Carbonic anhydrase 14,27107,59,0.62 [0.32-1.20],0.1538630369669508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA2,Carbonic anhydrase 2,26811,58,1.43 [1.06-1.93],0.018534496376385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA3,Carbonic anhydrase 3,27166,59,1.21 [0.85-1.73],0.2878723263396521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA4,Carbonic anhydrase 4,27215,59,0.78 [0.30-2.04],0.6100081376140898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA5A,"Carbonic anhydrase 5A, mitochondrial",26386,58,1.07 [0.84-1.36],0.6033546025846231
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA6,Carbonic anhydrase 6,26809,58,0.57 [0.40-0.82],0.0025352497530235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA7,Carbonic anhydrase 7,23016,42,0.47 [0.17-1.29],0.1438780994009987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA8,Carbonic anhydrase-related protein,22791,40,1.13 [0.44-2.91],0.8059564351295982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA9,Carbonic anhydrase 9,27107,59,1.22 [0.77-1.94],0.3858098417144944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CABP2,Calcium-binding protein 2,22801,38,1.09 [0.69-1.74],0.7001280303288873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,22691,40,0.59 [0.20-1.72],0.3331810055221636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,22720,41,0.96 [0.57-1.62],0.875085764711663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,22691,40,1.21 [0.78-1.87],0.4007374947779932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,23420,41,1.21 [0.85-1.71],0.2890875337340073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACYBP,Calcyclin-binding protein,22904,38,1.10 [0.81-1.49],0.5461111253399706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CADPS,Calcium-dependent secretion activator 1,22801,38,0.87 [0.40-1.86],0.7120029178910534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB1,Calbindin,26762,58,1.24 [0.71-2.16],0.4499063882203452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB2,Calretinin,26221,58,1.17 [0.59-2.32],0.6439724877645249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCA,Calcitonin,26653,58,1.24 [0.87-1.79],0.2352822273704067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCB,Calcitonin gene-related peptide 2,23402,42,1.06 [0.51-2.19],0.8817347070713275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,27017,59,1.01 [0.81-1.26],0.9350409839458264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,22859,42,1.11 [0.76-1.62],0.6061579924577052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALY,Neuron-specific vesicular protein calcyon,22720,41,1.59 [0.99-2.56],0.0553017248219578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,26244,55,1.52 [0.95-2.43],0.082924618308938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,22801,38,1.08 [0.63-1.83],0.7853779449359699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,23420,41,1.12 [0.86-1.47],0.4026823597099973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CANT1,Soluble calcium-activated nucleotidase 1,26815,57,3.03 [0.99-9.29],0.051985747391826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPG,Macrophage-capping protein,26669,58,1.50 [1.05-2.14],0.0259386260629308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPN3,Calpain-3,23323,40,1.16 [0.57-2.34],0.6847512644349774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPS,Calcyphosin,23402,42,0.96 [0.71-1.31],0.8006899737808002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CARHSP1,Calcium-regulated heat-stable protein 1,26221,58,1.30 [0.86-1.95],0.2075797847005182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASC3,Protein CASC3,22801,38,1.14 [0.55-2.38],0.7179469885223044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP1,Caspase-1,26221,58,1.38 [1.05-1.81],0.0198778847032379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP10,Caspase-10,26221,58,1.23 [0.89-1.70],0.2183962972726825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP2,Caspase-2,26837,59,1.10 [0.79-1.54],0.5789041161814312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP3,Caspase-3,27215,59,1.03 [0.80-1.34],0.7974378575230685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP4,Caspase-4,23016,42,1.18 [1.03-1.35],0.0180902472545414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP7,Caspase-7,23402,42,1.04 [0.73-1.49],0.8074101093939018
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP8,Caspase-8,27022,59,1.25 [0.88-1.77],0.2120553250864586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP9,Caspase-9,22791,40,1.37 [0.91-2.07],0.1300942908888226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASQ2,Calsequestrin-2,22720,41,1.29 [0.81-2.04],0.2826152465766059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAT,Catalase,23115,39,1.27 [0.75-2.13],0.377968608985692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLIF,Cobalamin binding intrinsic factor,26845,57,1.39 [1.03-1.87],0.0295318021758147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLN1,Cerebellin-1,22691,40,1.01 [0.74-1.39],0.939868900032614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLN4,Cerebellin-4,27107,59,0.42 [0.21-0.83],0.0121653168379285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBS,Cystathionine beta-synthase,22859,42,1.06 [0.60-1.85],0.8494165500034424
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBX2,Chromobox protein homolog 2,22720,41,1.28 [0.72-2.30],0.3987902582701784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,26703,58,1.32 [0.98-1.78],0.0637741759829042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCAR2,Cell cycle and apoptosis regulator protein 2,23402,42,1.08 [0.68-1.73],0.7357890977701306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC134,Coiled-coil domain-containing protein 134,23323,40,1.68 [1.11-2.54],0.0141575791289154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC28A,Coiled-coil domain-containing protein 28A,22801,38,1.29 [0.44-3.76],0.6431825360934904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC50,Coiled-coil domain-containing protein 50,23420,41,1.35 [1.03-1.77],0.0276167615216162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC80,Coiled-coil domain-containing protein 80,26888,57,1.78 [0.99-3.19],0.0526408722063514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,22859,42,1.17 [0.74-1.85],0.4981098326856124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL11,Eotaxin,27167,58,2.21 [1.19-4.10],0.012336335632586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL13,C-C motif chemokine 13,27116,58,1.19 [0.86-1.65],0.2975940495344804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL14,C-C motif chemokine 14,26796,59,1.62 [1.00-2.60],0.0487063192828249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL15,C-C motif chemokine 15,27215,59,1.21 [0.73-1.99],0.455690692226423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL16,C-C motif chemokine 16,27215,59,1.49 [0.94-2.37],0.0878326170394295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL17,C-C motif chemokine 17,26855,58,1.14 [0.89-1.47],0.3034864145668003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL18,C-C motif chemokine 18,26490,59,1.29 [0.97-1.71],0.0852463582310283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL19,C-C motif chemokine 19,27122,59,1.09 [0.94-1.26],0.24087083072839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL2,C-C motif chemokine 2,26662,58,1.16 [0.76-1.76],0.5000437444492932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL20,C-C motif chemokine 20,27167,58,1.22 [0.99-1.49],0.0581744633209571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL21,C-C motif chemokine 21,27019,58,1.39 [0.96-2.01],0.0815395156834059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL22,C-C motif chemokine 22,26641,58,1.58 [1.07-2.32],0.0202505406045799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL23,C-C motif chemokine 23,27019,58,2.28 [1.35-3.84],0.0019473833266797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL24,C-C motif chemokine 24,26976,58,1.03 [0.78-1.36],0.8417914131622364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL25,C-C motif chemokine 25,27167,58,2.09 [1.32-3.33],0.0017456660968243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL26,C-C motif chemokine 26,26837,59,1.18 [0.96-1.45],0.1268513856676167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL27,C-C motif chemokine 27,26888,57,1.08 [0.72-1.62],0.7137154287896716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL28,C-C motif chemokine 28,26755,59,1.55 [1.10-2.18],0.011549058124562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL3,C-C motif chemokine 3,26837,59,1.23 [0.95-1.60],0.1143861611502737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL4,C-C motif chemokine 4,26933,58,1.26 [0.99-1.61],0.0639104848247353
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL5,C-C motif chemokine 5,26974,59,1.12 [0.89-1.40],0.3468240771775602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL7,C-C motif chemokine 7,26837,59,1.33 [0.97-1.81],0.076170259052792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL8,C-C motif chemokine 8,27070,59,1.41 [0.96-2.07],0.0759523806852087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN1,CCN family member 1,26715,58,1.54 [1.11-2.12],0.0096170022862767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN2,CCN family member 2,26894,58,1.33 [0.89-1.98],0.1715561464812192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN3,CCN family member 3,27176,59,1.89 [1.03-3.45],0.0387587467121144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN4,CCN family member 4,27107,59,1.18 [0.68-2.03],0.5515053269570269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN5,CCN family member 5,26892,58,2.34 [1.34-4.08],0.002843128396175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCND2,G1/S-specific cyclin-D2,23016,42,1.50 [0.66-3.41],0.3392249037641898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCNE1,G1/S-specific cyclin-E1,22791,40,1.22 [0.95-1.57],0.1209920002908761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCS,Copper chaperone for superoxide dismutase,26703,58,1.18 [0.74-1.88],0.4917663055379481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCT5,T-complex protein 1 subunit epsilon,26244,55,1.50 [0.96-2.35],0.0728858155859136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD101,Immunoglobulin superfamily member 2,23331,41,0.87 [0.43-1.77],0.7054067156332102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD109,CD109 antigen,26892,58,1.29 [0.64-2.60],0.4774135106918694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD14,Monocyte differentiation antigen CD14,26300,59,2.26 [1.53-3.34],4.269274634062672e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD160,CD160 antigen,27167,58,1.16 [0.72-1.88],0.5441573346535789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD163,Scavenger receptor cysteine-rich type 1 protein M130,26974,59,1.61 [0.96-2.68],0.0685677977644538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD164,Sialomucin core protein 24,26892,58,1.44 [0.86-2.42],0.1653543964204844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD164L2,CD164 sialomucin-like 2 protein,22801,38,0.97 [0.41-2.28],0.9471808699271088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD177,CD177 antigen,26850,58,0.99 [0.83-1.18],0.8982866972373504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD1C,T-cell surface glycoprotein CD1c,26973,57,0.47 [0.20-1.12],0.0889232635049369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD2,T-cell surface antigen CD2,22720,41,1.34 [0.77-2.33],0.3053437683104095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD200,OX-2 membrane glycoprotein,26837,59,0.82 [0.34-1.98],0.6599892678507003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD200R1,Cell surface glycoprotein CD200 receptor 1,26751,59,1.37 [0.72-2.59],0.332625472423963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD207,C-type lectin domain family 4 member K,26319,56,1.41 [0.77-2.57],0.267884692922344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD209,CD209 antigen,26952,57,1.02 [0.56-1.83],0.9566017612273484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD22,B-cell receptor CD22,27167,58,1.11 [0.64-1.94],0.711828585307174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD226,CD226 antigen,22791,40,1.85 [0.94-3.65],0.0745446972972713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD244,Natural killer cell receptor 2B4,27167,58,1.62 [0.68-3.84],0.2741327425132479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD248,Endosialin,23449,42,0.77 [0.37-1.61],0.4837424348825273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD27,CD27 antigen,26973,57,2.01 [1.21-3.33],0.0069578588954459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD274,Programmed cell death 1 ligand 1,26703,58,2.62 [1.58-4.34],0.0001937950107599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD276,CD276 antigen,26892,58,3.30 [1.75-6.19],0.0002078793466318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD28,T-cell-specific surface glycoprotein CD28,26244,55,1.65 [0.91-2.97],0.0967416447387913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD2AP,CD2-associated protein,26888,57,1.26 [0.89-1.79],0.187093018164842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300A,CMRF35-like molecule 8,22952,38,2.26 [0.83-6.17],0.1114266500747981
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300C,CMRF35-like molecule 6,27122,59,2.00 [1.08-3.71],0.0271173174051677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300E,CMRF35-like molecule 2,27012,59,1.86 [1.10-3.14],0.0205224895496364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300LF,CMRF35-like molecule 1,27107,59,1.27 [0.85-1.89],0.2477905117948877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300LG,CMRF35-like molecule 9,26892,58,0.70 [0.38-1.29],0.2510572657202386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD302,CD302 antigen,26762,58,2.31 [1.17-4.58],0.0165096231737163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD33,Myeloid cell surface antigen CD33,26973,57,0.92 [0.70-1.22],0.5776383826624819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD34,Hematopoietic progenitor cell antigen CD34,27033,59,0.81 [0.31-2.12],0.6606454703934668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD36,Platelet glycoprotein 4,22791,40,2.28 [1.27-4.08],0.0057519460897168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,26762,58,0.86 [0.41-1.82],0.7012725658801258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3D,T-cell surface glycoprotein CD3 delta chain,22691,40,0.85 [0.32-2.26],0.7377245487573891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3E,T-cell surface glycoprotein CD3 epsilon chain,23016,42,0.94 [0.41-2.18],0.8846510961311569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3G,T-cell surface glycoprotein CD3 gamma chain,22791,40,0.99 [0.70-1.40],0.955434979345044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD4,T-cell surface glycoprotein CD4,26794,59,1.60 [0.99-2.60],0.0558853550564443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD40,Tumor necrosis factor receptor superfamily member 5,26890,58,1.55 [1.00-2.39],0.0479163184701962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD40LG,CD40 ligand,27167,58,1.12 [0.83-1.52],0.451258897930644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD46,Membrane cofactor protein,26702,59,1.43 [0.66-3.08],0.3627285103340081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD48,CD48 antigen,26976,58,2.30 [1.09-4.85],0.0284455644884596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5,T-cell surface glycoprotein CD5,27070,59,1.02 [0.52-2.01],0.9527603926571842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD55,Complement decay-accelerating factor,25935,57,1.04 [0.42-2.58],0.9298149574435678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD58,Lymphocyte function-associated antigen 3,26852,58,0.38 [0.11-1.33],0.1295334363409689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD59,CD59 glycoprotein,25899,58,2.44 [1.15-5.20],0.0202447073650959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5L,CD5 antigen-like,23366,41,2.15 [1.18-3.93],0.0124716482300741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD6,T-cell differentiation antigen CD6,27123,58,0.75 [0.49-1.15],0.1848315339291443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD63,CD63 antigen,26662,58,1.43 [0.91-2.26],0.124023558786312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD69,Early activation antigen CD69,26759,57,1.12 [0.85-1.46],0.4246201009237581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD7,T-cell antigen CD7,22742,40,1.98 [1.20-3.26],0.007076754161497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD70,CD70 antigen,26837,59,1.64 [0.96-2.80],0.0678339223496892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD72,B-cell differentiation antigen CD72,22952,38,2.19 [1.17-4.10],0.0146775076576172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD74,HLA class II histocompatibility antigen gamma chain,27122,59,2.92 [1.66-5.14],0.0001914542757163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD79B,B-cell antigen receptor complex-associated protein beta chain,27167,58,1.83 [1.16-2.87],0.0089668540846479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD80,T-lymphocyte activation antigen CD80,23456,41,2.04 [0.93-4.48],0.0767213376394212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD82,CD82 antigen,23016,42,1.10 [0.57-2.11],0.77982082554597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD83,CD83 antigen,26837,59,1.46 [0.77-2.79],0.2496428683993208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD84,SLAM family member 5,26837,59,1.22 [0.58-2.57],0.596677362304062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD86,T-lymphocyte activation antigen CD86,23331,41,2.26 [0.83-6.17],0.1124867646196798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD8A,T-cell surface glycoprotein CD8 alpha chain,27122,59,0.66 [0.42-1.06],0.086398229847826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD93,Complement component C1q receptor,25854,55,0.78 [0.36-1.71],0.5434536030295962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99,CD99 antigen,26892,58,1.72 [0.54-5.51],0.3574852074933496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99L2,CD99 antigen-like protein 2,26892,58,1.43 [0.55-3.74],0.4672700034871683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDA,Cytidine deaminase,23414,41,1.32 [0.74-2.35],0.3520791291301812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDAN1,Codanin-1,23402,42,0.44 [0.10-1.90],0.2707022485783373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC123,Cell division cycle protein 123 homolog,22605,39,0.89 [0.54-1.49],0.6678317779768262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC25A,M-phase inducer phosphatase 1,22605,39,0.94 [0.43-2.05],0.8728310385679495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC26,Anaphase-promoting complex subunit CDC26,23291,41,1.11 [0.72-1.70],0.6334386117460122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC27,Cell division cycle protein 27 homolog,26244,55,1.26 [0.87-1.83],0.2146380781078187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC37,Hsp90 co-chaperone Cdc37,26973,57,1.26 [0.95-1.65],0.1042959240860918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC42BPB,Serine/threonine-protein kinase MRCK beta,23331,41,1.15 [0.87-1.53],0.3268570110576909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDCP1,CUB domain-containing protein 1,26703,58,1.71 [1.13-2.59],0.0107008109783432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH1,Cadherin-1,25981,57,1.45 [0.87-2.42],0.149838063583587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH15,Cadherin-15,27072,59,0.95 [0.58-1.55],0.8434627402317012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH17,Cadherin-17,26888,57,1.20 [0.86-1.66],0.2816226033387841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH2,Cadherin-2,26888,57,1.24 [0.64-2.41],0.5249736615316452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH22,Cadherin-22,23016,42,0.59 [0.19-1.82],0.3603095660831963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH23,Cadherin-23,23402,42,0.48 [0.15-1.60],0.2326072858203835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH3,Cadherin-3,27122,59,1.08 [0.57-2.03],0.8144141213299756
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH4,Cadherin-4,22691,40,0.55 [0.25-1.19],0.130235275864313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH5,Cadherin-5,27215,59,1.03 [0.49-2.18],0.9361203553697696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH6,Cadherin-6,26888,57,1.45 [0.79-2.66],0.2305474416786406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR1,Cadherin-related family member 1,26221,58,0.58 [0.31-1.08],0.0845681223080318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR2,Cadherin-related family member 2,26762,58,1.26 [0.93-1.72],0.1402887605750122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR5,Cadherin-related family member 5,26888,57,0.60 [0.35-1.05],0.0730190421712642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDK1,Cyclin-dependent kinase 1,22605,39,2.00 [0.93-4.30],0.0744969400662915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,23420,41,1.42 [0.92-2.22],0.116366117504093
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKL5,Cyclin-dependent kinase-like 5,22691,40,1.20 [0.76-1.90],0.4232874811070257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKN1A,Cyclin-dependent kinase inhibitor 1,26762,58,1.13 [0.91-1.41],0.2725173211698186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,26762,58,1.03 [0.80-1.32],0.8131480207112995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDNF,Cerebral dopamine neurotrophic factor,26762,58,1.48 [0.81-2.71],0.2061224823147714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,26941,58,1.66 [0.67-4.11],0.2694868813569818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDSN,Corneodesmosin,27077,57,1.25 [0.74-2.12],0.4111693372366473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,26929,57,3.75 [1.34-10.50],0.0117615340990508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,23331,41,0.79 [0.54-1.15],0.2225199769989002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23016,42,0.94 [0.60-1.49],0.8037345068689109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,23331,41,0.90 [0.42-1.93],0.794569104032478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23016,42,1.20 [0.68-2.14],0.5257889719114615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,26837,59,1.48 [1.16-1.88],0.0013733921894244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,26244,55,1.07 [0.66-1.72],0.7960266956603691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,25896,55,1.13 [0.80-1.60],0.4899098444507789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,23449,42,2.35 [1.26-4.38],0.0074540269009866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,26386,58,1.78 [1.21-2.62],0.0035430286882167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEBPA,CCAAT/enhancer-binding protein alpha,22791,40,1.53 [0.91-2.57],0.1076937766245497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEBPB,CCAAT/enhancer-binding protein beta,26386,58,1.51 [0.90-2.54],0.1172381908750125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELA2A,Chymotrypsin-like elastase family member 2A,23449,42,0.61 [0.39-0.95],0.0273325213199151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELA3A,Chymotrypsin-like elastase family member 3A,27168,59,0.71 [0.48-1.05],0.0854568955774793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,22952,38,0.82 [0.28-2.38],0.7086253868622302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEMIP2,Cell surface hyaluronidase,22791,40,1.24 [0.61-2.50],0.5561640744915026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEND1,Cell cycle exit and neuronal differentiation protein 1,22691,40,1.20 [0.78-1.84],0.4077148662036742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CENPF,Centromere protein F,23016,42,1.23 [0.75-2.02],0.4206263486489362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CENPJ,Centromere protein J,23016,42,1.01 [0.67-1.52],0.9783673494200203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP112,Centrosomal protein of 112 kDa,22720,41,1.27 [0.71-2.26],0.426734665429627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP152,Centrosomal protein of 152 kDa,22605,39,0.69 [0.30-1.58],0.3834179834606922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP164,Centrosomal protein of 164 kDa,26345,55,0.78 [0.48-1.25],0.3018277533862926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP170,Centrosomal protein of 170 kDa,22859,42,1.17 [0.82-1.69],0.3909551042844122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP20,Centrosomal protein 20,26244,55,1.19 [0.87-1.62],0.2739720699343955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP290,Centrosomal protein of 290 kDa,23016,42,1.42 [0.97-2.07],0.0699690442550776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP350,Centrosome-associated protein 350,22605,39,1.01 [0.45-2.28],0.9799154559250288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP43,Centrosomal protein 43,26173,56,1.37 [0.98-1.90],0.0644647809810088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP85,Centrosomal protein of 85 kDa,26244,55,1.07 [0.73-1.55],0.7388202209711738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CERT,Ceramide transfer protein,26221,58,1.12 [0.77-1.64],0.5612031377378746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES1,Liver carboxylesterase 1,26947,59,0.92 [0.69-1.23],0.5898834601064876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES2,Cocaine esterase,26762,58,1.23 [0.82-1.83],0.3199932783705237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES3,Carboxylesterase 3,26762,58,1.11 [0.80-1.53],0.5429177572059225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CETN2,Centrin-2,26221,58,1.25 [0.90-1.74],0.1832363349763929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CETN3,Centrin-3,23331,41,1.18 [0.81-1.73],0.3859591073290338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFB,Complement factor B,23057,41,2.87 [1.11-7.44],0.0299977834071403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFC1,Cryptic protein,26244,55,1.48 [0.96-2.29],0.078751617595433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFD,Complement factor D,23501,41,3.20 [1.00-10.28],0.0507067135833131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFH,Complement factor H,22107,38,3.43 [0.92-12.85],0.0674310803814555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR2,Complement factor H-related protein 2,23318,41,1.28 [0.73-2.23],0.3952276232476579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR4,Complement factor H-related protein 4,23460,41,0.95 [0.64-1.42],0.8151992581023144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR5,Complement factor H-related protein 5,23160,39,1.64 [0.77-3.48],0.2018304614550963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFI,Complement factor I,23501,41,3.72 [0.84-16.41],0.0829276948824997
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFP,Properdin,23501,41,1.02 [0.26-4.00],0.9751221204880904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGA,Glycoprotein hormones alpha chain,26892,58,0.83 [0.59-1.15],0.2630436492298791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,23469,40,1.05 [0.49-2.27],0.904088050542296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGN,Cingulin,22801,38,1.06 [0.53-2.15],0.8614755078890187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGREF1,Cell growth regulator with EF hand domain protein 1,26888,57,1.51 [0.89-2.58],0.1294356171614736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,26244,55,1.22 [0.86-1.73],0.2585027767674221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHAD,Chondroadherin,22952,38,1.11 [0.62-1.97],0.7339417857529559
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",23402,42,1.99 [1.09-3.63],0.0244061381392115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD6,MICOS complex subunit MIC25,23323,40,2.36 [1.39-3.99],0.0014255179859172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHEK2,Serine/threonine-protein kinase Chk2,26386,58,0.56 [0.27-1.15],0.1147671578013261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHGA,Chromogranin-A,23449,42,1.26 [0.97-1.62],0.0798977866406357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHGB,Secretogranin-1,27022,59,1.41 [0.82-2.44],0.2184593529702863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHI3L1,Chitinase-3-like protein 1,26271,59,1.44 [1.11-1.86],0.0061931008768842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHIT1,Chitotriosidase-1,26995,59,1.07 [0.90-1.27],0.4362633017045209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHL1,Neural cell adhesion molecule L1-like protein,26933,58,1.11 [0.53-2.33],0.7902821342592445
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHM,Rab proteins geranylgeranyltransferase component A 1,22801,38,1.02 [0.61-1.69],0.9468490492381134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHMP1A,Charged multivesicular body protein 1a,26703,58,1.17 [0.87-1.57],0.3037514552809958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHMP6,Charged multivesicular body protein 6,23456,41,1.18 [0.69-2.02],0.5431674249457359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHP1,Calcineurin B homologous protein 1,22691,40,1.21 [0.86-1.70],0.2688046306972954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL1,Chordin-like protein 1,26976,58,3.03 [1.49-6.18],0.0022564164749866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL2,Chordin-like protein 2,26888,57,0.81 [0.51-1.30],0.3883898920656614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRM1,Muscarinic acetylcholine receptor M1,22801,38,1.42 [0.74-2.71],0.2940462074026056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIAPIN1,Anamorsin,26973,57,1.41 [0.98-2.02],0.0650426219336568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CILP,Cartilage intermediate layer protein 1,23449,42,1.28 [0.73-2.27],0.3921408830767919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CINP,Cyclin-dependent kinase 2-interacting protein,23016,42,0.68 [0.31-1.53],0.3551379679034081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIRBP,Cold-inducible RNA-binding protein,23331,41,1.03 [0.75-1.41],0.8701579317496125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIT,Citron Rho-interacting kinase,22801,38,1.23 [0.66-2.27],0.5128936336636774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKAP4,Cytoskeleton-associated protein 4,27038,58,2.51 [1.24-5.09],0.0107678124835513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKB,Creatine kinase B-type,23449,42,1.32 [0.82-2.14],0.2582663403142839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",26801,58,1.15 [0.81-1.64],0.4381578497832344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLASP1,CLIP-associating protein 1,22605,39,1.14 [0.77-1.68],0.5230433314892116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLC,Galectin-10,26847,57,1.29 [0.93-1.79],0.1250768921140175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC10A,C-type lectin domain family 10 member A,26703,58,1.51 [0.79-2.87],0.2120886202712057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC11A,C-type lectin domain family 11 member A,26842,58,2.14 [1.33-3.43],0.0017306092740752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC12A,C-type lectin domain family 12 member A,22791,40,1.82 [0.55-6.06],0.3261924662845124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC14A,C-type lectin domain family 14 member A,26892,58,1.03 [0.50-2.14],0.9274652323682964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC1A,C-type lectin domain family 1 member A,26386,58,1.36 [0.68-2.70],0.3857993483437369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC1B,C-type lectin domain family 1 member B,27122,59,1.18 [0.93-1.49],0.1748177467282345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC2L,C-type lectin domain family 2 member L,22801,38,0.93 [0.48-1.80],0.8198836106348262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC3B,Tetranectin,22937,41,0.60 [0.14-2.54],0.4862362891727899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4A,C-type lectin domain family 4 member A,26837,59,0.59 [0.32-1.09],0.0924924069849792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4C,C-type lectin domain family 4 member C,26837,59,0.64 [0.39-1.04],0.0718058630114219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4D,C-type lectin domain family 4 member D,26837,59,1.70 [1.19-2.41],0.0032948139473006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4G,C-type lectin domain family 4 member G,26837,59,1.37 [0.68-2.76],0.3714360033092214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4M,C-type lectin domain family 4 member M,23403,42,0.57 [0.30-1.05],0.0705948089343651
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC5A,C-type lectin domain family 5 member A,26802,57,1.63 [0.76-3.50],0.2107811536813226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC6A,C-type lectin domain family 6 member A,26244,55,2.05 [1.33-3.17],0.0012148701398415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC7A,C-type lectin domain family 7 member A,27167,58,1.34 [0.83-2.16],0.2309025589641592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLGN,Calmegin,22801,38,1.05 [0.53-2.09],0.8955978003880534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLIC5,Chloride intracellular channel protein 5,22801,38,0.73 [0.25-2.12],0.5673194144876934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLINT1,Clathrin interactor 1,22605,39,1.26 [0.82-1.95],0.2954453498862466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLIP2,CAP-Gly domain-containing linker protein 2,26837,59,1.06 [0.86-1.30],0.6022382376861255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLMP,CXADR-like membrane protein,27107,59,2.63 [0.89-7.78],0.0799849371495272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLNS1A,Methylosome subunit pICln,22801,38,1.39 [0.58-3.34],0.4615727537123938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",26653,58,1.13 [0.89-1.44],0.3108243653975816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLPS,Colipase,26853,58,0.84 [0.61-1.17],0.3150553581346609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSPN,Claspin,26171,58,1.15 [0.61-2.18],0.666032217240254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN1,Calsyntenin-1,26221,58,0.89 [0.55-1.42],0.6224848728704511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN2,Calsyntenin-2,27167,58,1.32 [0.75-2.31],0.3363637183644236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN3,Calsyntenin-3,23402,42,1.97 [0.87-4.50],0.1058892386408895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLTA,Clathrin light chain A,26386,58,0.96 [0.58-1.57],0.8643202753925746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLU,Clusterin,23501,41,0.99 [0.37-2.62],0.9840003339772968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLUL1,Clusterin-like protein 1,26849,57,0.89 [0.53-1.50],0.6722464709768616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CMC1,COX assembly mitochondrial protein homolog,23456,41,1.18 [0.86-1.63],0.3106781516861029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CMIP,C-Maf-inducing protein,23323,40,1.10 [0.77-1.58],0.5950990640865907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNDP1,Beta-Ala-His dipeptidase,26974,59,0.74 [0.47-1.16],0.1903178324886728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNGB3,Cyclic nucleotide-gated cation channel beta-3,22691,40,0.62 [0.29-1.34],0.2234696185880283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",22813,42,1.12 [0.78-1.63],0.540743184241982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNPY2,Protein canopy homolog 2,26386,58,1.10 [0.79-1.54],0.5618072984535284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNPY4,Protein canopy homolog 4,26762,58,1.20 [0.88-1.63],0.2535257643528781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNST,Consortin,26888,57,1.00 [0.81-1.24],0.992065495824821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTF,Ciliary neurotrophic factor,22691,40,1.28 [0.53-3.08],0.5843952956182161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN1,Contactin-1,27215,59,1.27 [0.55-2.92],0.5705192180592393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN2,Contactin-2,27107,59,1.78 [1.09-2.89],0.0200368795717184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN3,Contactin-3,26892,58,0.93 [0.48-1.80],0.8244114333848617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN4,Contactin-4,26892,58,1.39 [0.53-3.65],0.5080117907465095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN5,Contactin-5,26954,59,0.48 [0.26-0.90],0.0224879166853817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTNAP2,Contactin-associated protein-like 2,26837,59,1.48 [0.86-2.56],0.1613700303475103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTNAP4,Contactin-associated protein-like 4,22801,38,1.01 [0.75-1.37],0.9270457061591456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COCH,Cochlin,23456,41,1.28 [0.70-2.35],0.4188720267804615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL15A1,Collagen alpha-1(XV) chain,23449,42,1.69 [0.58-4.90],0.3322205950568442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL18A1,Collagen alpha-1(XVIII) chain,26998,58,7.15 [2.83-18.04],3.128531713926604e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL1A1,Collagen alpha-1(I) chain,27215,59,1.19 [0.50-2.85],0.6980666252425451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL24A1,Collagen alpha-1(XXIV) chain,23331,41,2.19 [1.21-3.96],0.009606200904009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL28A1,Collagen alpha-1(XXVIII) chain,22801,38,1.16 [0.77-1.74],0.4862566695383803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL2A1,Collagen alpha-1(II) chain,22859,42,1.01 [0.70-1.46],0.9520150537452112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL3A1,Collagen alpha-1(III) chain,23449,42,2.23 [0.70-7.14],0.1757215368327211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A1,Collagen alpha-1(IV) chain,26888,57,2.33 [1.36-4.00],0.0020873111601842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A4,Collagen alpha-4(IV) chain,22977,42,0.71 [0.47-1.08],0.1076395091839358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL5A1,Collagen alpha-1(V) chain,22952,38,1.76 [0.88-3.51],0.1089032513886475
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL6A3,Collagen alpha-3(VI) chain,27215,59,2.56 [1.48-4.45],0.0008259790013131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL9A1,Collagen alpha-1(IX) chain,26837,59,1.34 [0.87-2.06],0.1837234457306474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL9A2,Collagen alpha-2(IX) chain,23016,42,1.74 [1.27-2.39],0.0005487884046197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COLEC12,Collectin-12,26892,58,2.65 [1.16-6.09],0.0212306514681652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMMD1,COMM domain-containing protein 1,22859,42,1.24 [0.77-1.99],0.3800906398867243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMMD9,COMM domain-containing protein 9,23323,40,0.75 [0.33-1.73],0.4999415703500922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMP,Cartilage oligomeric matrix protein,26581,58,0.73 [0.37-1.47],0.3792093484133848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMT,Catechol O-methyltransferase,26106,57,1.06 [0.80-1.41],0.664086553657958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COPB2,Coatomer subunit beta',22720,41,1.35 [0.71-2.58],0.3583259031228848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COPE,Coatomer subunit epsilon,26221,58,1.13 [0.71-1.79],0.608704279406778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",22859,42,1.52 [0.90-2.57],0.1204818212368253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO1A,Coronin-1A,26314,56,1.17 [0.92-1.49],0.194572021266586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO6,Coronin-6,22691,40,1.06 [0.47-2.41],0.8930154113232359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",26762,58,1.37 [1.01-1.85],0.0411607934588205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COX6B1,Cytochrome c oxidase subunit 6B1,23456,41,1.09 [0.44-2.69],0.8457257564895858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA1,Carboxypeptidase A1,27215,59,0.83 [0.56-1.23],0.3494648140757569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA2,Carboxypeptidase A2,27023,59,1.01 [0.71-1.43],0.9711906649206802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA4,Carboxypeptidase A4,22487,38,0.79 [0.39-1.60],0.513105717230733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPB1,Carboxypeptidase B,27215,59,0.72 [0.48-1.08],0.1095169867726644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPB2,Carboxypeptidase B2,23450,41,1.92 [0.51-7.15],0.3314631255270585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPE,Carboxypeptidase E,26908,59,0.83 [0.47-1.47],0.5227791811591547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPLX2,Complexin-2,22605,39,1.22 [0.52-2.87],0.6477771616464864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPM,Carboxypeptidase M,26997,59,2.13 [1.18-3.85],0.0118167384491926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",22791,40,1.29 [0.48-3.49],0.6095724310248823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPPED1,Serine/threonine-protein phosphatase CPPED1,27122,59,1.29 [0.92-1.81],0.1363539221496137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPQ,Carboxypeptidase Q,23402,42,3.04 [1.27-7.28],0.0124692908731606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPTP,Ceramide-1-phosphate transfer protein,22720,41,1.03 [0.48-2.20],0.942607951837387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPVL,Probable serine carboxypeptidase CPVL,27072,59,1.52 [0.84-2.76],0.1652040386604318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM1,Probable carboxypeptidase X1,26973,57,1.32 [0.96-1.82],0.0892060548141729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM2,Inactive carboxypeptidase-like protein X2,23456,41,1.94 [0.89-4.25],0.0964550902023051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CR1,Complement receptor type 1,23383,40,0.95 [0.41-2.23],0.9121375798866638
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CR2,Complement receptor type 2,26974,59,1.18 [0.72-1.91],0.5130592228608335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,26244,55,1.19 [0.92-1.54],0.1918768639940694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRADD,Death domain-containing protein CRADD,26653,58,1.21 [0.89-1.65],0.2165487748853361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREB3,Cyclic AMP-responsive element-binding protein 3,22605,39,0.86 [0.47-1.57],0.6182994756187653
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREBZF,CREB/ATF bZIP transcription factor,22605,39,0.78 [0.23-2.62],0.6839493687485677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREG1,Protein CREG1,26537,56,1.65 [0.91-3.00],0.0995074053185743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRELD1,Protein disulfide isomerase CRELD1,22952,38,1.32 [0.59-2.99],0.5011398858055113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRELD2,Protein disulfide isomerase CRELD2,26976,58,1.07 [0.68-1.67],0.7734949233803385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRH,Corticoliberin,26199,55,1.13 [0.86-1.50],0.3706559860363718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRHBP,Corticotropin-releasing factor-binding protein,26892,58,3.86 [1.69-8.80],0.0013220703786741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRHR1,Corticotropin-releasing factor receptor 1,26386,58,1.25 [0.94-1.67],0.1247425275210133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIM1,Cysteine-rich motor neuron 1 protein,27019,58,1.47 [0.47-4.56],0.5049371060376254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIP2,Cysteine-rich protein 2,26703,58,2.19 [1.46-3.28],0.0001379268575025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRISP2,Cysteine-rich secretory protein 2,27107,59,0.83 [0.58-1.17],0.2842907998895627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRISP3,Cysteine-rich secretory protein 3,23250,39,1.34 [0.43-4.13],0.6131011753806064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRKL,Crk-like protein,26936,58,1.09 [0.88-1.36],0.4394039623482615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRLF1,Cytokine receptor-like factor 1,27019,58,1.69 [0.67-4.25],0.2646920555918464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRNN,Cornulin,26087,58,1.03 [0.74-1.44],0.8570203638132329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAC1,Cartilage acidic protein 1,27215,59,0.85 [0.39-1.85],0.6734714464724724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAM,Cytotoxic and regulatory T-cell molecule,26703,58,1.70 [1.09-2.64],0.0192189755732742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAP,Cartilage-associated protein,22801,38,1.04 [0.55-1.98],0.8942237059038145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRX,Cone-rod homeobox protein,26386,58,1.08 [0.89-1.31],0.4216164462738074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYBB1,Beta-crystallin B1,23456,41,1.24 [0.79-1.96],0.3473336972507579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYBB2,Beta-crystallin B2,23402,42,0.73 [0.42-1.29],0.2803481777732027
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYGD,Gamma-crystallin D,23402,42,1.14 [0.84-1.55],0.4009641339221418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYM,Ketimine reductase mu-crystallin,22691,40,1.00 [0.67-1.48],0.9816572134813216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYZL1,Quinone oxidoreductase-like protein 1,22859,42,1.07 [0.77-1.47],0.6915787980686231
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSDE1,Cold shock domain-containing protein E1,22720,41,1.04 [0.81-1.34],0.7394935168544621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1,Macrophage colony-stimulating factor 1,27019,58,3.04 [1.42-6.52],0.0042294343354104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1R,Macrophage colony-stimulating factor 1 receptor,23469,40,1.25 [0.59-2.65],0.5674201339264551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2,Granulocyte-macrophage colony-stimulating factor,22720,41,1.18 [0.50-2.76],0.7043318483772572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,26703,58,1.25 [0.89-1.77],0.2027534690474183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2RB,Cytokine receptor common subunit beta,22791,40,1.22 [0.60-2.47],0.5841742708364446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF3,Granulocyte colony-stimulating factor,26345,55,0.84 [0.51-1.40],0.5015861282575638
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF3R,Granulocyte colony-stimulating factor receptor,22791,40,2.04 [1.04-3.99],0.0379351438939243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSH1,Chorionic somatomammotropin hormone 1,23469,40,0.55 [0.19-1.57],0.263850002578773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSNK1D,Casein kinase I isoform delta,22791,40,1.44 [0.96-2.15],0.0780369972852491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSNK2A1,Casein kinase II subunit alpha,23420,41,0.89 [0.46-1.72],0.7244894171459142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSPG4,Chondroitin sulfate proteoglycan 4,23449,42,0.90 [0.36-2.21],0.8121037942200964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSPG5,Chondroitin sulfate proteoglycan 5,22691,40,1.08 [0.61-1.93],0.7876125752557656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSRP3,Cysteine and glycine-rich protein 3,22720,41,1.35 [1.07-1.70],0.0125464823110527
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST1,Cystatin-SN,20326,33,0.90 [0.64-1.27],0.5447012076499333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST3,Cystatin-C,26934,59,2.92 [1.44-5.90],0.0028536601133848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST5,Cystatin-D,26436,58,1.01 [0.67-1.54],0.94966259767661
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST6,Cystatin-M,26180,58,0.80 [0.49-1.30],0.3724799335832868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST7,Cystatin-F,26933,58,1.18 [0.98-1.43],0.0884915542331133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSTB,Cystatin-B,26512,57,2.96 [1.93-4.53],6.192063639491866e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTAG1A_CTAG1B,Cancer/testis antigen 1,22970,42,0.65 [0.35-1.22],0.1803866360801877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTBS,Di-N-acetylchitobiase,23129,39,1.14 [0.35-3.68],0.8315312803367283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTF1,Cardiotrophin-1,26386,58,1.11 [0.85-1.46],0.4345495408452975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTHRC1,Collagen triple helix repeat-containing protein 1,23449,42,1.28 [0.47-3.46],0.6234025857434462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTLA4,Cytotoxic T-lymphocyte protein 4,23449,42,0.97 [0.36-2.60],0.951497649866838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTNNA1,Catenin alpha-1,22691,40,0.38 [0.11-1.29],0.1208251131111533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRB1,Chymotrypsinogen B,26892,58,0.77 [0.51-1.18],0.22739433589489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRC,Chymotrypsin-C,26896,57,0.70 [0.49-0.99],0.046225622768295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRL,Chymotrypsin-like protease CTRL-1,23402,42,0.72 [0.47-1.09],0.1197432117460046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSB,Cathepsin B,26916,59,1.45 [0.98-2.16],0.0649531028399361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSC,Dipeptidyl peptidase 1,26858,58,1.22 [0.72-2.08],0.4573071019893838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSD,Cathepsin D,25113,55,1.42 [0.85-2.36],0.1785941320164045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSE,Cathepsin E,22952,38,0.94 [0.51-1.72],0.8350257027980064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSF,Cathepsin F,26973,57,0.92 [0.51-1.66],0.7730721419869682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSH,Pro-cathepsin H,26308,57,1.15 [0.84-1.59],0.3757320524910481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSL,Cathepsin L1,26888,57,3.35 [1.44-7.76],0.0048743288666828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSO,Cathepsin O,27167,58,1.69 [0.81-3.54],0.1652476780932716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSS,Cathepsin S,21096,44,3.79 [1.37-10.50],0.0104228230266473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSV,Cathepsin L2,27030,59,0.56 [0.32-0.99],0.0466787060210749
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSZ,Cathepsin Z,26880,58,2.10 [1.04-4.24],0.0396649492542945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CUZD1,CUB and zona pellucida-like domain-containing protein 1,22801,38,1.33 [0.69-2.57],0.3933053695641202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CWC15,Spliceosome-associated protein CWC15 homolog,23196,40,1.21 [0.79-1.86],0.3796894925868239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CX3CL1,Fractalkine,26703,58,1.84 [0.97-3.49],0.0612787477220752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXADR,Coxsackievirus and adenovirus receptor,26837,59,1.38 [0.95-2.02],0.0952177733537145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL1,Growth-regulated alpha protein,26852,58,1.10 [0.88-1.37],0.4133348999982469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL10,C-X-C motif chemokine 10,27019,58,1.59 [1.23-2.06],0.0004597933697694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL11,C-X-C motif chemokine 11,27122,59,1.37 [1.10-1.71],0.0052311852717901
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL12,Stromal cell-derived factor 1,26345,55,1.45 [0.83-2.50],0.1890087640228815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL13,C-X-C motif chemokine 13,27122,59,1.50 [1.23-1.82],6.071843890874351e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL14,C-X-C motif chemokine 14,26345,55,1.09 [0.76-1.58],0.6339784606810214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL16,C-X-C motif chemokine 16,27170,59,2.36 [0.93-5.98],0.0697747219826686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL17,C-X-C motif chemokine 17,27167,58,1.81 [1.09-2.99],0.0217041149396218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL3,C-X-C motif chemokine 3,26890,58,1.11 [0.86-1.43],0.4247575133262377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL5,C-X-C motif chemokine 5,26801,57,1.03 [0.84-1.26],0.7700760604349031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL6,C-X-C motif chemokine 6,27167,58,1.29 [0.97-1.71],0.0830048843135799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL8,Interleukin-8,26656,59,1.37 [1.08-1.73],0.0093555842922529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL9,C-X-C motif chemokine 9,27019,58,1.68 [1.30-2.18],8.16660218697369e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYB5A,Cytochrome b5,22605,39,1.08 [0.73-1.60],0.695119360891742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYB5R2,NADH-cytochrome b5 reductase 2,23050,41,1.35 [0.82-2.20],0.2348786519122342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",22720,41,0.88 [0.59-1.32],0.5485961400172774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYTH3,Cytohesin-3,22605,39,1.30 [0.93-1.82],0.1227626423900737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYTL1,Cytokine-like protein 1,23449,42,0.59 [0.17-2.02],0.4019138313461872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAAM1,Disheveled-associated activator of morphogenesis 1,22952,38,1.25 [0.87-1.81],0.2222565148874334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAB2,Disabled homolog 2,27107,59,1.04 [0.85-1.28],0.7014028077540615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAG1,Dystroglycan,27019,58,1.34 [0.82-2.19],0.2413670482406382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAND5,DAN domain family member 5,22791,40,1.60 [1.19-2.15],0.0019631768404931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAPK2,Death-associated protein kinase 2,22791,40,1.46 [0.97-2.20],0.0717860478192261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,26837,59,0.98 [0.81-1.18],0.7937255339807036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DARS1,"Aspartate--tRNA ligase, cytoplasmic",26653,58,1.11 [0.81-1.53],0.514140413196984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBH,Dopamine beta-hydroxylase,23427,40,1.00 [0.75-1.33],0.9926960769704926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBI,Acyl-CoA-binding protein,26762,57,1.27 [0.94-1.71],0.1141728868563037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBN1,Drebrin,22791,40,1.81 [1.09-3.01],0.0212587745444611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBNL,Drebrin-like protein,27019,58,1.07 [0.83-1.38],0.5924345414232963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",26973,57,1.47 [0.76-2.86],0.2562535303438195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCC,Netrin receptor DCC,22801,38,0.92 [0.23-3.74],0.9063205785558276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCDC2C,Doublecortin domain-containing protein 2C,22605,39,0.81 [0.47-1.39],0.4467341025577251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCLRE1C,Protein artemis,22605,39,0.69 [0.24-1.96],0.4854710968046646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCN,Decorin,26386,58,1.69 [0.65-4.41],0.2823287516850653
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTD,Deoxycytidylate deaminase,22952,38,1.02 [0.73-1.41],0.9265251988927632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN1,Dynactin subunit 1,27107,59,1.05 [0.74-1.48],0.7974217493229332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN2,Dynactin subunit 2,26762,58,1.07 [0.84-1.37],0.5674362055776648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN6,Dynactin subunit 6,26221,58,1.11 [0.82-1.49],0.4950128308703188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTPP1,dCTP pyrophosphatase 1,26888,57,1.53 [0.73-3.22],0.2604802958566778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCUN1D1,DCN1-like protein 1,22691,40,1.20 [0.86-1.68],0.2797239237897268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCUN1D2,DCN1-like protein 2,22605,39,0.97 [0.66-1.43],0.8666660943483142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCXR,L-xylulose reductase,26973,57,1.13 [0.73-1.74],0.5942100199576237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDA1,DET1- and DDB1-associated protein 1,22720,41,1.18 [0.62-2.24],0.6124751578721478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",26762,58,1.60 [1.02-2.51],0.0427913468690223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDC,Aromatic-L-amino-acid decarboxylase,26845,57,1.06 [0.65-1.72],0.8072788115048872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDHD2,Phospholipase DDHD2,23420,41,1.11 [0.71-1.75],0.6378973509413302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDI2,Protein DDI1 homolog 2,22952,38,1.44 [1.01-2.06],0.0468351498043521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDR1,Epithelial discoidin domain-containing receptor 1,27122,59,2.90 [1.16-7.24],0.0225323444939146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDT,D-dopachrome decarboxylase,23449,42,1.36 [0.73-2.55],0.3373015922039991
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX1,ATP-dependent RNA helicase DDX1,23331,41,1.12 [0.65-1.92],0.6929895827518798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX25,ATP-dependent RNA helicase DDX25,22801,38,0.71 [0.28-1.79],0.4624683017742205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX39A,ATP-dependent RNA helicase DDX39A,22791,40,1.11 [0.29-4.27],0.8816728035517969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX4,Probable ATP-dependent RNA helicase DDX4,22791,40,1.08 [0.65-1.82],0.7599317336615735
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX53,Probable ATP-dependent RNA helicase DDX53,22801,38,0.91 [0.37-2.24],0.8441837107440584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX58,Antiviral innate immune response receptor RIG-I,26244,55,1.38 [1.01-1.90],0.0454342338028325
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",26837,59,1.07 [0.84-1.35],0.6045492171710263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFA1_DEFA1B,Neutrophil defensin 1,26335,59,1.54 [1.11-2.12],0.0088525483206722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB103A_DEFB103B,Beta-defensin 103,22622,39,1.06 [0.50-2.22],0.8826990136608257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB104A_DEFB104B,Beta-defensin 104,22691,40,0.78 [0.41-1.47],0.4347807690965588
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB116,Beta-defensin 116,22691,40,0.93 [0.62-1.41],0.7500047844532965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB118,Beta-defensin 118,22691,40,1.16 [0.76-1.76],0.4943208970687097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB4A_DEFB4B,Beta-defensin 4A,26517,58,1.06 [0.91-1.23],0.4720606817091802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DENND2B,DENN domain-containing protein 2B,22720,41,1.44 [0.99-2.11],0.0589780708753029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DENR,Density-regulated protein,22791,40,1.06 [0.63-1.78],0.8294259537559089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DFFA,DNA fragmentation factor subunit alpha,27167,58,1.20 [0.86-1.67],0.2776866998642474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGCR6,Protein DGCR6,22691,40,0.90 [0.43-1.89],0.7810858320869575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGKA,Diacylglycerol kinase alpha,22791,40,1.57 [0.95-2.61],0.0811275429798011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGKZ,Diacylglycerol kinase zeta,26345,55,0.99 [0.49-1.99],0.9696012751955624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHODH,Dihydroorotate dehydrogenase,22720,41,1.20 [0.71-2.04],0.4954231033943815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHPS,Deoxyhypusine synthase,23323,40,1.32 [0.73-2.37],0.3591554802503947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,23402,42,1.38 [0.83-2.28],0.2119931386008288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIABLO,"Diablo homolog, mitochondrial",26802,57,1.05 [0.85-1.30],0.6654739695834084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIPK1C,Divergent protein kinase domain 1C,22801,38,1.36 [0.78-2.36],0.277272865216734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIPK2B,Divergent protein kinase domain 2B,22952,38,0.76 [0.23-2.48],0.6487794008643943
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK1,Dickkopf-related protein 1,27122,59,1.31 [0.89-1.93],0.1776753876043344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK3,Dickkopf-related protein 3,27215,59,1.50 [0.71-3.18],0.2880522870602919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK4,Dickkopf-related protein 4,26663,58,1.40 [0.89-2.21],0.1506022642342258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKKL1,Dickkopf-like protein 1,26762,58,0.96 [0.74-1.23],0.7235265002627389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLG4,Disks large homolog 4,23402,42,1.01 [0.66-1.53],0.9685724698865854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLGAP5,Disks large-associated protein 5,23420,41,0.55 [0.23-1.34],0.1894980314636468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLK1,Protein delta homolog 1,27215,59,0.67 [0.43-1.02],0.0632610619845105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL1,Delta-like protein 1,26973,57,2.46 [1.18-5.12],0.0164756338702733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL4,Delta-like protein 4,22859,42,0.90 [0.58-1.41],0.6439418436467104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DMD,Dystrophin,22859,42,1.48 [1.00-2.17],0.0479473284222051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DMP1,Dentin matrix acidic phosphoprotein 1,22859,42,0.85 [0.56-1.28],0.430550486731601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA1,DnaJ homolog subfamily A member 1,22605,39,0.53 [0.23-1.21],0.1329291894487056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA2,DnaJ homolog subfamily A member 2,27082,58,1.02 [0.77-1.36],0.8690748878438114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA4,DnaJ homolog subfamily A member 4,23402,42,1.03 [0.69-1.55],0.8746243590406251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB1,DnaJ homolog subfamily B member 1,26762,58,1.22 [0.94-1.58],0.1411607148332855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB14,DnaJ homolog subfamily B member 14,23331,41,1.22 [0.78-1.91],0.3758950884963826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB2,DnaJ homolog subfamily B member 2,22952,38,1.22 [0.71-2.12],0.4700520668632155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB6,DnaJ homolog subfamily B member 6,22739,37,1.17 [0.81-1.70],0.4001682034521139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB8,DnaJ homolog subfamily B member 8,26386,58,0.88 [0.57-1.36],0.5677023252773079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC21,DnaJ homolog subfamily C member 21,23402,42,1.07 [0.50-2.29],0.8712187179444029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC6,Putative tyrosine-protein phosphatase auxilin,22859,42,1.11 [0.78-1.57],0.5724867834006953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC9,DnaJ homolog subfamily C member 9,23331,41,1.17 [0.79-1.72],0.430741213880755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNER,Delta and Notch-like epidermal growth factor-related receptor,26848,57,0.66 [0.25-1.71],0.3877647228420725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNLZ,DNL-type zinc finger protein,22691,40,1.02 [0.74-1.39],0.919310885067128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNM1,Dynamin-1,23331,41,1.02 [0.79-1.33],0.8640712927383067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNM3,Dynamin-3,23420,41,1.20 [0.73-1.99],0.4709349144675029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNMBP,Dynamin-binding protein,26703,58,1.24 [0.87-1.78],0.2387981389302456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNPEP,Aspartyl aminopeptidase,23402,42,1.34 [0.80-2.24],0.2618060608258072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,26979,58,1.86 [1.24-2.80],0.0029125610407956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOC2B,Double C2-like domain-containing protein beta,22801,38,1.39 [0.72-2.69],0.3260281874947686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOCK9,Dedicator of cytokinesis protein 9,22691,40,0.99 [0.77-1.28],0.936199917066844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOK1,Docking protein 1,23402,42,1.01 [0.81-1.26],0.9215091488682102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOK2,Docking protein 2,26888,57,1.02 [0.84-1.24],0.8444106948685421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPEP1,Dipeptidase 1,26653,58,0.92 [0.59-1.43],0.7039633018064594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPEP2,Dipeptidase 2,26762,58,2.43 [1.13-5.27],0.0237795583052214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP10,Inactive dipeptidyl peptidase 10,26837,59,1.43 [0.79-2.61],0.2390485427926611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP4,Dipeptidyl peptidase 4,26369,58,1.34 [0.60-3.03],0.4765981437047244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP6,Dipeptidyl aminopeptidase-like protein 6,26762,58,1.15 [0.57-2.31],0.6989113179321468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP7,Dipeptidyl peptidase 2,26655,57,1.49 [1.00-2.21],0.0485369812823781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPT,Dermatopontin,27215,59,3.07 [1.15-8.20],0.0249437217405432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPY30,Protein dpy-30 homolog,27013,59,1.54 [1.12-2.11],0.0072106472287965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DRAXIN,Draxin,26703,58,1.33 [0.78-2.25],0.2927967587228008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DRG2,Developmentally-regulated GTP-binding protein 2,26762,58,1.09 [0.73-1.64],0.6666088307271958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSC2,Desmocollin-2,26613,58,1.79 [1.02-3.14],0.0407896835888226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSCAM,Down syndrome cell adhesion molecule,23420,41,0.93 [0.40-2.19],0.8695696526960194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG2,Desmoglein-2,26892,58,0.98 [0.41-2.31],0.9556745737795336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG3,Desmoglein-3,27019,59,0.95 [0.48-1.87],0.8778927838702256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG4,Desmoglein-4,26677,58,0.68 [0.44-1.05],0.0853874692825918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTD1,D-aminoacyl-tRNA deacylase 1,22952,38,1.10 [0.77-1.57],0.5982683716419188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTNB,Dystrobrevin beta,23283,40,2.28 [1.32-3.93],0.0031558940670868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX2,Probable E3 ubiquitin-protein ligase DTX2,22801,38,1.20 [0.79-1.83],0.4031066281536105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX3,Probable E3 ubiquitin-protein ligase DTX3,26762,58,2.72 [1.24-5.97],0.0125589723298846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTYMK,Thymidylate kinase,23456,41,1.26 [0.83-1.92],0.2847661272263626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUOX2,Dual oxidase 2,26386,58,1.02 [0.74-1.39],0.914467087587126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP13,Dual specificity protein phosphatase 13 isoform A,23323,40,1.63 [0.95-2.80],0.0763149427198423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP29,Dual specificity phosphatase 29,22801,38,1.13 [0.74-1.73],0.5620092658068199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP3,Dual specificity protein phosphatase 3,26221,58,0.99 [0.75-1.30],0.9261818245941628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",23331,41,1.25 [0.94-1.67],0.1168437983944913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DXO,Decapping and exoribonuclease protein,23402,42,1.15 [0.61-2.18],0.6667823093093657
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,23323,40,1.08 [0.59-1.97],0.8140329886264841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNLT1,Dynein light chain Tctex-type 1,22801,38,0.87 [0.58-1.30],0.4894691885547128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNLT3,Dynein light chain Tctex-type 3,23323,40,0.97 [0.48-1.93],0.925049158811128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,26703,58,1.13 [0.88-1.44],0.3396896249965805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBI3_IL27,Interleukin-27,27059,59,1.64 [0.79-3.38],0.1826547195759293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECE1,Endothelin-converting enzyme 1,26221,58,0.95 [0.49-1.84],0.8845346575560754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",23456,41,1.47 [1.06-2.04],0.0198440600068412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECHS1,"Enoyl-CoA hydratase, mitochondrial",22859,42,1.12 [0.83-1.51],0.448974681658809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECI2,Enoyl-CoA delta isomerase 2,22720,41,1.42 [0.96-2.10],0.0780218834994306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECM1,Extracellular matrix protein 1,22831,40,2.05 [0.81-5.21],0.1296887240043719
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECSCR,Endothelial cell-specific chemotaxis regulator,22691,40,0.69 [0.32-1.50],0.3477193278335385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDA2R,Tumor necrosis factor receptor superfamily member 27,27107,59,2.48 [1.45-4.25],0.0008906078169906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDAR,Tumor necrosis factor receptor superfamily member EDAR,26837,59,1.06 [0.83-1.36],0.6552647379591428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDDM3B,Epididymal secretory protein E3-beta,23323,40,0.70 [0.32-1.52],0.3654988559342949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,22720,41,0.88 [0.37-2.11],0.773843096314031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDF1,Endothelial differentiation-related factor 1,23420,41,1.09 [0.74-1.61],0.6640478809466537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,26386,58,1.67 [0.91-3.07],0.0999302716651412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDN1,Endothelin-1,22859,42,3.09 [1.19-8.04],0.0207859534080084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDNRB,Endothelin receptor type B,22791,40,1.44 [0.96-2.18],0.0788782603739286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EEF1D,Elongation factor 1-delta,23456,41,1.31 [0.96-1.77],0.0843741608134238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFCAB14,EF-hand calcium-binding domain-containing protein 14,23331,41,1.77 [0.72-4.35],0.2113584124583971
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFCAB2,Dynein regulatory complex protein 8,23016,42,1.66 [0.81-3.41],0.166864419225457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,26929,59,2.01 [0.98-4.10],0.0553530359253602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFHD1,EF-hand domain-containing protein D1,23420,41,0.86 [0.35-2.11],0.7451989238056227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA1,Ephrin-A1,26850,57,1.85 [0.84-4.09],0.1279737019080523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA4,Ephrin-A4,26662,58,2.24 [1.19-4.22],0.0128613680231766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNB2,Ephrin-B2,22801,38,1.00 [0.58-1.71],0.9903437733391914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGF,Pro-epidermal growth factor,26849,57,1.04 [0.83-1.30],0.7515487432526744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFL7,Epidermal growth factor-like protein 7,26244,55,1.28 [0.74-2.22],0.377674826950384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFLAM,Pikachurin,23331,41,1.12 [0.44-2.81],0.8133584296346561
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFR,Epidermal growth factor receptor,27215,59,0.54 [0.25-1.16],0.113757766745968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGLN1,Egl nine homolog 1,26837,59,1.36 [1.02-1.82],0.0382630383430268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EHBP1,EH domain-binding protein 1,23456,41,1.26 [0.85-1.85],0.2494776508570382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EHD3,EH domain-containing protein 3,22859,42,1.01 [0.78-1.30],0.9677776531100202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",23402,42,0.80 [0.43-1.50],0.4871587141153123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",23248,41,1.29 [0.99-1.67],0.0607055180350742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,22720,41,1.24 [0.81-1.90],0.3214391846145133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,22859,42,1.02 [0.50-2.10],0.956433552819952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4B,Eukaryotic translation initiation factor 4B,26703,58,1.17 [0.79-1.75],0.4297833484914162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4E,Eukaryotic translation initiation factor 4E,22791,40,1.15 [0.83-1.60],0.4060592668742286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,26888,57,1.54 [1.12-2.12],0.0076464142517161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,27167,58,1.04 [0.83-1.32],0.7181618484165226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,23420,41,1.37 [0.93-2.04],0.1154584903928817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF5,Eukaryotic translation initiation factor 5,22720,41,1.22 [0.68-2.20],0.5078610149571422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF5A,Eukaryotic translation initiation factor 5A-1,26345,55,1.00 [0.43-2.31],0.9978208658840232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELAC1,Zinc phosphodiesterase ELAC protein 1,23420,41,1.08 [0.76-1.54],0.6537159858608159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELAVL4,ELAV-like protein 4,22691,40,1.06 [0.74-1.51],0.7549690981305184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELN,Elastin,23456,41,2.03 [0.93-4.44],0.0768635346485639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELOA,Elongin-A,26762,58,1.35 [0.99-1.84],0.0607680628944862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELOB,Elongin-B,22720,41,1.13 [0.56-2.28],0.7306084612828985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENAH,Protein enabled homolog,26345,55,1.36 [0.83-2.20],0.2183835708024518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENDOU,Poly(U)-specific endoribonuclease,21659,38,0.68 [0.35-1.32],0.2520672264693909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENG,Endoglin,27215,59,3.23 [0.87-11.96],0.0789408487294327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO1,Alpha-enolase,26843,59,1.12 [0.83-1.50],0.4528388089066859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO2,Gamma-enolase,27122,59,1.26 [0.89-1.78],0.1925395404494221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO3,Beta-enolase,22859,42,0.81 [0.46-1.43],0.4723984487917141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENOPH1,Enolase-phosphatase E1,23323,40,0.95 [0.51-1.77],0.8805989438800874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,22720,41,1.96 [0.85-4.49],0.1132830128163369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPEP,Glutamyl aminopeptidase,22720,41,1.32 [0.85-2.07],0.2204713696140295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,27215,59,0.90 [0.41-1.97],0.7957988918746041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,27019,58,1.05 [0.58-1.90],0.8658591199439315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,22859,42,0.72 [0.33-1.60],0.4236797649164491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,26044,56,1.12 [0.85-1.47],0.405837422165297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENSA,Alpha-endosulfine,23323,40,1.47 [0.98-2.21],0.0596812743698976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,26244,55,1.21 [0.72-2.06],0.4737430600303176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,26386,58,1.24 [0.40-3.85],0.708626285583243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,26386,58,1.73 [0.68-4.41],0.2497895687445451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTR1,Endosome-associated-trafficking regulator 1,22859,42,1.65 [1.07-2.52],0.0223516200242602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EP300,Histone acetyltransferase p300,22791,40,1.44 [0.77-2.71],0.2566330654232731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPB41L5,Band 4.1-like protein 5,22801,38,0.94 [0.55-1.58],0.8040562372014499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPCAM,Epithelial cell adhesion molecule,26898,58,0.98 [0.77-1.23],0.829280625926503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPGN,Epigen,23323,40,0.94 [0.46-1.92],0.8631731808150448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA1,Ephrin type-A receptor 1,26979,58,1.27 [0.64-2.53],0.4994428363553465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA10,Ephrin type-A receptor 10,26221,58,1.05 [0.75-1.47],0.7670063833088625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA2,Ephrin type-A receptor 2,25935,55,1.99 [1.21-3.27],0.0064517891627763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA4,Ephrin type-A receptor 4,22952,38,0.44 [0.15-1.27],0.1299992656067587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB4,Ephrin type-B receptor 4,27215,59,2.82 [1.29-6.18],0.0094603504255877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB6,Ephrin type-B receptor 6,26653,58,1.68 [0.82-3.44],0.1560135025612537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHX2,Bifunctional epoxide hydrolase 2,26386,58,0.84 [0.55-1.27],0.4015924136605123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPN1,Epsin-1,23016,42,0.40 [0.15-1.04],0.0604800753811713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPO,Erythropoietin,26837,59,0.91 [0.65-1.27],0.5667904296962629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPPK1,Epiplakin,22859,42,1.41 [0.97-2.03],0.0706145602269138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,27061,59,1.56 [0.76-3.22],0.2235763396414953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB2,Receptor tyrosine-protein kinase erbB-2,26973,57,1.29 [0.48-3.46],0.6109592477557088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB3,Receptor tyrosine-protein kinase erbB-3,26815,58,0.64 [0.18-2.27],0.4889307423273442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB4,Receptor tyrosine-protein kinase erbB-4,26973,57,0.83 [0.31-2.19],0.7075458764688951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBIN,Erbin,26762,58,1.09 [0.87-1.37],0.4620143211702296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERC2,ERC protein 2,22801,38,0.80 [0.48-1.33],0.3835421611923051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERCC1,DNA excision repair protein ERCC-1,22605,39,1.43 [0.77-2.65],0.2626705692304106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EREG,Proepiregulin,26653,58,1.23 [0.94-1.60],0.1341370272975057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERI1,3'-5' exoribonuclease 1,23016,42,0.56 [0.22-1.46],0.2376266615490476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERMAP,Erythroid membrane-associated protein,22791,40,1.36 [0.69-2.66],0.3765922319072243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,23323,40,2.24 [1.41-3.54],0.0006123715923818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERP29,Endoplasmic reticulum resident protein 29,22952,38,1.09 [0.84-1.42],0.5054413995705087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERP44,Endoplasmic reticulum resident protein 44,26715,58,1.38 [0.56-3.40],0.4856984089570132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,22720,41,1.03 [0.53-2.00],0.9225890541363108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESAM,Endothelial cell-selective adhesion molecule,27215,59,1.72 [0.86-3.44],0.1270233093105195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESM1,Endothelial cell-specific molecule 1,26892,58,1.41 [0.72-2.78],0.3154258694831891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESPL1,Separin,22605,39,0.67 [0.34-1.34],0.2590939653726412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESR1,Estrogen receptor,22791,40,1.47 [1.02-2.10],0.0371911282160536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESYT2,Extended synaptotagmin-2,23402,42,1.26 [0.89-1.78],0.1984237541919162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI2B,Protein EVI2B,22605,39,1.23 [0.66-2.31],0.5179573248566323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI5,Ecotropic viral integration site 5 protein homolog,22791,40,1.03 [0.74-1.44],0.8620718584726198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVPL,Envoplakin,23016,42,0.86 [0.34-2.19],0.7589203850909643
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EXOSC10,Exosome component 10,22720,41,1.06 [0.66-1.70],0.8168031102749703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EXTL1,Exostosin-like 1,22720,41,0.79 [0.39-1.59],0.5031368813238273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EZR,Ezrin,27122,59,1.75 [0.71-4.33],0.2245374852086375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F10,Coagulation factor X,23469,40,2.18 [1.13-4.22],0.02022505971043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F11,Coagulation factor XI,23162,41,0.66 [0.22-1.97],0.4510306516864525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F11R,Junctional adhesion molecule A,26892,58,1.39 [0.93-2.06],0.1062207851883038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F12,Coagulation factor XII,23501,41,1.30 [0.63-2.70],0.4804527284864055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F13B,Coagulation factor XIII B chain,23366,41,1.02 [0.31-3.29],0.9787101413051132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F2,Prothrombin,23501,41,2.05 [0.28-15.12],0.4812467142997644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F2R,Proteinase-activated receptor 1,26976,58,1.32 [0.88-1.97],0.1852930735725841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F3,Tissue factor,26946,59,1.01 [0.44-2.28],0.987023725908352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F7,Coagulation factor VII,26933,59,0.82 [0.38-1.76],0.6076206661417742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F9,Coagulation factor IX,26928,59,0.67 [0.19-2.45],0.5481381216513288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP1,"Fatty acid-binding protein, liver",26892,58,1.16 [0.92-1.47],0.2156725291043501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP2,"Fatty acid-binding protein, intestinal",26888,57,1.01 [0.75-1.37],0.946250239602432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP3,"Fatty acid-binding protein, heart",23456,41,1.49 [0.86-2.59],0.1573355282006711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP4,"Fatty acid-binding protein, adipocyte",27215,59,1.35 [0.88-2.09],0.1718330359659297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP5,Fatty acid-binding protein 5,27036,59,1.57 [1.16-2.10],0.0029449288440984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP6,Gastrotropin,26343,57,1.14 [0.78-1.67],0.488936294900698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP9,Fatty acid-binding protein 9,26837,59,0.70 [0.46-1.06],0.0940679389469627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FADD,FAS-associated death domain protein,26888,57,1.15 [0.85-1.56],0.3659277518373242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM13A,Protein FAM13A,23331,41,1.32 [0.86-2.02],0.1980221379551923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM171A2,Protein FAM171A2,23420,41,1.16 [1.00-1.36],0.0549298486204301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM171B,Protein FAM171B,23323,40,1.18 [0.43-3.28],0.7449120703996246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM172A,Cotranscriptional regulator FAM172A,22859,42,0.92 [0.56-1.49],0.729766417986089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM20A,Pseudokinase FAM20A,23456,41,2.14 [0.93-4.89],0.0725863018252771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3B,Protein FAM3B,26762,58,1.11 [0.57-2.16],0.7527438152962452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3C,Protein FAM3C,26845,57,2.33 [1.11-4.92],0.0260954787387762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3D,Protein FAM3D,23331,41,1.16 [0.81-1.65],0.4278941933883483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAP,Prolyl endopeptidase FAP,27215,59,1.00 [0.43-2.35],0.993415539874614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FARSA,Phenylalanine--tRNA ligase alpha subunit,22801,38,0.79 [0.48-1.31],0.3570968389234601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAS,Tumor necrosis factor receptor superfamily member 6,27129,59,1.61 [1.02-2.53],0.0393504469711544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FASLG,Tumor necrosis factor ligand superfamily member 6,27167,58,0.77 [0.42-1.42],0.4071916385036106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBLN2,Fibulin-2,23449,42,1.83 [0.75-4.46],0.1857057350178625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBN2,Fibrillin-2,22801,38,1.28 [0.77-2.12],0.3342116343087713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBP1,"Fructose-1,6-bisphosphatase 1",26888,57,0.87 [0.62-1.21],0.3951511698139892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,23456,41,1.42 [0.96-2.08],0.0755634659452865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCAR,Immunoglobulin alpha Fc receptor,26837,59,1.71 [1.07-2.75],0.0260071668307726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,23420,41,1.74 [0.55-5.52],0.3500349181541379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCER2,Low affinity immunoglobulin epsilon Fc receptor,26892,58,1.16 [0.73-1.84],0.5409485895392615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,26757,59,1.04 [0.70-1.55],0.8406654391823174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,26244,55,1.02 [0.67-1.54],0.9383405606232652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,26889,59,1.16 [0.73-1.84],0.5382931333129026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCN1,Ficolin-1,23427,40,1.39 [0.77-2.52],0.2794028633939264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCN2,Ficolin-2,26755,59,0.87 [0.50-1.50],0.6167983265203623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL1,Fc receptor-like protein 1,26888,57,1.05 [0.62-1.76],0.8634867740945216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL2,Fc receptor-like protein 2,27038,57,1.10 [0.70-1.73],0.6761999949844381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL3,Fc receptor-like protein 3,26345,55,0.83 [0.54-1.28],0.4006854571381314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL5,Fc receptor-like protein 5,26892,58,1.18 [0.79-1.77],0.4097459296160601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL6,Fc receptor-like protein 6,26837,59,0.93 [0.67-1.29],0.658101670738989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRLB,Fc receptor-like B,26244,55,1.37 [1.01-1.87],0.0431499149795296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX1,"Adrenodoxin, mitochondrial",22720,41,1.75 [1.39-2.20],1.9579267411931394e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX2,"Ferredoxin-2, mitochondrial",22720,41,1.36 [0.91-2.04],0.1297848548590138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FEN1,Flap endonuclease 1,26244,55,1.25 [0.96-1.63],0.0959076106265303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FES,Tyrosine-protein kinase Fes/Fps,26244,55,1.07 [0.65-1.76],0.7979722984838854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FETUB,Fetuin-B,26928,59,1.06 [0.52-2.15],0.8662992580322472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGA,Fibrinogen alpha chain,22925,39,1.50 [0.56-4.08],0.4214894067528528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",23420,41,1.17 [0.81-1.69],0.4126144039872801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF12,Fibroblast growth factor 12,22791,40,1.08 [0.61-1.92],0.7925614506384163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF16,Fibroblast growth factor 16,22791,40,1.54 [1.06-2.23],0.0227820370117592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF19,Fibroblast growth factor 19,27019,58,1.24 [0.92-1.67],0.1575803721876455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF2,Fibroblast growth factor 2,26837,59,1.32 [0.96-1.83],0.0892767799139701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF20,Fibroblast growth factor 20,22791,40,1.33 [0.80-2.21],0.2721256154990442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF21,Fibroblast growth factor 21,27059,59,1.23 [1.01-1.49],0.0352579377061725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF23,Fibroblast growth factor 23,27066,59,1.66 [1.26-2.18],0.0003019186621724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF3,Fibroblast growth factor 3,22791,40,1.82 [1.09-3.05],0.0222630703387713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF5,Fibroblast growth factor 5,26345,55,1.80 [0.96-3.38],0.0678205651599548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF6,Fibroblast growth factor 6,22791,40,1.52 [1.10-2.09],0.0106338431815385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF7,Fibroblast growth factor 7,22605,39,1.11 [0.79-1.57],0.5489222428048643
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF9,Fibroblast growth factor 9,22564,39,0.68 [0.35-1.30],0.2427599905089851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP1,Fibroblast growth factor-binding protein 1,26973,57,0.76 [0.37-1.58],0.465098488850469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP2,Fibroblast growth factor-binding protein 2,23449,42,0.87 [0.48-1.57],0.6329082118565803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP3,Fibroblast growth factor-binding protein 3,23402,42,1.69 [0.76-3.78],0.2010362928066683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR2,Fibroblast growth factor receptor 2,26973,57,2.06 [0.74-5.77],0.1674687232027439
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR4,Fibroblast growth factor receptor 4,22952,38,1.07 [0.60-1.90],0.8253163356704497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGL1,Fibrinogen-like protein 1,23469,40,1.66 [1.04-2.66],0.0328328240077546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGR,Tyrosine-protein kinase Fgr,26221,58,1.30 [0.98-1.73],0.0733673521784671
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FH,"Fumarate hydratase, mitochondrial",22691,40,0.88 [0.58-1.34],0.557153915188863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FHIP2A,FHF complex subunit HOOK interacting protein 2A,22720,41,0.89 [0.47-1.68],0.7182368977123029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FHIT,Bis(5'-adenosyl)-triphosphatase,26221,58,1.27 [0.92-1.73],0.1412466111353033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FIS1,Mitochondrial fission 1 protein,26893,58,1.20 [0.89-1.60],0.2273805610008727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,23420,41,1.11 [0.82-1.50],0.50107866883443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,26952,57,1.00 [0.81-1.23],0.9824658980108728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,26703,58,1.45 [0.86-2.44],0.1668242086510078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,26703,58,1.15 [0.90-1.48],0.2689457782573258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,26171,58,1.33 [0.92-1.94],0.1327176668068466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBPL,FK506-binding protein-like,23331,41,1.11 [0.67-1.85],0.6795512031543567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLI1,Friend leukemia integration 1 transcription factor,26244,55,1.19 [0.96-1.46],0.1143373243930566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,26703,58,1.84 [0.83-4.11],0.135739089405681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT1,Vascular endothelial growth factor receptor 1,26719,58,2.87 [1.42-5.82],0.0034581534246624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT3,Receptor-type tyrosine-protein kinase FLT3,26244,55,1.47 [0.84-2.57],0.1800046286827768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT3LG,Fms-related tyrosine kinase 3 ligand,27167,58,1.56 [0.78-3.16],0.2116776293927915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT4,Vascular endothelial growth factor receptor 3,26973,57,1.57 [0.76-3.24],0.2263939484944114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FMNL1,Formin-like protein 1,26221,58,1.35 [1.08-1.70],0.009210658915216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FMR1,Synaptic functional regulator FMR1,26244,55,1.53 [0.78-3.01],0.2159417072485641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FN1,Fibronectin,23501,41,1.08 [0.35-3.30],0.8944107061032962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FNDC1,Fibronectin type III domain-containing protein 1,23402,42,1.30 [0.69-2.48],0.4186109018840246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,23323,40,1.63 [0.86-3.10],0.1359393290793323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLH1,Glutamate carboxypeptidase 2,22791,40,1.26 [1.03-1.55],0.0253608633772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR1,Folate receptor alpha,26846,57,1.40 [0.63-3.11],0.4118237469805323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR2,Folate receptor beta,27122,59,1.71 [0.81-3.63],0.1618512509531222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR3,Folate receptor gamma,26887,57,1.12 [1.01-1.24],0.0367561954583154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOS,Proto-oncogene c-Fos,22564,39,1.45 [0.64-3.31],0.3764144283489404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOSB,Protein fosB,26221,58,1.71 [1.25-2.34],0.0007502906742025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXJ3,Forkhead box protein J3,22791,40,1.23 [0.67-2.26],0.5113633222834078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXO1,Forkhead box protein O1,26837,59,1.15 [0.88-1.51],0.3038785556556461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXO3,Forkhead box protein O3,26244,55,1.20 [0.95-1.51],0.1357283072016396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRMD4B,FERM domain-containing protein 4B,22720,41,1.12 [0.74-1.70],0.5965677896512722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRMD7,FERM domain-containing protein 7,22801,38,1.20 [0.49-2.93],0.6881070497528092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRZB,Secreted frizzled-related protein 3,26608,58,2.20 [0.85-5.71],0.1043436289756721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSHB,Follitropin subunit beta,22859,42,0.91 [0.58-1.44],0.694327520611738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FST,Follistatin,26976,58,0.84 [0.52-1.34],0.4593809873890643
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL1,Follistatin-related protein 1,22859,42,0.87 [0.23-3.28],0.8378184096511563
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL3,Follistatin-related protein 3,26847,58,2.37 [1.24-4.54],0.0091828493827538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FTCD,Formimidoyltransferase-cyclodeaminase,23362,42,1.03 [0.73-1.44],0.8804581051666979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUCA1,Tissue alpha-L-fucosidase,27060,59,1.04 [0.78-1.38],0.787854289330888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUOM,Fucose mutarotase,22952,38,1.32 [0.83-2.09],0.2380723118592935
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FURIN,Furin,26973,57,1.92 [0.95-3.87],0.0674691318500832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUS,RNA-binding protein FUS,26204,55,1.76 [1.09-2.84],0.0204899014021144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",22967,42,0.60 [0.33-1.09],0.0959288402283955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,27122,59,1.23 [0.75-2.01],0.406148615428216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT8,"Alpha-(1,6)-fucosyltransferase",26703,58,1.22 [0.83-1.78],0.3082091303267741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FXN,"Frataxin, mitochondrial",27107,59,1.26 [0.93-1.71],0.1345622710104882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FXYD5,FXYD domain-containing ion transport regulator 5,26345,55,0.96 [0.66-1.40],0.8506672425912174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FYB1,FYN-binding protein 1,26853,58,1.07 [0.83-1.37],0.6128672866282188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FZD10,Frizzled-10,22801,38,1.20 [0.79-1.81],0.3916473933142257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FZD8,Frizzled-8,22691,40,1.15 [0.61-2.15],0.6630824910291624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAP,Gamma-aminobutyric acid receptor-associated protein,23323,40,1.80 [1.25-2.58],0.0014652921091224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23016,42,0.91 [0.56-1.50],0.7174011670744986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,22691,40,0.58 [0.31-1.12],0.1046454197637655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAD1,Glutamate decarboxylase 1,22605,39,1.09 [0.33-3.58],0.8850816266074323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAD2,Glutamate decarboxylase 2,22791,40,1.32 [0.81-2.16],0.2604414624424457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23016,42,0.76 [0.35-1.65],0.4849654490699857
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,22859,42,1.18 [0.68-2.04],0.5516889753770927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAGE2A,G antigen 2A,22605,39,1.37 [1.03-1.83],0.0307591234798682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAL,Galanin peptides,27019,58,0.75 [0.51-1.09],0.1332581075061579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,26762,58,2.73 [1.27-5.89],0.0104114454940174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,27107,59,1.23 [0.51-2.97],0.6376845761695458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,26345,55,0.97 [0.55-1.73],0.926441395769865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,23456,41,0.47 [0.15-1.43],0.1808752939187634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT7,N-acetylgalactosaminyltransferase 7,26762,58,1.29 [0.43-3.88],0.6471298504380703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAMT,Guanidinoacetate N-methyltransferase,22720,41,1.24 [0.66-2.32],0.5102277815360834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,22456,37,1.52 [0.55-4.15],0.4187699625824466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GART,Trifunctional purine biosynthetic protein adenosine-3,23420,41,1.02 [0.34-3.02],0.97609312541101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS2,Growth arrest-specific protein 2,23016,42,1.00 [0.56-1.77],0.987493603740263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS6,Growth arrest-specific protein 6,27036,59,5.28 [2.22-12.55],0.0001672917880481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GASK1A,Golgi-associated kinase 1A,22720,41,1.39 [0.72-2.68],0.326127997528307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAST,Gastrin,23402,42,1.11 [0.92-1.34],0.2766108628994829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,22605,39,0.41 [0.13-1.32],0.1346131483708221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",22859,42,1.14 [0.79-1.65],0.4955641060680138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBA,Lysosomal acid glucosylceramidase,22801,38,1.41 [0.86-2.33],0.1762385199635138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP1,Guanylate-binding protein 1,23360,42,1.29 [0.84-1.97],0.2417622283890384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP2,Guanylate-binding protein 2,26345,55,0.98 [0.65-1.47],0.920929507124359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP4,Guanylate-binding protein 4,26221,58,0.70 [0.41-1.18],0.1768476855708182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP6,Guanylate-binding protein 6,22720,41,0.86 [0.41-1.80],0.6937915368273504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GC,Vitamin D-binding protein,23501,41,1.09 [0.35-3.39],0.8880519498482725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCC1,GRIP and coiled-coil domain-containing protein 1,23402,42,1.14 [0.86-1.50],0.3514705885847801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCG,Pro-glucagon,26244,55,1.16 [0.97-1.40],0.111035739662276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,22407,36,1.52 [0.94-2.46],0.0886416608775373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCLM,Glutamate--cysteine ligase regulatory subunit,22720,41,1.24 [0.75-2.06],0.4052155147354741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",26762,58,1.73 [0.91-3.30],0.0966494180500684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF15,Growth/differentiation factor 15,27215,59,2.30 [1.63-3.22],1.628671436478583e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF2,Growth/differentiation factor 2,26888,57,2.26 [1.20-4.24],0.0111882850686282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDNF,Glial cell line-derived neurotrophic factor,26221,58,1.07 [0.59-1.95],0.8193651347855324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GET3,ATPase GET3,23456,41,1.22 [0.76-1.94],0.4099761889716076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFAP,Glial fibrillary acidic protein,26204,55,2.05 [1.35-3.11],0.0007287273708198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFER,FAD-linked sulfhydryl oxidase ALR,26244,55,1.40 [0.98-2.00],0.0641441007898168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,26244,55,0.97 [0.79-1.19],0.7908927140431246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA1,GDNF family receptor alpha-1,27059,59,5.18 [2.59-10.34],3.171672510451553e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA2,GDNF family receptor alpha-2,26762,58,1.00 [0.35-2.90],0.9957732411748706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA3,GDNF family receptor alpha-3,26621,58,1.30 [0.59-2.87],0.5088601571014489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRAL,GDNF family receptor alpha-like,22689,41,0.87 [0.53-1.43],0.5847064903684929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGA1,ADP-ribosylation factor-binding protein GGA1,26221,58,0.82 [0.54-1.24],0.3422465907879095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGACT,Gamma-glutamylaminecyclotransferase,23456,41,1.12 [0.74-1.69],0.6032406818909025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGCT,Gamma-glutamylcyclotransferase,23408,41,1.22 [0.67-2.21],0.5226315681792593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGH,Gamma-glutamyl hydrolase,26418,57,1.25 [0.66-2.36],0.4935643057852613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT1,Glutathione hydrolase 1 proenzyme,26850,57,1.70 [1.16-2.52],0.0072041345408047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT5,Glutathione hydrolase 5 proenzyme,26703,58,0.90 [0.32-2.52],0.8483044171853135
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GH1,Somatotropin,26845,57,0.97 [0.84-1.11],0.6317762570806432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GH2,Growth hormone variant,26244,55,0.91 [0.78-1.07],0.2513555559042551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHR,Growth hormone receptor,22952,38,0.62 [0.21-1.87],0.3966222215520558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHRHR,Growth hormone-releasing hormone receptor,26221,58,0.79 [0.47-1.31],0.3555881323418681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHRL,Appetite-regulating hormone,26888,57,1.05 [0.79-1.39],0.7591124144251716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GID8,Glucose-induced degradation protein 8 homolog,23420,41,0.94 [0.36-2.50],0.905650750235344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIGYF2,GRB10-interacting GYF protein 2,23420,41,1.36 [0.94-1.98],0.1007297977057462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIMAP7,GTPase IMAP family member 7,22952,38,0.67 [0.23-1.89],0.4452713715188717
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIMAP8,GTPase IMAP family member 8,22605,39,1.08 [0.61-1.90],0.7884578003324956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIP,Gastric inhibitory polypeptide,22859,42,0.88 [0.52-1.47],0.6166568894383508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC2,PDZ domain-containing protein GIPC2,23402,42,2.31 [0.97-5.54],0.0600586702869038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC3,PDZ domain-containing protein GIPC3,23331,41,1.02 [0.75-1.39],0.8752791113842507
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPR,Gastric inhibitory polypeptide receptor,22791,40,1.06 [0.60-1.85],0.8512715521217324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIT1,ARF GTPase-activating protein GIT1,22791,40,1.09 [0.80-1.49],0.5858549142474139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GJA8,Gap junction alpha-8 protein,22605,39,0.60 [0.33-1.12],0.1092607778103526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GKN1,Gastrokine-1,25705,55,1.04 [0.44-2.45],0.9301464748025382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLA,Alpha-galactosidase A,22904,38,1.84 [0.87-3.93],0.1126486184477953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLB1,Beta-galactosidase,26703,58,1.85 [1.08-3.16],0.0250506180432768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLI2,Zinc finger protein GLI2,22791,40,2.16 [1.29-3.62],0.0034242245204295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLO1,Lactoylglutathione lyase,26386,58,1.84 [1.28-2.65],0.0009539507393233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLOD4,Glyoxalase domain-containing protein 4,26850,58,1.68 [0.88-3.19],0.1139680870875011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLP1R,Glucagon-like peptide 1 receptor,22691,40,1.10 [0.52-2.32],0.799774678254874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLRX,Glutaredoxin-1,26713,57,1.43 [0.97-2.11],0.0709128964437453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",22952,38,1.27 [0.91-1.77],0.1581299048568932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,26221,58,0.52 [0.26-1.02],0.0583660539553624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLYR1,Putative oxidoreductase GLYR1,23323,40,1.23 [0.80-1.89],0.3402874911924764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GM2A,Ganglioside GM2 activator,22883,42,1.11 [0.56-2.23],0.7585848929802845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMFG,Glia maturation factor gamma,23456,41,1.12 [0.74-1.70],0.5814394230512658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMPR,GMP reductase 1,27167,58,1.38 [0.87-2.20],0.1712818310479617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMPR2,GMP reductase 2,22952,38,1.05 [0.66-1.65],0.847328347635722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNAS,Neuroendocrine secretory protein 55,23420,41,0.77 [0.50-1.16],0.2111884178068198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,26244,55,1.29 [0.92-1.81],0.1451558162786394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,22801,38,0.97 [0.52-1.81],0.929668529850633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNLY,Granulysin,26892,58,1.05 [0.67-1.64],0.8326374257452456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNPDA1,Glucosamine-6-phosphate isomerase 1,22859,42,1.29 [0.61-2.74],0.5055378591829645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNPDA2,Glucosamine-6-phosphate isomerase 2,22952,38,1.30 [0.57-2.99],0.5306839950555122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOLGA3,Golgin subfamily A member 3,23420,41,0.98 [0.67-1.44],0.9202214082668212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOLM2,Protein GOLM2,27122,59,1.73 [0.67-4.46],0.2573785847044265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,26837,59,1.02 [0.81-1.28],0.8685727749279767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GORASP2,Golgi reassembly-stacking protein 2,23331,41,1.23 [0.67-2.26],0.5125548178510715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOT1,"Aspartate aminotransferase, cytoplasmic",23449,42,1.88 [1.14-3.08],0.0129609435311179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP1BA,Platelet glycoprotein Ib alpha chain,26753,59,1.03 [0.50-2.09],0.941236707541788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP1BB,Platelet glycoprotein Ib beta chain,22720,41,1.51 [0.97-2.36],0.0673802742072944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,26044,58,1.02 [0.78-1.34],0.8578722850691407
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP5,Platelet glycoprotein V,22952,38,0.86 [0.37-2.00],0.7212040765481913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP6,Platelet glycoprotein VI,26853,58,1.13 [0.86-1.47],0.3768458620873086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPA33,Cell surface A33 antigen,26762,58,0.93 [0.79-1.10],0.3766934129502156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPC1,Glypican-1,27107,59,0.93 [0.43-2.02],0.8533318272876402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPC5,Glypican-5,26703,58,1.22 [0.81-1.85],0.340188512800343
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPD1,Glycerol-3-phosphate dehydrogenase,23323,40,1.80 [1.15-2.84],0.0105709511526365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPHA2,Glycoprotein hormone alpha-2,23331,41,0.56 [0.23-1.36],0.2025127984301014
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPI,Glucose-6-phosphate isomerase,23469,40,1.59 [0.89-2.84],0.1195109071978121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,23331,41,0.90 [0.60-1.36],0.6281597722090712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPKOW,G-patch domain and KOW motifs-containing protein,26221,58,1.26 [0.63-2.52],0.5050502824780365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPNMB,Transmembrane glycoprotein NMB,26154,56,1.76 [0.76-4.08],0.1873185395784573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR101,Probable G-protein coupled receptor 101,22691,40,0.54 [0.26-1.14],0.1050446627941091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR158,Probable G-protein coupled receptor 158,23420,41,1.06 [0.48-2.33],0.8831845212622361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR15L,Protein GPR15L,23331,41,1.72 [1.12-2.64],0.0130959575568532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR37,Prosaposin receptor GPR37,26386,58,1.31 [0.92-1.85],0.1320795160740865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPRC5C,G-protein coupled receptor family C group 5 member C,23323,40,1.69 [1.20-2.39],0.0028268474537131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRAP2,GRB2-related adapter protein 2,26888,57,1.00 [0.83-1.20],0.988331126018552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,23456,41,1.24 [0.79-1.96],0.3527761552814239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRIK2,"Glutamate receptor ionotropic, kainate 2",23420,41,1.64 [1.01-2.67],0.043675165920916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",22691,40,0.89 [0.48-1.63],0.7014281724087695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRK5,G protein-coupled receptor kinase 5,26386,58,0.92 [0.56-1.51],0.7505435668424656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRN,Progranulin,26768,57,2.60 [1.04-6.53],0.0411201429340665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRP,Gastrin-releasing peptide,22859,42,1.19 [0.70-2.01],0.5172025460341929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRPEL1,"GrpE protein homolog 1, mitochondrial",26762,58,1.38 [0.98-1.93],0.0654167515110286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRSF1,G-rich sequence factor 1,22486,39,1.21 [0.85-1.74],0.2939431955969853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSAP,Gamma-secretase-activating protein,26244,55,1.04 [0.79-1.35],0.7929285562083117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSN,Gelsolin,23389,40,0.51 [0.22-1.20],0.1230576199522635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSR,"Glutathione reductase, mitochondrial",23335,40,2.80 [0.76-10.30],0.1213149427880349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTA1,Glutathione S-transferase A1,26847,57,0.75 [0.55-1.02],0.066134014263655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTA3,Glutathione S-transferase A3,26244,55,0.71 [0.50-1.01],0.053387594039144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTM4,Glutathione S-transferase Mu 4,22720,41,1.01 [0.67-1.53],0.9611632132258292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTP1,Glutathione S-transferase P,26059,58,0.81 [0.56-1.16],0.2516700867119999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTT2B,Glutathione S-transferase theta-2B,23402,42,0.95 [0.84-1.07],0.3938668313055575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23016,42,1.02 [0.69-1.51],0.9028128329698414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GTPBP2,GTP-binding protein 2,22801,38,1.05 [0.71-1.55],0.7948388522323299
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUCA2A,Guanylin,26768,58,1.43 [0.73-2.79],0.2931424408798649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUCY2C,Heat-stable enterotoxin receptor,23016,42,1.23 [0.92-1.64],0.155661401776836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUK1,Guanylate kinase,22720,41,1.19 [0.57-2.49],0.6354373740852255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUSB,Beta-glucuronidase,27014,59,1.32 [0.92-1.88],0.12763550697147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GYS1,"Glycogen [starch] synthase, muscle",26386,58,1.19 [0.93-1.53],0.1595013971243577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMA,Granzyme A,27167,58,1.01 [0.53-1.92],0.98124756658393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMB,Granzyme B,26837,59,1.23 [0.90-1.67],0.1932774204410197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMH,Granzyme H,26386,58,1.16 [0.88-1.51],0.2961488906566613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,H2AP,Huntingtin-interacting protein M,22605,39,1.03 [0.56-1.87],0.9336272933330804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",22720,41,1.13 [0.77-1.66],0.5296012800862192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",27022,59,1.22 [0.91-1.64],0.182969779933089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAO1,Hydroxyacid oxidase 1,27107,59,1.14 [0.96-1.34],0.1317627134427187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HARS1,"Histidine--tRNA ligase, cytoplasmic",26892,58,1.18 [0.87-1.60],0.2776083901109994
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR1,Hepatitis A virus cellular receptor 1,27070,59,1.49 [1.06-2.10],0.0214361476322233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR2,Hepatitis A virus cellular receptor 2,26892,58,2.46 [1.40-4.34],0.0018143547483086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBEGF,Proheparin-binding EGF-like growth factor,27022,59,1.08 [0.79-1.47],0.6486930218144753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBQ1,Hemoglobin subunit theta-1,27107,59,1.36 [0.96-1.94],0.0842752539264256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBZ,Hemoglobin subunit zeta,23456,41,0.98 [0.74-1.30],0.9017657931295766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HCG22,Protein PBMUCL2,22720,41,1.21 [0.82-1.77],0.3381446302933367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HCLS1,Hematopoietic lineage cell-specific protein,27167,58,1.38 [0.90-2.12],0.1392692556604235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDAC8,Histone deacetylase 8,22791,40,1.33 [0.92-1.94],0.1306985234871515
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDAC9,Histone deacetylase 9,22691,40,0.61 [0.31-1.19],0.1456989993325981
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDDC2,5'-deoxynucleotidase HDDC2,23331,41,1.56 [0.84-2.88],0.1560512170384919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGF,Hepatoma-derived growth factor,27074,59,1.38 [1.09-1.75],0.007629632473436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGFL2,Hepatoma-derived growth factor-related protein 2,23402,42,0.98 [0.61-1.57],0.9413998916962604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEBP1,Heme-binding protein 1,26386,58,0.85 [0.54-1.34],0.4843469666087369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEG1,Protein HEG homolog 1,22952,38,2.36 [0.74-7.47],0.145052443841136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEPACAM2,HEPACAM family member 2,23402,42,1.02 [0.49-2.09],0.9675174016498134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEPH,Hephaestin,23456,41,1.13 [0.35-3.66],0.8408055456469019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEXIM1,Protein HEXIM1,26837,59,1.13 [0.85-1.50],0.3880865408291456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGF,Hepatocyte growth factor,27167,58,2.76 [1.58-4.83],0.0003698825468745
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGFAC,Hepatocyte growth factor activator,23240,39,0.64 [0.32-1.29],0.2079366818133059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,26244,55,1.23 [0.92-1.64],0.1700284588662095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HHEX,Hematopoietically-expressed homeobox protein HHEX,23402,42,1.52 [1.04-2.22],0.0309985466627776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIF1A,Hypoxia-inducible factor 1-alpha,22791,40,1.17 [0.81-1.69],0.3932041097665248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIP1,Huntingtin-interacting protein 1,22720,41,1.44 [0.71-2.93],0.3168902057177324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIP1R,Huntingtin-interacting protein 1-related protein,23359,42,1.71 [1.14-2.56],0.0100227349229266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HJV,Hemojuvelin,23420,41,0.98 [0.50-1.94],0.9649723884491148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HK2,Hexokinase-2,26386,58,0.99 [0.43-2.27],0.9747743530573296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",23420,41,1.74 [0.69-4.39],0.238476153461003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",26759,58,0.81 [0.42-1.53],0.5116468833343673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",26837,59,1.39 [0.65-3.00],0.3942388832867123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMBS,Porphobilinogen deaminase,27107,59,1.79 [1.07-2.97],0.0258413561059321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMCN2,Hemicentin-2,22911,38,1.32 [0.75-2.31],0.3334187699211293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",22859,42,1.14 [0.65-2.01],0.6527447127861116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",22720,41,0.56 [0.26-1.24],0.15529828334121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMMR,Hyaluronan mediated motility receptor,22566,39,0.99 [0.53-1.86],0.984815186209278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMOX1,Heme oxygenase 1,26581,57,0.98 [0.59-1.62],0.9383660943898376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMOX2,Heme oxygenase 2,26221,58,1.50 [1.00-2.25],0.0479324637330927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNF1A,Hepatocyte nuclear factor 1-alpha,22801,38,0.81 [0.47-1.40],0.4531414078043918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNMT,Histamine N-methyltransferase,26571,58,1.17 [0.72-1.90],0.5224203577705305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,26304,58,1.26 [0.95-1.67],0.1127273945777551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,23420,41,1.32 [0.77-2.26],0.3142538295448157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPCAL1,Hippocalcin-like protein 1,27167,58,1.12 [0.81-1.55],0.4893330680619133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPGDS,Hematopoietic prostaglandin D synthase,26244,55,0.58 [0.30-1.12],0.1059797648439846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPSE,Heparanase,23132,42,1.10 [0.80-1.52],0.5441346073309059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRAS,GTPase Hras,22972,42,1.16 [0.93-1.45],0.1906800127347879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,22859,42,1.08 [0.52-2.25],0.8313165949814092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRG,Histidine-rich glycoprotein,23366,41,0.47 [0.19-1.18],0.1066912266358237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS1BP3,HCLS1-binding protein 3,22859,42,1.11 [0.79-1.55],0.5498119306493408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,26762,58,0.91 [0.50-1.68],0.774446063451989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,27107,59,1.33 [0.72-2.47],0.3616492129569723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,22791,40,2.00 [0.82-4.87],0.1274756557168153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSBP1,Heat shock factor-binding protein 1,22859,42,1.14 [0.83-1.55],0.421043577388193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,26837,59,1.64 [0.92-2.94],0.0933325814056001
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,23402,42,1.37 [0.88-2.14],0.1656085869010957
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD17B3,Testosterone 17-beta-dehydrogenase 3,22720,41,0.90 [0.47-1.71],0.7376853564504503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,22859,42,1.30 [0.72-2.33],0.3869189317906185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSP90B1,Endoplasmin,26090,57,1.01 [0.71-1.44],0.9555925497299304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPA1A,Heat shock 70 kDa protein 1A,26979,58,1.41 [1.04-1.90],0.0246485082852979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPA2,Heat shock-related 70 kDa protein 2,23323,40,1.45 [0.65-3.22],0.3660043217445247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB1,Heat shock protein beta-1,26451,57,0.87 [0.63-1.22],0.4299201224796323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB6,Heat shock protein beta-6,27107,59,2.12 [1.21-3.69],0.0084016198183852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,26663,59,1.73 [0.77-3.91],0.1850930065832958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1A,5-hydroxytryptamine receptor 1A,22691,40,1.09 [0.78-1.53],0.6083851823419828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1B,5-hydroxytryptamine receptor 1B,22691,40,0.69 [0.30-1.57],0.3730212581528351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTRA2,"Serine protease HTRA2, mitochondrial",26973,57,1.27 [0.87-1.83],0.2115573982800221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HYAL1,Hyaluronidase-1,26709,59,2.98 [1.35-6.56],0.0066956171969984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HYOU1,Hypoxia up-regulated protein 1,27215,59,0.72 [0.26-2.03],0.5352797517465486
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICA1,Islet cell autoantigen 1,26345,55,0.91 [0.67-1.24],0.5599191869609045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM1,Intercellular adhesion molecule 1,26758,59,2.15 [1.04-4.44],0.0385916799807409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM2,Intercellular adhesion molecule 2,27215,59,2.17 [1.04-4.54],0.0394767856926521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM3,Intercellular adhesion molecule 3,27215,59,3.15 [1.42-7.00],0.004912376742474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM4,Intercellular adhesion molecule 4,26837,59,1.17 [0.75-1.82],0.5010778466166333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM5,Intercellular adhesion molecule 5,26888,57,1.04 [0.61-1.77],0.893741409788665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICOSLG,ICOS ligand,26762,58,1.22 [0.36-4.11],0.7495814001938949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ID4,DNA-binding protein inhibitor ID-4,23016,42,1.16 [0.66-2.05],0.6064153568545543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDI2,Isopentenyl-diphosphate delta-isomerase 2,26221,58,0.86 [0.51-1.45],0.5708556755903762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDO1,"Indoleamine 2,3-dioxygenase 1",22859,42,1.60 [1.16-2.21],0.004100705740903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDS,Iduronate 2-sulfatase,27167,58,0.71 [0.05-9.98],0.8001920495668186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDUA,Alpha-L-iduronidase,27107,59,2.53 [1.47-4.35],0.0007946445215853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,22756,41,3.00 [1.77-5.10],4.4452616893619216e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23016,42,0.82 [0.45-1.48],0.5112431872975256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23016,42,1.78 [1.00-3.20],0.0517849578082449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNAR1,Interferon alpha/beta receptor 1,23331,41,1.50 [0.55-4.09],0.4266853210605776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNG,Interferon gamma,26345,55,1.14 [0.92-1.41],0.2280673730664459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR1,Interferon gamma receptor 1,27019,58,2.32 [0.79-6.82],0.1273591010645534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR2,Interferon gamma receptor 2,26703,58,0.86 [0.54-1.36],0.508636889363971
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNL1,Interferon lambda-1,26221,58,1.22 [0.74-2.01],0.4379440332472492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNL2,Interferon lambda-2,22691,40,0.86 [0.50-1.49],0.600902323235891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNLR1,Interferon lambda receptor 1,26837,59,0.94 [0.50-1.79],0.8584625607390344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNW1,Interferon omega-1,22720,41,0.85 [0.34-2.08],0.7137767389755787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFT20,Intraflagellar transport protein 20 homolog,22801,38,1.72 [0.95-3.10],0.0721968042214478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGBP1,Immunoglobulin-binding protein 1,23420,41,1.31 [0.83-2.08],0.2440054738340392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,22691,40,1.28 [0.80-2.05],0.3094744123636611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,23449,42,2.04 [0.66-6.28],0.214894823729716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF1R,Insulin-like growth factor 1 receptor,26762,58,1.38 [0.51-3.77],0.5256013219742512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,22720,41,0.79 [0.37-1.69],0.544403608360136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF2R,Cation-independent mannose-6-phosphate receptor,26892,58,1.56 [0.56-4.33],0.3901043111273325
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP1,Insulin-like growth factor-binding protein 1,27166,59,1.07 [0.88-1.31],0.4803470443379132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP2,Insulin-like growth factor-binding protein 2,27170,59,1.66 [1.14-2.42],0.0087175951361953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP3,Insulin-like growth factor-binding protein 3,26974,59,0.70 [0.32-1.51],0.3655966722004912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP4,Insulin-like growth factor-binding protein 4,26531,56,2.11 [1.36-3.27],0.0008167805550318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP6,Insulin-like growth factor-binding protein 6,26755,59,1.74 [0.86-3.51],0.1242696630505152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP7,Insulin-like growth factor-binding protein 7,27215,59,2.94 [2.10-4.13],4.2656258500433966e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBPL1,Insulin-like growth factor-binding protein-like 1,26888,57,2.55 [1.40-4.63],0.0022172451777413
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFL4,Insulin growth factor-like family member 4,22791,40,1.06 [0.73-1.52],0.7701051848608508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGHMBP2,DNA-binding protein SMUBP-2,22720,41,1.35 [0.85-2.15],0.2093421093888704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLC2,Immunoglobulin lambda constant 2,23452,41,1.92 [1.14-3.22],0.0137262511848473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLON5,IgLON family member 5,22605,39,1.12 [0.86-1.47],0.4019608134805497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF21,Immunoglobulin superfamily member 21,22859,42,0.49 [0.20-1.21],0.1233033887375174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF3,Immunoglobulin superfamily member 3,26762,58,2.06 [1.27-3.35],0.0034935553685442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF8,Immunoglobulin superfamily member 8,26888,57,1.46 [0.68-3.14],0.3367483292387379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF9,Protein turtle homolog A,23456,41,1.25 [0.88-1.78],0.2181186532557695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IKBKG,NF-kappa-B essential modulator,26837,59,1.00 [0.78-1.29],0.9821783120286846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IKZF2,Zinc finger protein Helios,26244,55,1.00 [0.76-1.32],0.9892849465659304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10,Interleukin-10,26345,55,1.14 [0.90-1.44],0.2782292667755816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10RA,Interleukin-10 receptor subunit alpha,26345,55,0.83 [0.51-1.35],0.4583806033400981
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10RB,Interleukin-10 receptor subunit beta,27019,58,1.03 [0.46-2.29],0.9451073589821888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL11,Interleukin-11,26345,55,1.00 [0.70-1.45],0.9801293412111602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12A_IL12B,Interleukin-12,26762,58,1.42 [1.10-1.85],0.0077325345282841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12B,Interleukin-12 subunit beta,27167,58,1.54 [1.03-2.31],0.0371917084147864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12RB1,Interleukin-12 receptor subunit beta-1,26345,55,1.32 [0.72-2.42],0.3713024494655673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12RB2,Interleukin-12 receptor subunit beta-2,22791,40,1.70 [0.99-2.93],0.0561777846052977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13,Interleukin-13,26345,55,1.14 [0.75-1.74],0.5282292655087808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13RA1,Interleukin-13 receptor subunit alpha-1,26553,57,0.38 [0.12-1.19],0.0966191508736335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13RA2,Interleukin-13 receptor subunit alpha-2,22691,40,1.04 [0.37-2.94],0.9402093278802472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15,Interleukin-15,26837,59,1.98 [1.09-3.59],0.0250643091331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15RA,Interleukin-15 receptor subunit alpha,26345,55,1.67 [0.85-3.30],0.1365455875844474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL16,Pro-interleukin-16,27167,58,1.19 [0.70-2.00],0.5213396257204688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17A,Interleukin-17A,26316,55,1.06 [0.63-1.80],0.8139496936263487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17C,Interleukin-17C,26345,55,1.18 [0.88-1.58],0.2653892193357058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17D,Interleukin-17D,26345,55,1.61 [0.99-2.62],0.0533574784216529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17F,Interleukin-17F,26345,55,0.86 [0.61-1.22],0.3934399580354631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17RA,Interleukin-17 receptor A,26892,58,0.86 [0.51-1.45],0.5771494399410191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17RB,Interleukin-17 receptor B,26495,59,1.08 [0.70-1.68],0.721307506940343
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18,Interleukin-18,26806,58,1.57 [1.02-2.41],0.0386301314951115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18BP,Interleukin-18-binding protein,26974,59,1.94 [1.00-3.78],0.0501295463655679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18R1,Interleukin-18 receptor 1,27167,58,2.01 [1.02-3.95],0.0427522049528685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18RAP,Interleukin-18 receptor accessory protein,26537,58,1.09 [0.97-1.23],0.1630962788870281
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL19,Interleukin-19,26212,56,1.21 [0.88-1.66],0.2419200166424853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1A,Interleukin-1 alpha,26345,55,1.05 [0.71-1.56],0.7949602028518314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1B,Interleukin-1 beta,26216,55,1.33 [0.93-1.90],0.1132633607764766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R1,Interleukin-1 receptor type 1,26850,57,2.10 [0.79-5.59],0.1387031686161003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R2,Interleukin-1 receptor type 2,26851,58,1.33 [0.40-4.37],0.6412785691539123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RAP,Interleukin-1 receptor accessory protein,26892,58,0.91 [0.53-1.56],0.7330395541642125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RL1,Interleukin-1 receptor-like 1,27129,59,1.32 [0.79-2.22],0.2843083474630499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RL2,Interleukin-1 receptor-like 2,26345,55,1.19 [0.63-2.24],0.596780329564056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RN,Interleukin-1 receptor antagonist protein,26845,58,1.58 [1.14-2.19],0.0059369374524607
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2,Interleukin-2,26345,55,1.18 [0.55-2.51],0.6759882992394098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20,Interleukin-20,26345,55,1.47 [1.12-1.92],0.0051194889687953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20RA,Interleukin-20 receptor subunit alpha,26345,55,0.62 [0.31-1.23],0.1675089328793477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20RB,Interleukin-20 receptor subunit beta,22791,40,0.74 [0.35-1.57],0.4374253282118198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL21R,Interleukin-21 receptor,22791,40,1.16 [0.72-1.85],0.5426411292195412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL22,Interleukin-22,23323,40,1.32 [0.90-1.93],0.1577263408421456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL22RA1,Interleukin-22 receptor subunit alpha-1,26345,55,0.75 [0.40-1.43],0.3863340812090201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL24,Interleukin-24,26345,55,1.10 [0.71-1.70],0.6608121707976302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL25,Interleukin-25,22529,39,0.74 [0.31-1.80],0.5107440772057839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RA,Interleukin-2 receptor subunit alpha,26683,59,1.56 [0.91-2.67],0.1024040570659814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RB,Interleukin-2 receptor subunit beta,26345,55,0.73 [0.36-1.48],0.3806606842021065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RG,Cytokine receptor common subunit gamma,23323,40,1.16 [0.64-2.11],0.6223016006899513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL3,Interleukin-3,22605,39,0.80 [0.51-1.28],0.3548608066457184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL31,Interleukin-31,22791,40,1.43 [0.99-2.05],0.0549843709353403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL31RA,Interleukin-31 receptor subunit alpha,22695,40,1.15 [0.54-2.45],0.7212916871926032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL32,Interleukin-32,26837,59,1.68 [1.05-2.69],0.0294802733336925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL33,Interleukin-33,26345,55,1.14 [0.61-2.12],0.6891666367336358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL34,Interleukin-34,26181,58,0.99 [0.52-1.90],0.9787273092655304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36A,Interleukin-36 alpha,22791,40,0.82 [0.44-1.53],0.537561539905822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36G,Interleukin-36 gamma,22699,40,1.43 [1.02-2.00],0.0393238008325914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL3RA,Interleukin-3 receptor subunit alpha,26345,55,0.50 [0.23-1.08],0.0781819179739498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4,Interleukin-4,26345,55,1.00 [0.77-1.30],0.9976224818989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4R,Interleukin-4 receptor subunit alpha,26837,59,2.25 [1.39-3.64],0.0009870883377097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5,Interleukin-5,26345,55,1.19 [1.05-1.35],0.0072082300747149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5RA,Interleukin-5 receptor subunit alpha,26837,59,1.68 [1.15-2.44],0.0068080691939187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6,Interleukin-6,26762,58,1.25 [0.98-1.58],0.0670854942957169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6R,Interleukin-6 receptor subunit alpha,26707,59,2.27 [1.17-4.42],0.0153595349967008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6ST,Interleukin-6 receptor subunit beta,26888,57,2.43 [0.66-8.95],0.1821554135353273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL7,Interleukin-7,26837,59,1.12 [0.79-1.59],0.5361909536349359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL7R,Interleukin-7 receptor subunit alpha,26892,58,0.63 [0.42-0.96],0.0334429098251574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL9,Interleukin-9,23016,42,0.61 [0.30-1.24],0.1760461964445615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,26185,58,1.20 [0.82-1.76],0.3421174379431853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMMT,MICOS complex subunit MIC60,23323,40,1.65 [1.04-2.63],0.0330757021592476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPA1,Inositol monophosphatase 1,26703,58,1.23 [0.85-1.78],0.2786385277108501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPACT,Protein IMPACT,23402,42,1.41 [0.85-2.36],0.183740260643668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPG1,Interphotoreceptor matrix proteoglycan 1,22691,40,0.66 [0.21-2.08],0.4751143204322948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ING1,Inhibitor of growth protein 1,26171,58,1.12 [0.69-1.81],0.6419633331710305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INHBB,Inhibin beta B chain,22952,38,1.69 [0.98-2.93],0.0592499882284402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INHBC,Inhibin beta C chain,26892,58,1.07 [0.61-1.86],0.8200366284687689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP1,Inositol polyphosphate 1-phosphatase,26762,58,1.06 [0.69-1.64],0.7749689767270146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",22859,42,1.07 [0.63-1.80],0.8043767883603992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",23420,41,0.69 [0.31-1.54],0.3608556502856714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",26762,58,1.06 [0.84-1.35],0.6232088242930686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL3,Insulin-like 3,23402,42,0.90 [0.56-1.45],0.6764690258228848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL4,Early placenta insulin-like peptide,23323,40,0.75 [0.37-1.54],0.4375881166945519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL5,Insulin-like peptide INSL5,23331,41,1.11 [0.82-1.50],0.5163055746630105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSR,Insulin receptor,22791,40,3.25 [0.58-18.32],0.1809844296120983
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IPCEF1,Interactor protein for cytohesin exchange factors 1,26662,58,1.04 [0.80-1.35],0.7696640746745382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IQGAP2,Ras GTPase-activating-like protein IQGAP2,26762,58,1.21 [0.80-1.83],0.3722465830220748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",26386,58,1.10 [0.86-1.42],0.4385792164930951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAK1,Interleukin-1 receptor-associated kinase 1,26345,55,1.01 [0.71-1.44],0.970854342904504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAK4,Interleukin-1 receptor-associated kinase 4,26837,59,1.10 [0.88-1.38],0.3861295888371238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,25851,55,1.11 [0.58-2.13],0.7571886963308022
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISM1,Isthmin-1,26837,59,0.74 [0.41-1.35],0.3248380837527986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISM2,Isthmin-2,23449,42,0.87 [0.43-1.76],0.6924143395000141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IST1,IST1 homolog,23170,41,1.17 [0.87-1.58],0.305340167869084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA11,Integrin alpha-11,26837,59,0.47 [0.24-0.92],0.0267700887465502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA2,Integrin alpha-2,22952,38,0.75 [0.30-1.87],0.5436629100742596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA5,Integrin alpha-5,26892,58,1.89 [0.77-4.64],0.1675811871403879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA6,Integrin alpha-6,26837,59,1.56 [1.08-2.24],0.0171340194608381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAL,Integrin alpha-L,22791,40,1.41 [0.68-2.91],0.3587186822603502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAM,Integrin alpha-M,26892,58,0.59 [0.28-1.25],0.1647548701451605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAV,Integrin alpha-V,27107,59,0.82 [0.40-1.67],0.5813243854470211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAX,Integrin alpha-X,23016,42,0.74 [0.39-1.38],0.3397553115778323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1,Integrin beta-1,26842,59,0.91 [0.31-2.68],0.8586214600290746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP1,Integrin beta-1-binding protein 1,26244,55,1.96 [1.24-3.11],0.0040012349428381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP2,Integrin beta-1-binding protein 2,26386,58,1.01 [0.82-1.24],0.9564490015103704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB2,Integrin beta-2,26716,57,1.19 [0.52-2.72],0.6721538250814361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB5,Integrin beta-5,26973,57,1.25 [0.68-2.30],0.470568349414922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB6,Integrin beta-6,26345,55,0.69 [0.31-1.54],0.3693046794866558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB7,Integrin beta-7,27107,59,1.12 [0.68-1.84],0.6561894469413172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGBL1,Integrin beta-like protein 1,23449,42,2.59 [1.40-4.77],0.0023473334281676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,23501,41,1.80 [0.41-7.90],0.4363423560860667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,26974,59,1.59 [0.86-2.94],0.1353086146784652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,23501,41,2.25 [0.88-5.77],0.0918725364390994
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,23323,40,1.52 [0.90-2.57],0.1153853308762149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITM2A,Integral membrane protein 2A,26837,59,1.66 [1.14-2.40],0.0074561865260881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPA,Inosine triphosphate pyrophosphatase,22720,41,1.06 [0.67-1.65],0.8117703186234572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",22859,42,0.98 [0.64-1.51],0.9384818357614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",22691,40,1.16 [0.62-2.18],0.6395938640854963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",26221,58,1.10 [0.70-1.74],0.6785403760685722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IZUMO1,Izumo sperm-egg fusion protein 1,22605,39,0.90 [0.45-1.79],0.7564572905615592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM2,Junctional adhesion molecule B,27122,59,2.45 [1.13-5.28],0.0226554561680913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM3,Junctional adhesion molecule C,22952,38,1.58 [0.93-2.69],0.0929751627700565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JCHAIN,Immunoglobulin J chain,26345,55,1.17 [0.80-1.71],0.4137076259516185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,22605,39,1.38 [0.92-2.07],0.1203513993263083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JPT2,Jupiter microtubule associated homolog 2,23331,41,1.10 [0.78-1.55],0.6014515994100458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JUN,Transcription factor AP-1,26345,55,1.26 [0.87-1.83],0.2272878572665596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,26762,58,1.26 [0.73-2.16],0.4098202909325971
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KAZN,Kazrin,23331,41,1.15 [0.86-1.54],0.3317357405230205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNC4,Potassium voltage-gated channel subfamily C member 4,22691,40,0.78 [0.41-1.49],0.4571422706895941
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNH2,Potassium voltage-gated channel subfamily H member 2,22801,38,0.89 [0.56-1.42],0.6353424559437992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNIP4,Kv channel-interacting protein 4,26221,58,0.52 [0.28-0.97],0.0405703476179306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCTD5,BTB/POZ domain-containing protein KCTD5,22959,41,1.78 [1.16-2.72],0.0078363485804036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KDM3A,Lysine-specific demethylase 3A,22791,40,1.26 [0.98-1.62],0.0727422451229936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KDR,Vascular endothelial growth factor receptor 2,26973,57,0.87 [0.34-2.25],0.7757920126898465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KEL,Kell blood group glycoprotein,26221,58,1.06 [0.55-2.01],0.8653638665394128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KHDC3L,KH domain-containing protein 3,22605,39,0.76 [0.42-1.37],0.3662503001439755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KHK,Ketohexokinase,22859,42,0.93 [0.59-1.49],0.7757128659055443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA0319,Dyslexia-associated protein KIAA0319,23402,42,2.24 [1.14-4.40],0.0190415310723103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA1549,UPF0606 protein KIAA1549,23016,42,0.97 [0.64-1.47],0.8854357678785924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA1549L,UPF0606 protein KIAA1549L,23016,42,0.39 [0.13-1.19],0.0990886428100065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA2013,Uncharacterized protein KIAA2013,23323,40,0.65 [0.30-1.40],0.2687170266534203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF1C,Kinesin-like protein KIF1C,22720,41,1.51 [0.86-2.63],0.1512363996555733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF20B,Kinesin-like protein KIF20B,22691,40,1.30 [0.96-1.75],0.0860651830542628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF22,Kinesin-like protein KIF22,22720,41,1.06 [0.83-1.36],0.6294925278308685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIFBP,KIF-binding protein,26762,58,1.05 [0.79-1.40],0.7278189436121925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,23323,40,1.19 [0.85-1.67],0.3027053554263692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,26244,55,0.98 [0.72-1.32],0.8936547849357679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,23331,41,1.11 [0.94-1.31],0.2328741443227541
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,26244,55,1.05 [0.86-1.27],0.6505242262325328
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,22605,39,0.85 [0.54-1.34],0.4741096527918851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIRREL1,Kin of IRRE-like protein 1,22691,40,1.16 [0.76-1.78],0.5001096241065313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIRREL2,Kin of IRRE-like protein 2,26221,58,0.81 [0.44-1.47],0.4825899211036268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIT,Mast/stem cell growth factor receptor Kit,26928,59,0.55 [0.26-1.17],0.1186904477283369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KITLG,Kit ligand,26888,57,0.66 [0.35-1.22],0.1857327556929721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLB,Beta-klotho,26221,58,0.86 [0.63-1.20],0.3807049537098037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLF4,Krueppel-like factor 4,22691,40,1.98 [1.14-3.44],0.0155389165784105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLHL41,Kelch-like protein 41,23420,41,0.98 [0.50-1.89],0.9428161220779304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK1,Kallikrein-1,26610,56,1.05 [0.88-1.25],0.5821972002366423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK10,Kallikrein-10,26885,56,1.31 [0.76-2.26],0.335835971987572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK11,Kallikrein-11,26715,55,1.16 [0.55-2.43],0.7020209796651489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK12,Kallikrein-12,26244,55,1.08 [0.91-1.28],0.3656935749152673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK13,Kallikrein-13,26297,58,0.78 [0.47-1.30],0.3368274953188858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK14,Kallikrein-14,27107,59,1.37 [0.84-2.21],0.2033879779172681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK15,Kallikrein-15,23286,40,1.42 [0.81-2.48],0.2151078583217304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK3,Prostate-specific antigen,23449,42,0.99 [0.58-1.67],0.9603697349650784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK4,Kallikrein-4,27107,59,1.34 [0.95-1.91],0.0975825100964927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK6,Kallikrein-6,26935,57,0.59 [0.28-1.23],0.1581328544495355
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK7,Kallikrein-7,22340,38,1.05 [0.46-2.39],0.9117955116041224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK8,Kallikrein-8,25997,54,1.08 [0.55-2.10],0.8199260883919871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLKB1,Plasma kallikrein,23029,41,1.19 [0.36-3.97],0.7777075482587333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRB1,Killer cell lectin-like receptor subfamily B member 1,27167,58,1.45 [0.81-2.61],0.2126748792529939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,22691,40,0.79 [0.44-1.44],0.4500337882481964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRD1,Natural killer cells antigen CD94,27167,58,1.27 [0.77-2.09],0.3541599030204614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRF1,Killer cell lectin-like receptor subfamily F member 1,22791,40,1.16 [0.63-2.15],0.6339529545071133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRK1,NKG2-D type II integral membrane protein,23402,42,1.11 [0.58-2.10],0.7557032216151935
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT14,"Keratin, type I cytoskeletal 14",25371,57,0.50 [0.19-1.28],0.1482826577220414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT17,"Keratin, type I cytoskeletal 17",22720,41,1.77 [0.93-3.37],0.0799213833873596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT18,"Keratin, type I cytoskeletal 18",26762,58,1.20 [0.92-1.57],0.1823480907032797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT19,"Keratin, type I cytoskeletal 19",26798,59,1.49 [1.12-1.99],0.0066658817585195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT5,"Keratin, type II cytoskeletal 5",26221,58,0.78 [0.47-1.28],0.3244487055864761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT6C,"Keratin, type II cytoskeletal 6C",22720,41,0.61 [0.23-1.58],0.3070659739982798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT8,"Keratin, type II cytoskeletal 8",22691,40,1.28 [0.97-1.71],0.0861232358882771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KYAT1,Kynurenine--oxoglutarate transaminase 1,26843,57,1.13 [0.76-1.70],0.5392870331994333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KYNU,Kynureninase,27167,58,1.23 [0.75-2.04],0.4136407641496852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,L1CAM,Neural cell adhesion molecule L1,26973,57,0.77 [0.34-1.76],0.5423843020328275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,23456,41,1.23 [0.90-1.70],0.198811039251347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LACRT,Extracellular glycoprotein lacritin,23283,40,0.51 [0.24-1.12],0.0936993446398663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LACTB2,Endoribonuclease LACTB2,26888,57,1.14 [0.80-1.62],0.4587792235536089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAG3,Lymphocyte activation gene 3 protein,26762,58,0.98 [0.55-1.75],0.9409308179402088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,26892,58,2.04 [1.31-3.19],0.0017399966582908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,26703,58,1.10 [0.87-1.38],0.4362837286820176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMA1,Laminin subunit alpha-1,22720,41,1.04 [0.61-1.76],0.8852154531944215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMA4,Laminin subunit alpha-4,27019,58,1.86 [0.96-3.60],0.0667043579847194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMB1,Laminin subunit beta-1,22859,42,0.60 [0.22-1.61],0.3110324425827063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP1,Lysosome-associated membrane glycoprotein 1,22793,41,0.89 [0.28-2.84],0.842248109634216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP2,Lysosome-associated membrane glycoprotein 2,26074,56,6.62 [1.83-23.93],0.0039406731177583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP3,Lysosome-associated membrane glycoprotein 3,27123,58,1.52 [0.99-2.35],0.0568846334445136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMTOR5,Ragulator complex protein LAMTOR5,23323,40,1.21 [0.62-2.33],0.5768582833086535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAP3,Cytosol aminopeptidase,26345,55,1.37 [0.89-2.10],0.1491687860607119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LARP1,La-related protein 1,23323,40,1.35 [0.97-1.90],0.0792774912951254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAT,Linker for activation of T-cells family member 1,27167,58,1.06 [0.78-1.44],0.7232294464899235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAT2,Linker for activation of T-cells family member 2,26762,58,1.04 [0.86-1.26],0.6636851750140939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LATS1,Serine/threonine-protein kinase LATS1,22791,40,1.18 [0.83-1.69],0.3608622787993483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAYN,Layilin,26653,58,1.82 [0.99-3.33],0.0527743547876062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LBP,Lipopolysaccharide-binding protein,26974,59,1.38 [0.94-2.04],0.103054710846784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LBR,Delta(14)-sterol reductase LBR,27122,59,1.32 [1.00-1.73],0.0471711043078919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCAT,Phosphatidylcholine-sterol acyltransferase,23469,40,1.07 [0.27-4.25],0.9278597435391276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCN15,Lipocalin-15,23420,41,0.96 [0.59-1.58],0.8838028618577164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCN2,Neutrophil gelatinase-associated lipocalin,26065,57,1.51 [0.87-2.61],0.1395704804094798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCP1,Plastin-2,23449,42,1.38 [0.78-2.45],0.2739067177762243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LDLR,Low-density lipoprotein receptor,26958,57,1.26 [0.82-1.93],0.2962509132267139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LDLRAP1,Low density lipoprotein receptor adapter protein 1,23420,41,1.24 [0.91-1.69],0.1696011350381282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LECT2,Leukocyte cell-derived chemotaxin-2,23456,41,1.68 [1.14-2.46],0.0082254552742821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEFTY2,Left-right determination factor 2,27059,59,1.15 [0.72-1.85],0.5641126992865004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEG1,Protein LEG1 homolog,22147,37,0.87 [0.54-1.39],0.5550691381934361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LELP1,Late cornified envelope-like proline-rich protein 1,22691,40,0.97 [0.65-1.45],0.878202456137871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEO1,RNA polymerase-associated protein LEO1,23420,41,1.08 [0.48-2.44],0.8546040269079694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEP,Leptin,26888,57,1.04 [0.71-1.52],0.8560823929728428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEPR,Leptin receptor,26888,57,1.17 [0.55-2.50],0.683344766377673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LETM1,Mitochondrial proton/calcium exchanger protein,23420,41,1.54 [0.95-2.50],0.0819681860268672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS1,Galectin-1,26888,57,2.05 [1.11-3.79],0.0213473424118898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS3,Galectin-3,26955,59,1.55 [0.74-3.23],0.2415213295309845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS3BP,Galectin-3-binding protein,23501,41,2.08 [1.13-3.84],0.0191333104933141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS4,Galectin-4,26892,58,1.54 [1.03-2.28],0.034580300946575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS7_LGALS7B,Galectin-7,26800,58,1.48 [0.91-2.40],0.1122644617384728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS8,Galectin-8,27122,59,1.20 [0.83-1.74],0.3383128024188161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS9,Galectin-9,26890,58,2.55 [1.34-4.83],0.0042138234860029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGMN,Legumain,27019,58,2.36 [1.29-4.29],0.005061233869904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LHB,Lutropin subunit beta,26244,55,1.28 [1.03-1.60],0.0254251257137289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,26931,58,1.34 [0.94-1.90],0.1058989538732851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIF,Leukemia inhibitory factor,26221,58,1.09 [0.71-1.68],0.6844022831949668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIFR,Leukemia inhibitory factor receptor,26837,59,1.08 [0.41-2.82],0.8755965555856372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,26892,58,1.38 [0.71-2.70],0.3387030687796982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,23449,42,1.02 [0.82-1.28],0.8289090011478886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,22720,41,1.49 [1.01-2.20],0.0451887378829178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,26845,57,1.61 [0.77-3.36],0.2045184713521115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,23456,41,1.21 [0.80-1.82],0.3573756041607453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,27215,59,1.74 [0.75-4.01],0.1972138853198876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,27084,59,1.85 [0.93-3.69],0.0800557537776576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,26345,55,1.78 [1.07-2.96],0.0271761095117265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,27215,59,0.94 [0.68-1.29],0.6876850375997555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIPF,Gastric triacylglycerol lipase,22859,42,1.22 [0.77-1.94],0.4030192756051947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMNB1,Lamin-B1,23285,41,1.57 [1.15-2.15],0.0043658435574409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMNB2,Lamin-B2,23402,42,1.50 [0.55-4.11],0.4341300731249211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD1,Leiomodin-1,23420,41,1.54 [0.82-2.89],0.1802102564205351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD2,Leiomodin-2,22691,40,0.65 [0.36-1.16],0.1465971516056393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LONP1,"Lon protease homolog, mitochondrial",22859,42,1.09 [0.78-1.54],0.6048827539258692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPA,Apolipoprotein(a),22917,40,1.06 [0.89-1.25],0.5393178902941724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPCAT2,Lysophosphatidylcholine acyltransferase 2,26762,58,1.39 [0.97-1.99],0.0699487973957427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPL,Lipoprotein lipase,26888,57,1.01 [0.60-1.69],0.981318944468911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPO,Lactoperoxidase,26061,57,1.44 [1.00-2.07],0.0478980442596264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPP,Lipoma-preferred partner,22720,41,1.36 [0.87-2.12],0.1765413818844368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,22720,41,1.23 [0.82-1.85],0.3198870639425845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,22801,38,0.98 [0.51-1.90],0.9617139830862051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRG1,Leucine-rich alpha-2-glycoprotein,23501,41,2.04 [0.69-6.05],0.2002901555068043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,27022,59,1.36 [0.69-2.67],0.3748662212692772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,22702,40,2.05 [1.10-3.82],0.0235064042293888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP1,Prolow-density lipoprotein receptor-related protein 1,26762,58,0.91 [0.37-2.22],0.8354879756043674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP11,Low-density lipoprotein receptor-related protein 11,26888,57,1.60 [0.85-3.00],0.142482489830004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP2,Low-density lipoprotein receptor-related protein 2,22801,38,0.57 [0.21-1.52],0.2597710273330841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP2BP,LRP2-binding protein,22801,38,0.99 [0.69-1.41],0.9479193280698128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,27122,59,0.89 [0.58-1.36],0.6006709879135876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC25,Leucine-rich repeat-containing protein 25,26762,58,1.63 [0.93-2.83],0.0869130687674403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC37A2,Leucine-rich repeat-containing protein 37A2,23331,41,2.01 [1.01-3.99],0.0472263793586835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC38,Leucine-rich repeat-containing protein 38,22801,38,0.77 [0.39-1.56],0.4721763725315264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC59,Leucine-rich repeat-containing protein 59,23456,41,1.44 [0.83-2.50],0.1972642422265403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,23323,40,1.55 [0.88-2.74],0.1305589669034694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRN1,Leucine-rich repeat neuronal protein 1,26345,55,0.58 [0.31-1.07],0.0820378536668948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,22801,38,1.46 [0.82-2.61],0.2000659948819569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,23420,41,0.56 [0.17-1.85],0.3406903391481405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSM1,U6 snRNA-associated Sm-like protein LSm1,26244,55,1.15 [0.79-1.67],0.462873188276631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSM8,U6 snRNA-associated Sm-like protein LSm8,23016,42,0.72 [0.45-1.15],0.1729828903144195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSP1,Lymphocyte-specific protein 1,26837,59,1.72 [1.01-2.93],0.044092224271877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTA,Lymphotoxin-alpha,26837,59,0.96 [0.54-1.71],0.8918118247975284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTA4H,Leukotriene A-4 hydrolase,27107,59,0.95 [0.64-1.42],0.8150194660553483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTB,Lymphotoxin-beta,23323,40,0.60 [0.22-1.68],0.3308907394802115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP2,Latent-transforming growth factor beta-binding protein 2,27215,59,2.53 [1.30-4.92],0.0062605544993632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP3,Latent-transforming growth factor beta-binding protein 3,26244,55,1.38 [0.97-1.96],0.0728304662995227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBR,Tumor necrosis factor receptor superfamily member 3,26766,58,1.58 [0.72-3.48],0.2545005489593199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTO1,Protein LTO1 homolog,26345,55,0.81 [0.43-1.52],0.5092382101825009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LUZP2,Leucine zipper protein 2,23323,40,1.16 [0.62-2.18],0.635929919412453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LXN,Latexin,26579,58,1.21 [0.88-1.67],0.2412564996733834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY6D,Lymphocyte antigen 6D,26755,57,1.44 [0.81-2.55],0.2115404121086736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY75,Lymphocyte antigen 75,26837,59,1.11 [0.60-2.04],0.7397398195101809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY9,T-lymphocyte surface antigen Ly-9,26601,57,1.11 [0.50-2.48],0.7984819079609484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY96,Lymphocyte antigen 96,26703,58,2.14 [1.30-3.51],0.0026227707229246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYAR,Cell growth-regulating nucleolar protein,26244,55,1.02 [0.66-1.59],0.928005603361388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYN,Tyrosine-protein kinase Lyn,26762,58,1.09 [0.83-1.44],0.5378021518996148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD1,Ly6/PLAUR domain-containing protein 1,26221,58,1.07 [0.77-1.50],0.6850123835840455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD3,Ly6/PLAUR domain-containing protein 3,26757,56,0.85 [0.42-1.71],0.6407481863083292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD8,Ly6/PLAUR domain-containing protein 8,26244,55,1.26 [0.81-1.96],0.3122192575504998
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPLA2,Acyl-protein thioesterase 2,22691,40,0.85 [0.61-1.20],0.3616848524882062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,22801,38,0.86 [0.61-1.21],0.3833201473221359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,23501,41,0.74 [0.16-3.32],0.6914033153978425
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYZL2,Lysozyme-like protein 2,22605,39,1.00 [0.41-2.43],0.999765575888236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LZTFL1,Leucine zipper transcription factor-like protein 1,22952,38,1.17 [0.76-1.79],0.4797235265213133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,M6PR,Cation-dependent mannose-6-phosphate receptor,22859,42,1.06 [0.53-2.15],0.8607428200365842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,26609,58,1.51 [1.12-2.05],0.0071500392058072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAEA,E3 ubiquitin-protein transferase MAEA,26244,55,0.80 [0.42-1.53],0.4989291411540643
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAG,Myelin-associated glycoprotein,22801,38,1.26 [0.66-2.40],0.4754377687817072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGEA3,Melanoma-associated antigen 3,23016,42,0.83 [0.63-1.10],0.18976021271826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGED1,Melanoma-associated antigen D1,26244,55,1.48 [0.97-2.24],0.0660161579942951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAMDC2,MAM domain-containing protein 2,23456,41,0.63 [0.27-1.49],0.2932577153131398
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAMDC4,Apical endosomal glycoprotein,23323,40,0.88 [0.50-1.56],0.6561230919882075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",22859,42,0.70 [0.21-2.28],0.5526290912149547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAN2B2,Epididymis-specific alpha-mannosidase,23456,41,1.05 [0.63-1.73],0.8561009001745963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",22605,39,1.12 [0.63-2.00],0.7046747670073772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANF,Mesencephalic astrocyte-derived neurotrophic factor,27019,58,1.03 [0.85-1.26],0.7462328538747873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANSC1,MANSC domain-containing protein 1,26973,57,1.75 [0.76-4.05],0.1916664279149057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANSC4,MANSC domain-containing protein 4,22720,41,1.22 [0.81-1.84],0.3431142437321234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,22691,40,0.58 [0.22-1.56],0.2833626453061606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,22720,41,1.00 [0.64-1.57],0.988668696966334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2,Microtubule-associated protein 2,23402,42,1.54 [0.91-2.60],0.1097249543681877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,23331,41,1.21 [0.76-1.90],0.4205840564868833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,26837,59,1.03 [0.82-1.29],0.8035569919907954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,26244,55,1.14 [0.90-1.44],0.285447295993171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,26653,58,1.12 [0.90-1.38],0.3058428480194562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPK13,Mitogen-activated protein kinase 13,22605,39,1.30 [0.71-2.38],0.4015277266643576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPK9,Mitogen-activated protein kinase 9,26837,59,1.17 [0.68-2.02],0.5644675319271926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPKAPK2,MAP kinase-activated protein kinase 2,23016,42,0.94 [0.63-1.41],0.7753835003175555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPRE3,Microtubule-associated protein RP/EB family member 3,22605,39,1.00 [0.80-1.25],0.9903755680849656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPT,Microtubule-associated protein tau,26221,58,1.07 [0.69-1.67],0.7504959544854157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MARCO,Macrophage receptor MARCO,26888,57,1.73 [0.72-4.16],0.2239875755143699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MARS1,"Methionine--tRNA ligase, cytoplasmic",22904,38,1.17 [0.81-1.68],0.4001324291664394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MASP1,Mannan-binding lectin serine protease 1,26653,58,1.94 [0.72-5.28],0.1925411508372606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN2,Matrilin-2,26941,58,3.10 [1.45-6.61],0.0033841875861692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN3,Matrilin-3,26662,58,1.26 [0.61-2.60],0.5351106542680552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAVS,Mitochondrial antiviral-signaling protein,26244,55,1.15 [0.89-1.48],0.2976597478279422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAX,Protein max,26221,58,1.13 [0.91-1.42],0.2677185954689752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MB,Myoglobin,27215,59,1.23 [0.80-1.90],0.3491763638659854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MBL2,Mannose-binding protein C,23161,41,1.06 [0.80-1.41],0.6775487465618601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCAM,Cell surface glycoprotein MUC18,26974,59,0.73 [0.37-1.45],0.3707720706781722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",23420,41,0.73 [0.33-1.61],0.4411238119516668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCEMP1,Mast cell-expressed membrane protein 1,22791,40,1.41 [1.06-1.89],0.0185060989971774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCFD2,Multiple coagulation factor deficiency protein 2,26776,57,1.34 [0.78-2.28],0.2861590945692616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCTS1,Malignant T-cell-amplified sequence 1,23331,41,0.53 [0.14-2.04],0.3541198353355526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,26703,58,1.26 [0.90-1.77],0.1817822078779062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDH1,"Malate dehydrogenase, cytoplasmic",23336,40,1.45 [0.74-2.86],0.2807287188135359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDK,Midkine,26898,57,1.60 [1.23-2.09],0.0005031825407305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDM1,Nuclear protein MDM1,22801,38,1.47 [0.57-3.78],0.4220738086643016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",22859,42,1.12 [0.81-1.54],0.5044082171876656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MED18,Mediator of RNA polymerase II transcription subunit 18,26244,55,1.19 [0.87-1.64],0.268850629204588
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MED21,Mediator of RNA polymerase II transcription subunit 21,22720,41,0.93 [0.49-1.75],0.8110336964682128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF10,Multiple epidermal growth factor-like domains protein 10,26892,58,0.97 [0.51-1.82],0.913754249109422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF11,Multiple epidermal growth factor-like domains protein 11,22720,41,1.73 [0.97-3.10],0.0651988308540631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF9,Multiple epidermal growth factor-like domains protein 9,27129,59,0.55 [0.17-1.77],0.3160313659189831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MELTF,Melanotransferrin,23456,41,1.28 [0.47-3.49],0.6273754017292106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MENT,Protein MENT,22952,38,1.46 [0.35-6.01],0.599496545166887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEP1A,Meprin A subunit alpha,23331,41,1.36 [0.91-2.02],0.1354837088485697
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEP1B,Meprin A subunit beta,26888,57,1.05 [0.86-1.28],0.6520518001469099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEPE,Matrix extracellular phosphoglycoprotein,26892,58,0.54 [0.25-1.16],0.113411907144757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MERTK,Tyrosine-protein kinase Mer,27167,58,3.47 [1.60-7.51],0.0015744535901036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MESD,LRP chaperone MESD,26892,58,1.09 [0.90-1.32],0.3621712394888997
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MET,Hepatocyte growth factor receptor,26957,56,0.67 [0.21-2.09],0.4880640106405918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP1,Methionine aminopeptidase 1,26221,58,1.04 [0.47-2.28],0.9270242069435404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",26837,59,1.09 [0.83-1.44],0.5205708356296619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP2,Methionine aminopeptidase 2,27059,59,1.23 [0.83-1.84],0.3039857625816737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP3,Microfibril-associated glycoprotein 3,26386,58,0.87 [0.53-1.44],0.5874522962280104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP3L,Microfibrillar-associated protein 3-like,22801,38,1.05 [0.67-1.63],0.8438894908154468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP4,Microfibril-associated glycoprotein 4,22952,38,0.97 [0.36-2.61],0.9577983220439318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP5,Microfibrillar-associated protein 5,27215,59,1.25 [0.71-2.21],0.4404776862110257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFGE8,Lactadherin,26892,58,1.24 [0.73-2.11],0.4313203120561886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MGLL,Monoglyceride lipase,26976,58,1.03 [0.79-1.35],0.8134870495309707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MGMT,Methylated-DNA--protein-cysteine methyltransferase,26837,59,1.02 [0.85-1.23],0.8285889626461508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MIA,Melanoma-derived growth regulatory protein,26973,57,1.09 [0.58-2.05],0.7858788056788639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MICALL2,MICAL-like protein 2,22801,38,1.00 [0.63-1.60],0.9872841241446888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,26837,59,1.00 [0.87-1.17],0.9492571127420356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MIF,Macrophage migration inhibitory factor,26853,58,1.38 [0.97-1.95],0.0696151082452705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MILR1,Allergin-1,26345,55,1.48 [0.94-2.33],0.0892568025479032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,23323,40,1.19 [0.89-1.57],0.2387896942621847
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MINK1,Misshapen-like kinase 1,23402,42,1.02 [0.74-1.40],0.902248185211888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MITD1,MIT domain-containing protein 1,26703,58,1.03 [0.81-1.31],0.8177643248943316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MKI67,Proliferation marker protein Ki-67,22791,40,1.68 [1.06-2.65],0.0257933680071457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MLLT1,Protein ENL,22605,39,1.07 [0.70-1.65],0.7429819997789371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MLN,Promotilin,26837,59,1.03 [0.79-1.33],0.8396286826456414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MME,Neprilysin,26762,58,1.25 [0.97-1.62],0.0898567014087451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP1,Interstitial collagenase,25848,56,1.17 [0.89-1.53],0.2521320672776245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP10,Stromelysin-2,26859,58,1.33 [0.92-1.91],0.125404312918688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP12,Macrophage metalloelastase,26887,59,1.24 [0.81-1.90],0.3237356930863275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP13,Collagenase 3,26221,58,1.42 [0.70-2.86],0.3305727204959122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP15,Matrix metalloproteinase-15,23456,41,0.78 [0.37-1.65],0.5202787227919549
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP3,Stromelysin-1,26892,58,0.96 [0.59-1.54],0.856066211330222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP7,Matrilysin,26339,58,2.59 [1.59-4.22],0.0001226634350875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP8,Neutrophil collagenase,27076,59,1.40 [1.04-1.88],0.0272150662142145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP9,Matrix metalloproteinase-9,26850,58,1.57 [1.07-2.31],0.0212625165182021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",22720,41,1.68 [1.05-2.69],0.0289928941380714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MN1,Transcriptional activator MN1,22801,38,0.62 [0.31-1.23],0.1713791551238774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNAT1,CDK-activating kinase assembly factor MAT1,23016,42,1.57 [0.96-2.56],0.0717371909805937
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNDA,Myeloid cell nuclear differentiation antigen,26847,57,1.30 [1.10-1.54],0.0025654287036174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MOCS2,Molybdopterin synthase catalytic subunit,22952,38,1.13 [0.72-1.79],0.5924414230137618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MOG,Myelin-oligodendrocyte glycoprotein,27107,59,0.93 [0.46-1.88],0.8492527828872036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORC3,MORC family CW-type zinc finger protein 3,23402,42,0.94 [0.32-2.75],0.906469256754702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORF4L1,Mortality factor 4-like protein 1,23016,42,1.37 [0.81-2.34],0.240129753125232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORF4L2,Mortality factor 4-like protein 2,22605,39,0.82 [0.33-2.02],0.6622880960859691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORN4,MORN repeat-containing protein 4,22605,39,0.75 [0.46-1.23],0.2582592698855104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPHOSPH8,M-phase phosphoprotein 8,26386,58,1.08 [0.80-1.47],0.6073867751369848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPI,Mannose-6-phosphate isomerase,26762,58,1.22 [0.94-1.60],0.1348195714128773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,26976,58,1.06 [0.78-1.45],0.7018344563170358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPO,Myeloperoxidase,26892,58,1.35 [0.86-2.12],0.1902985699282317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPRIP,Myosin phosphatase Rho-interacting protein,23274,40,1.30 [0.70-2.41],0.4107308130276703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRC1,Macrophage mannose receptor 1,23469,40,2.34 [0.91-6.01],0.0784725876606241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRI1,Methylthioribose-1-phosphate isomerase,22801,38,1.08 [0.68-1.73],0.7362017704383338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL24,"39S ribosomal protein L24, mitochondrial",22720,41,1.01 [0.45-2.24],0.9797849377306164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL28,"39S ribosomal protein L28, mitochondrial",23420,41,0.98 [0.43-2.24],0.960880399052678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL46,"39S ribosomal protein L46, mitochondrial",26221,58,0.97 [0.41-2.27],0.9388792570812056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL52,"39S ribosomal protein L52, mitochondrial",22566,39,2.97 [1.21-7.26],0.0171118279024195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",23420,41,1.37 [1.02-1.84],0.0383216419107847
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPS16,"28S ribosomal protein S16, mitochondrial",22791,40,0.61 [0.17-2.22],0.4510042899111162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSLN,Mesothelin,26721,58,1.20 [0.81-1.77],0.3537561499784086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSLNL,Mesothelin-like protein,22801,38,0.84 [0.35-1.99],0.6858156485322687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSMB,Beta-microseminoprotein,26796,59,1.08 [0.78-1.49],0.6512565856403838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSR1,Macrophage scavenger receptor types I and II,27122,59,1.58 [0.94-2.65],0.0823142022198952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSRA,Mitochondrial peptide methionine sulfoxide reductase,26973,57,1.19 [0.86-1.65],0.2818077496147904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MST1,Hepatocyte growth factor-like protein,23106,39,1.47 [0.74-2.91],0.2719807222997225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSTN,Growth/differentiation factor 8,26386,58,0.55 [0.35-0.87],0.0107738377036883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTDH,Protein LYRIC,22791,40,1.34 [0.98-1.84],0.070539508840539
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",23402,42,0.65 [0.18-2.28],0.4962259536679697
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23016,42,1.16 [0.89-1.51],0.2620604820202101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTIF3,"Translation initiation factor IF-3, mitochondrial",23331,41,1.11 [0.80-1.56],0.5301149871680424
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTPN,Myotrophin,26386,58,0.43 [0.18-1.03],0.0584234603819441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTR,Methionine synthase,22720,41,0.87 [0.52-1.46],0.5995363305167088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTSS1,Protein MTSS 1,23331,41,1.06 [0.81-1.39],0.6586010729444057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTSS2,Protein MTSS 2,23323,40,1.27 [0.94-1.71],0.1223575979975381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTUS1,Microtubule-associated tumor suppressor 1,23016,42,0.98 [0.58-1.66],0.9331131301997068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC13,Mucin-13,26221,58,1.20 [0.76-1.89],0.4374508202036288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC16,Mucin-16,26762,58,0.98 [0.87-1.11],0.7730022734269281
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC2,Mucin-2,23449,42,0.90 [0.65-1.24],0.5206895046898816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUCL3,Mucin-like protein 3,22605,39,0.63 [0.25-1.57],0.316319998246926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MVK,Mevalonate kinase,26345,55,1.01 [0.74-1.38],0.9379271319862638
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MXRA8,Matrix remodeling-associated protein 8,22952,38,0.38 [0.15-0.99],0.0472399432644359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC1,"Myosin-binding protein C, slow-type",23456,41,1.15 [0.74-1.78],0.5267127245949541
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC2,"Myosin-binding protein C, fast-type",22859,42,1.31 [1.03-1.65],0.0255044828526532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,23420,41,1.21 [0.82-1.79],0.3322789913166092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYDGF,Myeloid-derived growth factor,23456,41,1.15 [0.85-1.55],0.3612275584762537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH4,Myosin-4,22720,41,0.70 [0.32-1.57],0.3930183270263658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH7B,Myosin-7B,22605,39,0.95 [0.47-1.91],0.8756056684504239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH9,Myosin-9,23449,42,1.03 [0.79-1.33],0.8450471629364847
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",22720,41,0.87 [0.39-1.96],0.7371615310598622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL3,Myosin light chain 3,22859,42,0.94 [0.61-1.45],0.7766000354033791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL4,Myosin light chain 4,22859,42,1.13 [0.68-1.89],0.6366041574151076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL6B,Myosin light chain 6B,22801,38,1.01 [0.71-1.42],0.9693106635299232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",22801,38,1.30 [0.74-2.30],0.3575771701524712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYO6,Unconventional myosin-VI,23420,41,1.28 [0.63-2.58],0.4893980370182369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYO9B,Unconventional myosin-IXb,26345,55,1.07 [0.75-1.53],0.7010665207545967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOC,Myocilin,26892,58,1.02 [0.61-1.71],0.9335867015992952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM1,Myomesin-1,22691,40,0.85 [0.42-1.74],0.6661081487278835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM2,Myomesin-2,22720,41,0.68 [0.32-1.42],0.3025763595435443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM3,Myomesin-3,22952,38,0.85 [0.60-1.21],0.3647699564289063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MZB1,Marginal zone B- and B1-cell-specific protein,26984,58,1.54 [1.02-2.33],0.0387303170088582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MZT1,Mitotic-spindle organizing protein 1,26244,55,1.16 [0.74-1.81],0.5177269722902283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAA10,N-alpha-acetyltransferase 10,22720,41,1.23 [0.68-2.19],0.4940101209246229
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAA80,N-alpha-acetyltransferase 80,22801,38,1.07 [0.83-1.39],0.5998281067233371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAAA,N-acylethanolamine-hydrolyzing acid amidase,26574,58,1.12 [0.76-1.66],0.5758532637093766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NACC1,Nucleus accumbens-associated protein 1,23323,40,1.52 [0.97-2.39],0.0679036954085422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NADK,NAD kinase,26888,57,1.33 [0.94-1.88],0.105456466511584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGA,Alpha-N-acetylgalactosaminidase,22742,40,1.49 [1.05-2.11],0.0274169640274182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGK,N-acetyl-D-glucosamine kinase,22813,42,1.14 [0.68-1.92],0.6096432101875284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,22952,38,1.11 [0.26-4.71],0.8889997886694904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAMPT,Nicotinamide phosphoribosyltransferase,26244,55,1.43 [1.07-1.89],0.0139300719698805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAP1L4,Nucleosome assembly protein 1-like 4,23291,41,1.10 [0.53-2.27],0.8061762530436746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAPRT,Nicotinate phosphoribosyltransferase,23402,42,0.76 [0.29-1.99],0.5781432239907295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NARS1,"Asparagine--tRNA ligase, cytoplasmic",23420,41,0.74 [0.41-1.34],0.317798248585984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBL1,Neuroblastoma suppressor of tumorigenicity 1,26973,57,2.26 [0.98-5.21],0.0550576957811698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBN,Nibrin,26345,55,1.19 [0.81-1.73],0.3819851483504968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAM1,Neural cell adhesion molecule 1,26974,59,1.69 [0.77-3.71],0.1871813163886766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAM2,Neural cell adhesion molecule 2,26892,58,1.47 [0.63-3.44],0.3704689050740019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAN,Neurocan core protein,27122,59,0.70 [0.39-1.29],0.2545417469466022
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCF2,Neutrophil cytosol factor 2,26802,59,1.31 [1.06-1.63],0.012576689935184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCK2,Cytoplasmic protein NCK2,27019,58,1.08 [0.87-1.35],0.495804528907465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCLN,Nicalin,26345,55,1.16 [0.78-1.74],0.459747364545079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCR1,Natural cytotoxicity triggering receptor 1,26799,59,1.34 [0.72-2.49],0.3591105317335403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,23331,41,1.99 [0.85-4.66],0.1142621910752939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCS1,Neuronal calcium sensor 1,27107,59,2.72 [1.24-5.98],0.0128708622112509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDRG1,Protein NDRG1,26221,58,0.80 [0.52-1.22],0.3012386393935867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,23323,40,0.95 [0.59-1.53],0.8419469364359796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,22750,40,1.24 [0.53-2.88],0.6249382320735737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,23331,41,1.22 [0.88-1.69],0.237604173210963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",26244,55,1.01 [0.74-1.39],0.9332538568015384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEB,Nebulin,22720,41,1.49 [0.82-2.71],0.1867534704278852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECAP2,Adaptin ear-binding coat-associated protein 2,22720,41,1.24 [0.84-1.84],0.2783426196107904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN1,Nectin-1,22791,40,1.56 [0.74-3.31],0.2448932229020711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN2,Nectin-2,26845,57,2.78 [1.35-5.71],0.0053597701296945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN4,Nectin-4,26973,57,1.36 [0.65-2.82],0.4143817687126224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,22791,40,1.01 [0.54-1.88],0.9779925597092458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEDD9,Enhancer of filamentation 1,22791,40,1.98 [1.14-3.42],0.0149388484538743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEFL,Neurofilament light polypeptide,26135,57,1.96 [1.24-3.11],0.0041557536688217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEK7,Serine/threonine-protein kinase Nek7,23016,42,0.98 [0.66-1.46],0.9146321456645062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NELL1,Protein kinase C-binding protein NELL1,26973,57,1.35 [0.79-2.32],0.2728668409703702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NELL2,Protein kinase C-binding protein NELL2,27019,58,0.91 [0.41-2.06],0.8285919990754462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NENF,Neudesin,23323,40,0.92 [0.67-1.25],0.5835664590951898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEO1,Neogenin,23420,41,0.56 [0.14-2.35],0.4318335814885453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEXN,Nexilin,23469,40,1.15 [0.75-1.76],0.5311018642988156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFASC,Neurofascin,27167,58,1.61 [0.71-3.67],0.2530927198617144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFAT5,Nuclear factor of activated T-cells 5,22791,40,1.17 [0.85-1.61],0.3373483770694298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",26837,59,0.99 [0.78-1.26],0.922571664481427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",26345,55,0.95 [0.62-1.45],0.7960808571702859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFE2,Transcription factor NF-E2 45 kDa subunit,22859,42,1.08 [0.73-1.61],0.7022574521628495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFIC,Nuclear factor 1 C-type,23420,41,0.62 [0.24-1.64],0.3350242167154628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKB1,Nuclear factor NF-kappa-B p105 subunit,22720,41,1.29 [0.86-1.93],0.2160246991965527
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKB2,Nuclear factor NF-kappa-B p100 subunit,23016,42,0.92 [0.51-1.65],0.7698341100399124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKBIE,NF-kappa-B inhibitor epsilon,26244,55,1.32 [0.83-2.09],0.2384481383900623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",23331,41,1.18 [0.88-1.57],0.2708777518095518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFX1,Transcriptional repressor NF-X1,22720,41,1.24 [0.81-1.88],0.3177563704499012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFYA,Nuclear transcription factor Y subunit alpha,22720,41,1.62 [0.98-2.69],0.0614554414380007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGF,Beta-nerve growth factor,26703,58,0.84 [0.12-5.77],0.8572664355542421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGFR,Tumor necrosis factor receptor superfamily member 16,23456,41,0.88 [0.30-2.59],0.8219782346587771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGRN,Neugrin,23402,42,1.60 [0.54-4.78],0.3983445163445267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NHLRC3,NHL repeat-containing protein 3,22394,37,4.31 [1.54-12.08],0.0053939930908858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NID1,Nidogen-1,26882,59,1.83 [1.07-3.15],0.0281125243676021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NID2,Nidogen-2,26892,58,1.16 [0.86-1.56],0.337239440537498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NINJ1,Ninjurin-1,26244,55,1.17 [0.80-1.70],0.4259422951399355
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NIT1,Deaminated glutathione amidase,22859,42,1.01 [0.55-1.85],0.9753247462718218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NIT2,Omega-amidase NIT2,23373,40,1.18 [0.79-1.77],0.428373322321727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NLGN1,Neuroligin-1,22801,38,0.60 [0.30-1.19],0.1457355629636951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NLGN2,Neuroligin-2,22691,40,0.88 [0.44-1.74],0.70810153530223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NME1,Nucleoside diphosphate kinase A,22791,40,0.66 [0.16-2.77],0.573504449779745
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NME3,Nucleoside diphosphate kinase 3,26941,58,1.78 [0.84-3.78],0.1304428877393417
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMI,N-myc-interactor,23242,40,1.42 [0.99-2.05],0.0584141351221313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,26703,58,1.30 [1.02-1.65],0.031456305822318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMRK2,Nicotinamide riboside kinase 2,22605,39,0.70 [0.28-1.76],0.4494969482127939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,23420,41,1.28 [0.91-1.79],0.1510951448375704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOMO1,Nodal modulator 1,26892,58,0.73 [0.27-1.97],0.5399476522965808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOP56,Nucleolar protein 56,22720,41,0.89 [0.65-1.23],0.4840967571366659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS1,"Nitric oxide synthase, brain",26221,58,1.37 [0.86-2.17],0.1813281700754606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS2,"Nitric oxide synthase, inducible",22720,41,1.00 [0.46-2.18],0.9991490982832916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS3,"Nitric oxide synthase, endothelial",26221,58,1.48 [1.07-2.03],0.0162918047186164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH1,Neurogenic locus notch homolog protein 1,27215,59,1.01 [0.23-4.41],0.9939886132205916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH2,Neurogenic locus notch homolog protein 2,23449,42,1.30 [0.34-5.06],0.7024318214846029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH3,Neurogenic locus notch homolog protein 3,27215,59,1.03 [0.53-2.02],0.9256148635114392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPC2,NPC intracellular cholesterol transporter 2,23056,42,2.22 [1.23-4.02],0.0085191129468851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPDC1,Neural proliferation differentiation and control protein 1,26888,57,2.59 [1.44-4.69],0.0015984795417402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPHS1,Nephrin,22791,40,1.43 [0.63-3.25],0.3974782616661447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPHS2,Podocin,22791,40,1.08 [0.83-1.41],0.5515105335468136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPL,N-acetylneuraminate lyase,23456,41,2.03 [1.16-3.54],0.0125790577679741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPB,Natriuretic peptides B,26386,58,1.11 [0.92-1.32],0.274047619542636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPC,C-type natriuretic peptide,26837,59,1.06 [0.63-1.78],0.8228016749613196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPR1,Atrial natriuretic peptide receptor 1,22720,41,1.28 [0.64-2.53],0.4879093113170467
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTN,Neuroplastin,26244,55,1.15 [0.90-1.46],0.2598902084098677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTX1,Neuronal pentraxin-1,26892,58,1.08 [0.59-1.97],0.7988279318039967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTX2,Neuronal pentraxin-2,23449,42,2.15 [0.88-5.28],0.093785581624136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTXR,Neuronal pentraxin receptor,26888,57,1.21 [0.64-2.30],0.5632930976542643
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPY,Pro-neuropeptide Y,27107,59,1.24 [0.87-1.78],0.2396997752629667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRCAM,Neuronal cell adhesion molecule,26888,57,1.16 [0.51-2.65],0.7303096697991229
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRGN,Neurogranin,23469,40,1.18 [0.85-1.64],0.3114474348398601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRN1,Neuritin,23420,41,1.33 [0.80-2.24],0.2736988055008587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP1,Neuropilin-1,27021,59,2.17 [1.02-4.64],0.0450586179543192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP2,Neuropilin-2,26892,58,1.25 [0.57-2.76],0.5756990748653774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRTN,Neurturin,26345,55,0.66 [0.39-1.12],0.1220839451195771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRXN3,Neurexin-3,22801,38,1.13 [0.52-2.47],0.7553572112425262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NSFL1C,NSFL1 cofactor p47,27122,59,1.47 [1.06-2.05],0.0227678761076303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",23456,41,1.22 [0.81-1.82],0.3412679010842818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C1A,Cytosolic 5'-nucleotidase 1A,23402,42,2.13 [1.34-3.37],0.0013896901823465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C3A,Cytosolic 5'-nucleotidase 3A,26799,59,0.92 [0.71-1.19],0.5075235549853498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5E,5'-nucleotidase,26973,57,1.48 [1.05-2.08],0.0264909841414352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTF3,Neurotrophin-3,26837,59,1.36 [0.74-2.49],0.3242865044038819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTF4,Neurotrophin-4,26244,55,0.83 [0.41-1.67],0.5999821356904786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTRK2,BDNF/NT-3 growth factors receptor,26888,57,1.85 [0.74-4.62],0.1863588964452502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTRK3,NT-3 growth factor receptor,27122,59,0.60 [0.21-1.73],0.3482902595393441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTproBNP,N-terminal prohormone of brain natriuretic peptide,26888,57,1.18 [0.95-1.46],0.1326476160642483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUB1,NEDD8 ultimate buster 1,26837,59,1.10 [0.84-1.43],0.5022603425118267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,23323,40,1.04 [0.76-1.42],0.8129570834132908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUCB2,Nucleobindin-2,27059,59,1.48 [0.80-2.71],0.2091173910253732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDC,Nuclear migration protein nudC,27167,58,1.05 [0.73-1.53],0.7802026372817572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,22859,42,0.31 [0.07-1.45],0.1373388795172298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,22720,41,0.81 [0.41-1.59],0.5323191115199997
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT16,U8 snoRNA-decapping enzyme,23289,41,1.43 [1.02-1.99],0.0357961547725704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],26762,58,0.98 [0.65-1.48],0.9245192119029536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT5,ADP-sugar pyrophosphatase,26892,58,1.43 [0.95-2.15],0.087770586101311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUMB,Protein numb homolog,22791,40,1.16 [0.80-1.68],0.421224021477171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUP50,Nuclear pore complex protein Nup50,22720,41,0.76 [0.26-2.17],0.6062219807677722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPE4,NXPE family member 4,22720,41,0.91 [0.36-2.31],0.8489760574671658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPH1,Neurexophilin-1,26221,58,1.25 [0.69-2.26],0.4526574701485979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPH3,Neurexophilin-3,22791,40,1.14 [0.42-3.10],0.8029952545494414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OBP2B,Odorant-binding protein 2b,26619,58,1.15 [0.79-1.67],0.4672625083131276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OCLN,Occludin,23420,41,2.21 [1.27-3.82],0.0047348506280813
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ODAM,Odontogenic ameloblast-associated protein,26181,58,1.10 [0.75-1.62],0.6193596094701173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OFD1,Oral-facial-digital syndrome 1 protein,23016,42,0.96 [0.60-1.53],0.8472346673397793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGA,Protein O-GlcNAcase,23331,41,1.35 [0.89-2.04],0.159760388793625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGFR,Opioid growth factor receptor,26762,58,1.84 [0.95-3.58],0.0724620045790724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGN,Mimecan,26892,58,1.79 [1.06-3.01],0.0288712825276729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23016,42,0.64 [0.34-1.19],0.1556427285873604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLFM4,Olfactomedin-4,22094,35,1.04 [0.79-1.37],0.7599169998507647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLR1,Oxidized low-density lipoprotein receptor 1,26627,57,1.42 [1.01-1.99],0.0430722425473902
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMD,Osteomodulin,27019,58,0.74 [0.45-1.21],0.2286537140820861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMG,Oligodendrocyte-myelin glycoprotein,26762,58,0.78 [0.55-1.13],0.1866895791691273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMP,Olfactory marker protein,22691,40,1.64 [1.10-2.44],0.0150347938814744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPHN1,Oligophrenin-1,23402,42,1.04 [0.79-1.37],0.7822546278360304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPLAH,5-oxoprolinase,22859,42,1.22 [0.80-1.87],0.3594027156717463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPTC,Opticin,26762,58,0.79 [0.46-1.38],0.411349187936575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ORM1,Alpha-1-acid glycoprotein 1,23421,41,5.77 [1.63-20.49],0.0066501685018731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSBPL2,Oxysterol-binding protein-related protein 2,23402,42,0.46 [0.16-1.31],0.1460743862935605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSCAR,Osteoclast-associated immunoglobulin-like receptor,26941,58,2.26 [1.13-4.51],0.0213278910156414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSM,Oncostatin-M,26712,59,1.43 [1.04-1.96],0.0284996918128774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSMR,Oncostatin-M-specific receptor subunit beta,27021,59,1.19 [0.39-3.63],0.765286549856953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSTN,Osteocrin,22801,38,1.08 [0.54-2.13],0.8322151039725293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTOA,Otoancorin,22691,40,1.12 [0.67-1.85],0.672276507529487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTUD6B,Deubiquitinase OTUD6B,23331,41,1.33 [0.81-2.17],0.2582857012657797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTUD7B,OTU domain-containing protein 7B,23420,41,1.35 [0.85-2.15],0.2003998998008744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",22859,42,1.18 [0.77-1.82],0.4527419154472849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OXT,Oxytocin-neurophysin 1,27122,59,0.94 [0.79-1.12],0.4909527235577864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,P4HB,Protein disulfide-isomerase,26762,57,1.26 [0.69-2.32],0.4481977217801044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PACS2,Phosphofurin acidic cluster sorting protein 2,22720,41,1.47 [0.93-2.31],0.0960155918518625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PADI2,Protein-arginine deiminase type-2,26345,55,1.29 [0.95-1.76],0.1083137117138843
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PADI4,Protein-arginine deiminase type-4,26181,58,1.05 [0.78-1.41],0.7516591375289116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAEP,Glycodelin,26703,58,0.95 [0.71-1.26],0.7154228116803014
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,23420,41,1.00 [0.77-1.30],0.9738094502832274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23016,42,0.98 [0.54-1.79],0.9433210155549644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,26386,58,1.38 [0.94-2.01],0.0963648259934228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAGR1,PAXIP1-associated glutamate-rich protein 1,22859,42,0.81 [0.40-1.66],0.572152562380788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,22564,39,0.88 [0.47-1.64],0.6802788090851619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAK4,Serine/threonine-protein kinase PAK 4,26221,58,1.12 [0.78-1.61],0.5435892278688419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALLD,Palladin,22791,40,1.08 [0.53-2.22],0.8340481770854324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM,Paralemmin-1,23210,41,1.42 [0.54-3.70],0.4733720276725086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM2,Paralemmin-2,23402,42,2.46 [1.35-4.49],0.003295782912223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM3,Paralemmin-3,22720,41,0.93 [0.58-1.48],0.75925386764299
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAM,Peptidyl-glycine alpha-amidating monooxygenase,27070,59,3.51 [1.42-8.66],0.0065352196616979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAMR1,Inactive serine protease PAMR1,26892,58,1.59 [0.67-3.76],0.2881058881115922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAPPA,Pappalysin-1,26345,55,1.53 [0.91-2.59],0.1103203552772759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARD3,Partitioning defective 3 homolog,23016,42,0.78 [0.49-1.23],0.2879300083085891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARK7,Parkinson disease protein 7,26892,58,1.49 [0.98-2.28],0.0641902342222277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARP1,Poly [ADP-ribose] polymerase 1,26837,59,1.22 [0.89-1.68],0.2087721735714708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAXX,Protein PAXX,22952,38,1.47 [0.79-2.74],0.2293788884778228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBK,Lymphokine-activated killer T-cell-originated protein kinase,22605,39,0.83 [0.30-2.27],0.7123852885120614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBLD,Phenazine biosynthesis-like domain-containing protein,26221,58,0.91 [0.57-1.45],0.6894745089329131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,23331,41,1.80 [0.88-3.71],0.1084266902906123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCARE,Photoreceptor cilium actin regulator,22691,40,1.23 [0.96-1.57],0.0963792036649939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,22909,38,1.42 [0.79-2.56],0.2412609696337256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCBP2,Poly(rC)-binding protein 2,23420,41,1.18 [0.78-1.79],0.4244144921761623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH1,Protocadherin-1,27085,58,0.70 [0.22-2.18],0.5332864016738843
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH12,Protocadherin-12,23420,41,1.01 [0.32-3.18],0.987829257493483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH17,Protocadherin-17,26888,57,2.05 [1.11-3.81],0.0222135085015593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH7,Protocadherin-7,23331,41,1.19 [0.56-2.57],0.6486868782542552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH9,Protocadherin-9,23331,41,0.73 [0.31-1.75],0.4822463802685037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDHB15,Protocadherin beta-15,23323,40,1.20 [0.59-2.44],0.6233623275719502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCNA,Proliferating cell nuclear antigen,22605,39,0.99 [0.61-1.62],0.975327193370273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCSK7,Proprotein convertase subtilisin/kexin type 7,23323,40,1.00 [0.52-1.92],0.9990789441414366
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCSK9,Proprotein convertase subtilisin/kexin type 9,27215,59,1.91 [1.07-3.42],0.0284047078332864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCYT2,Ethanolamine-phosphate cytidylyltransferase,23331,41,1.23 [0.83-1.82],0.3051142925897169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDAP1,28 kDa heat- and acid-stable phosphoprotein,23456,41,1.10 [0.81-1.49],0.5418338654974644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD1,Programmed cell death protein 1,27067,59,1.39 [0.87-2.24],0.1696774441972297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD1LG2,Programmed cell death 1 ligand 2,26762,58,1.84 [0.92-3.68],0.0861920903457907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD5,Programmed cell death protein 5,27122,59,1.57 [1.08-2.28],0.0171827562713223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD6,Programmed cell death protein 6,26888,57,2.16 [1.27-3.65],0.0042036197289292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCL2,Phosducin-like protein 2,22605,39,0.99 [0.56-1.75],0.9772469089623596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",22605,39,1.33 [0.91-1.96],0.1437616372599005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",22720,41,0.83 [0.46-1.50],0.5296049626357908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",22952,38,1.05 [0.77-1.41],0.7729391314163802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFA,Platelet-derived growth factor subunit A,27215,59,1.27 [0.92-1.75],0.1425435247874744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFB,Platelet-derived growth factor subunit B,27019,58,1.19 [0.91-1.57],0.208283392386855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFC,Platelet-derived growth factor C,26244,55,0.88 [0.38-2.02],0.7553135938201965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRA,Platelet-derived growth factor receptor alpha,26888,57,1.47 [0.67-3.22],0.3399842883337248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRB,Platelet-derived growth factor receptor beta,27215,59,0.51 [0.27-0.96],0.0357507111799193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA2,Protein disulfide-isomerase A2,22605,39,0.71 [0.29-1.70],0.4418320169261819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA3,Protein disulfide-isomerase A3,22952,38,2.16 [1.38-3.39],0.0007392361667057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA4,Protein disulfide-isomerase A4,23449,42,1.15 [0.72-1.86],0.5607493542718174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA5,Protein disulfide-isomerase A5,22605,39,1.17 [0.74-1.86],0.503743284605606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDLIM5,PDZ and LIM domain protein 5,23420,41,1.02 [0.79-1.31],0.8886312073211324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDLIM7,PDZ and LIM domain protein 7,27019,58,1.05 [0.87-1.26],0.5969524723363617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",26244,55,1.36 [0.97-1.92],0.0752333723537928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDRG1,p53 and DNA damage-regulated protein 1,22801,38,1.00 [0.56-1.79],0.9901418670556088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,22605,39,0.66 [0.30-1.48],0.3136422869952077
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZD2,PDZ domain-containing protein 2,22720,41,1.34 [0.88-2.04],0.1709451333952838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,22791,40,2.06 [1.28-3.31],0.0029853005139984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEAR1,Platelet endothelial aggregation receptor 1,27215,59,1.71 [0.62-4.76],0.3030075299599443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEBP1,Phosphatidylethanolamine-binding protein 1,26892,58,1.50 [1.03-2.18],0.0340046380982678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PECAM1,Platelet endothelial cell adhesion molecule,26892,58,1.05 [0.49-2.26],0.9036848537554438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PECR,Peroxisomal trans-2-enoyl-CoA reductase,22859,42,1.03 [0.39-2.77],0.9486154857326596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PENK,Proenkephalin-A,22952,38,1.19 [0.46-3.11],0.7223791972828038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEPD,Xaa-Pro dipeptidase,23469,40,0.92 [0.29-2.97],0.8933567706864709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PER3,Period circadian protein homolog 3,22791,40,1.02 [0.80-1.31],0.8519337654277606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PF4,Platelet factor 4,23328,41,1.04 [0.77-1.41],0.8086058591915917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN2,Prefoldin subunit 2,26221,58,1.37 [0.97-1.93],0.0697292985798916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN4,Prefoldin subunit 4,22605,39,1.35 [0.87-2.11],0.1854166979854954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN6,Prefoldin subunit 6,22801,38,0.90 [0.53-1.52],0.6909826251843962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",26715,58,1.23 [0.92-1.65],0.1708310355363138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGA4,Pepsin A-4,23469,40,1.41 [0.95-2.11],0.0889689338438295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",23456,41,1.30 [0.76-2.22],0.3353897772448475
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGF,Placenta growth factor,27167,58,2.80 [1.51-5.18],0.001030827873858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP1,Peptidoglycan recognition protein 1,27084,59,1.99 [1.28-3.09],0.0020706477422109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23202,41,1.67 [0.63-4.46],0.3043518773143898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP4,Peptidoglycan recognition protein 4,22720,41,1.16 [0.77-1.73],0.4828769972453623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGM2,Phosphoglucomutase-2,22801,38,0.74 [0.37-1.48],0.39166936568747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGR,Progesterone receptor,22791,40,1.25 [1.01-1.56],0.0418625675716546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHACTR2,Phosphatase and actin regulator 2,23420,41,1.08 [0.84-1.41],0.5456470882901044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHLDB1,Pleckstrin homology-like domain family B member 1,23331,41,1.38 [0.81-2.35],0.2373125024656669
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHLDB2,Pleckstrin homology-like domain family B member 2,22605,39,1.05 [0.78-1.41],0.7603623528359271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,26703,58,1.62 [0.73-3.59],0.2400449102322946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,22952,38,1.37 [0.64-2.92],0.4162447146014598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI16,Peptidase inhibitor 16,23469,40,0.47 [0.15-1.51],0.205617715097785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI3,Elafin,26538,59,1.25 [0.85-1.83],0.2586185907083942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",23420,41,1.21 [0.83-1.76],0.3228241980053055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIGR,Polymeric immunoglobulin receptor,26546,57,2.90 [1.64-5.13],0.0002461874514723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,26837,59,1.32 [0.92-1.88],0.1300003207866145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,26892,58,2.06 [0.95-4.47],0.067226079095208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,22791,40,1.21 [0.75-1.97],0.4348298707490386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRA,Paired immunoglobulin-like type 2 receptor alpha,26892,58,2.27 [1.31-3.95],0.0036895990875712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRB,Paired immunoglobulin-like type 2 receptor beta,26888,57,1.68 [1.07-2.62],0.0230575523670567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,22952,38,1.30 [0.81-2.09],0.2796256332842608
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PITHD1,PITH domain-containing protein 1,22564,39,1.06 [0.74-1.50],0.7550553503238676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD1,Polycystin-1,23456,41,0.46 [0.15-1.40],0.1709763147509813
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD2,Polycystin-2,22720,41,1.73 [1.15-2.59],0.0078824763592246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKLR,Pyruvate kinase PKLR,26936,58,1.46 [1.08-1.98],0.014678767052019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKN3,Serine/threonine-protein kinase N3,23016,42,1.10 [0.75-1.61],0.6384940784718187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G10,Group 10 secretory phospholipase A2,26703,58,1.09 [0.74-1.62],0.6560051070113603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G15,Phospholipase A2 group XV,26973,57,3.70 [1.65-8.31],0.0014915986825699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G1B,Phospholipase A2,27165,59,0.63 [0.38-1.03],0.0673887773433433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G2A,"Phospholipase A2, membrane associated",26808,59,1.05 [0.71-1.55],0.8183880943004247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G4A,Cytosolic phospholipase A2,27019,58,1.07 [0.82-1.40],0.6035299984310855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G7,Platelet-activating factor acetylhydrolase,26892,58,0.95 [0.47-1.92],0.8887372339903026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAT,Tissue-type plasminogen activator,27129,59,1.81 [1.15-2.86],0.0107315297750822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAU,Urokinase-type plasminogen activator,26892,58,1.66 [1.08-2.54],0.0202948027276735
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAUR,Urokinase plasminogen activator surface receptor,26727,58,5.46 [2.61-11.43],6.46840704092852e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLB1,"Phospholipase B1, membrane-associated",23402,42,0.76 [0.47-1.22],0.2521433537156599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",22791,40,1.91 [1.39-2.63],6.614935275426966e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",23402,42,1.08 [0.79-1.46],0.628550297454626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLEKHO1,Pleckstrin homology domain-containing family O member 1,23402,42,1.15 [0.76-1.74],0.5140112387996432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLG,Plasminogen,22889,41,2.99 [1.20-7.48],0.0191798433189059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLIN1,Perilipin-1,26221,58,1.44 [0.82-2.54],0.2052730175214361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLIN3,Perilipin-3,26888,57,1.32 [0.78-2.22],0.3026941589292239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLPBP,Pyridoxal phosphate homeostasis protein,26888,57,1.24 [0.89-1.75],0.2073018056888142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLSCR3,Phospholipid scramblase 3,23365,42,1.51 [0.93-2.43],0.0931554524189163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLTP,Phospholipid transfer protein,27120,59,0.47 [0.25-0.87],0.0159686913199875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXDC1,Plexin domain-containing protein 1,26244,55,1.28 [0.67-2.43],0.4526905429522637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXDC2,Plexin domain-containing protein 2,23402,42,0.65 [0.20-2.07],0.4621910015358753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNA4,Plexin-A4,26837,59,1.14 [0.86-1.50],0.3726031130765959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB2,Plexin-B2,27088,59,2.86 [1.14-7.15],0.0245654590629775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB3,Plexin-B3,26798,57,1.24 [0.76-2.03],0.3921758716327015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,26752,56,0.95 [0.83-1.08],0.4180362669118049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMCH,Pro-MCH,22720,41,0.83 [0.52-1.32],0.4292167560882308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMM2,Phosphomannomutase 2,22720,41,1.49 [0.93-2.38],0.0996075264032638
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMS1,PMS1 protein homolog 1,22801,38,1.00 [0.54-1.85],0.990596969714656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMVK,Phosphomevalonate kinase,26177,58,1.00 [0.81-1.23],0.97932044701992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIP,Pancreatic triacylglycerol lipase,23469,40,0.71 [0.44-1.15],0.1685161432699442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIPRP1,Inactive pancreatic lipase-related protein 1,23402,42,0.94 [0.64-1.38],0.7631512056312492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIPRP2,Pancreatic lipase-related protein 2,26892,58,0.96 [0.89-1.03],0.2733143359647566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNMA1,Paraneoplastic antigen Ma1,22859,42,0.83 [0.48-1.44],0.5003458366270297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNMA2,Paraneoplastic antigen Ma2,22691,40,0.98 [0.50-1.94],0.9569170556922064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",26345,55,1.07 [0.88-1.30],0.5143810687819276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PODXL,Podocalyxin,26762,58,1.68 [0.36-7.77],0.5067915167271893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PODXL2,Podocalyxin-like protein 2,26973,57,0.73 [0.31-1.71],0.4663400449918076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POF1B,Protein POF1B,22791,40,1.29 [0.72-2.32],0.3868970134712499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2A,DNA-directed RNA polymerase II subunit RPB1,22791,40,2.01 [1.09-3.71],0.024436134475525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",26762,58,1.60 [1.00-2.57],0.0509145555279988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POMC,Pro-opiomelanocortin,22859,42,1.03 [0.67-1.60],0.8821853990785584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON1,Serum paraoxonase/arylesterase 1,23469,40,0.77 [0.27-2.20],0.6296321852385214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON2,Serum paraoxonase/arylesterase 2,26386,58,1.69 [0.88-3.24],0.1144851796205438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON3,Serum paraoxonase/lactonase 3,27019,58,0.99 [0.45-2.20],0.985063955635617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POSTN,Periostin,23449,42,0.74 [0.34-1.65],0.4673570192990022
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPBP,Platelet basic protein,23328,41,1.07 [0.75-1.52],0.727529474300919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPCDC,Phosphopantothenoylcysteine decarboxylase,27122,59,1.47 [0.92-2.35],0.1077323088312755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIB,Peptidyl-prolyl cis-trans isomerase B,26904,59,1.05 [0.82-1.34],0.7139519186543523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIE,Peptidyl-prolyl cis-trans isomerase E,23016,42,0.91 [0.56-1.50],0.7241755906675363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",23449,42,1.29 [0.87-1.91],0.2113750288300904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPL,Periplakin,22791,40,2.33 [1.43-3.77],0.0006263443540539
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1A,Protein phosphatase 1A,26244,55,1.36 [0.72-2.56],0.3464765649237314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1B,Protein phosphatase 1B,22791,40,1.34 [0.94-1.93],0.1099266776314847
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1F,Protein phosphatase 1F,23456,41,1.19 [0.68-2.10],0.5372107750720891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPME1,Protein phosphatase methylesterase 1,26762,58,1.65 [1.14-2.40],0.0076635628777449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,23323,40,1.10 [0.76-1.57],0.6218898825835741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,26973,57,1.13 [0.89-1.43],0.3222636670133874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23016,42,0.94 [0.61-1.45],0.7834007742977942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,23420,41,1.19 [0.85-1.65],0.3101375904909622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,23420,41,1.31 [0.67-2.56],0.4373619457552796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R2,Protein phosphatase inhibitor 2,26888,57,1.10 [0.82-1.47],0.5364984984383431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R9B,Neurabin-2,27167,58,0.93 [0.72-1.19],0.5455114114275863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,23331,41,1.06 [0.82-1.36],0.6514713859638868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP3R1,Calcineurin subunit B type 1,26703,58,1.40 [0.80-2.44],0.2428031004144673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPT1,Palmitoyl-protein thioesterase 1,22801,38,1.10 [0.77-1.58],0.6038205434875279
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPY,Pancreatic prohormone,26870,57,0.93 [0.74-1.17],0.5153222585343133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PQBP1,Polyglutamine-binding protein 1,26244,55,1.25 [0.90-1.74],0.1767248377866379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRAME,Melanoma antigen preferentially expressed in tumors,22605,39,0.91 [0.27-3.02],0.8745466903435317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRAP1,Proline-rich acidic protein 1,23449,42,1.88 [0.91-3.88],0.0881788754470662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRC1,Protein regulator of cytokinesis 1,23323,40,1.29 [0.86-1.91],0.217049162422273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRCP,Lysosomal Pro-X carboxypeptidase,27050,59,1.72 [0.95-3.12],0.0740365901825917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX1,Peroxiredoxin-1,26155,56,1.10 [0.84-1.44],0.4874894598469088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX2,Peroxiredoxin-2,23072,40,1.09 [0.69-1.73],0.7077136922275193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",26345,55,1.04 [0.75-1.45],0.8214625640934138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX5,"Peroxiredoxin-5, mitochondrial",27167,58,0.96 [0.69-1.34],0.8059721984073822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX6,Peroxiredoxin-6,27107,59,1.27 [0.88-1.83],0.1969421950665675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PREB,Prolactin regulatory element-binding protein,26345,55,1.12 [0.52-2.40],0.7781132585060186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRELP,Prolargin,26892,58,2.72 [1.01-7.28],0.0468053726845833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG2,Bone marrow proteoglycan,23449,42,1.77 [1.05-2.96],0.0306845203898709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG3,Proteoglycan 3,23449,42,1.46 [0.81-2.61],0.2051423490115896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,26345,55,1.21 [0.79-1.84],0.3828880582786672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,22801,38,0.64 [0.21-1.93],0.42546509906087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,26888,57,1.06 [0.80-1.40],0.6658776402231917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,23365,42,1.27 [0.89-1.81],0.1888016337371922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKCQ,Protein kinase C theta type,26345,55,1.35 [0.88-2.07],0.16476378807348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKD2,Serine/threonine-protein kinase D2,22720,41,1.34 [0.86-2.10],0.201273022630797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKG1,cGMP-dependent protein kinase 1,22952,38,1.02 [0.79-1.30],0.895781427837665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,26244,55,1.12 [0.79-1.59],0.5245779646304224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRL,Prolactin,27122,59,1.13 [0.83-1.53],0.4390794907531946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRND,Prion-like protein doppel,23402,42,0.71 [0.41-1.25],0.2372723158068254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROC,Vitamin K-dependent protein C,26928,59,0.85 [0.33-2.18],0.7394454090269333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROCR,Endothelial protein C receptor,22720,41,0.66 [0.23-1.83],0.4216105505140353
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROK1,Prokineticin-1,26837,59,1.57 [1.12-2.20],0.0082116285930635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROS1,Vitamin K-dependent protein S,23501,41,2.02 [0.75-5.43],0.1660352841135368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR4,Proline-rich protein 4,22789,38,1.11 [0.71-1.72],0.6502882855074219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR5,Proline-rich protein 5,22791,40,1.82 [1.26-2.62],0.0013280739109961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRRT3,Proline-rich transmembrane protein 3,22859,42,1.15 [0.54-2.47],0.7180375685799965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS2,Trypsin-2,26974,59,0.72 [0.46-1.15],0.1682787853410836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS22,Brain-specific serine protease 4,22791,40,1.86 [1.26-2.75],0.0017260591904704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS27,Serine protease 27,26802,57,1.29 [0.73-2.26],0.3840363612497243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS53,Serine protease 53,23402,42,0.75 [0.33-1.66],0.4730345411148663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS8,Prostasin,26803,58,1.52 [0.88-2.63],0.1303876480206327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,26221,58,1.05 [0.85-1.29],0.6628433292672293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTG,Protogenin,27107,59,0.92 [0.37-2.32],0.8628858366072112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTN3,Myeloblastin,26191,57,1.48 [1.00-2.20],0.0486705955368696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRUNE2,Protein prune homolog 2,23016,42,2.06 [1.27-3.36],0.0036093509213684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSAP,Prosaposin,23228,42,2.15 [1.10-4.24],0.0261215887134238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSAPL1,Proactivator polypeptide-like 1,23331,41,1.00 [0.56-1.80],0.9999276248981008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSCA,Prostate stem cell antigen,23331,41,1.17 [1.02-1.34],0.0278018861977808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSG1,Pregnancy-specific beta-1-glycoprotein 1,26703,58,1.09 [0.88-1.33],0.4314610740695968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSIP1,PC4 and SFRS1-interacting protein,26837,59,1.19 [0.87-1.62],0.2773746775403113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMA1,Proteasome subunit alpha type-1,26244,55,0.87 [0.49-1.53],0.6335152350523052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMC3,26S proteasome regulatory subunit 6A,22605,39,0.77 [0.27-2.17],0.6195283761612781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD1,26S proteasome non-ATPase regulatory subunit 1,23420,41,1.28 [0.73-2.22],0.3862995101055697
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD5,26S proteasome non-ATPase regulatory subunit 5,22801,38,1.02 [0.60-1.75],0.934645179100256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD9,26S proteasome non-ATPase regulatory subunit 9,26762,58,1.51 [1.05-2.15],0.0247207634587793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSME1,Proteasome activator complex subunit 1,26665,57,1.75 [0.96-3.17],0.0659822398086572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSME2,Proteasome activator complex subunit 2,26577,57,2.09 [1.14-3.81],0.0163144172360255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMG3,Proteasome assembly chaperone 3,26837,59,1.64 [1.09-2.46],0.017025328204558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMG4,Proteasome assembly chaperone 4,22791,40,1.49 [0.97-2.27],0.0668149676109011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSPN,Persephin,26837,59,1.10 [0.87-1.38],0.431164015543515
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSRC1,Proline/serine-rich coiled-coil protein 1,26244,55,1.14 [0.77-1.69],0.5198039497677254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22113,37,0.98 [0.73-1.32],0.908544454408572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",26221,58,1.20 [0.56-2.59],0.6336161298261385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGDS,Prostaglandin-H2 D-isomerase,26663,59,1.85 [0.93-3.67],0.0775050690271732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGES2,Prostaglandin E synthase 2,22600,40,1.78 [1.08-2.95],0.0239739456890645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGR1,Prostaglandin reductase 1,23456,41,1.07 [0.75-1.52],0.7273566728402167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTH,Parathyroid hormone,22801,38,1.14 [0.78-1.66],0.4891750547083716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,26837,59,1.07 [0.60-1.91],0.8078255611954714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTK7,Inactive tyrosine-protein kinase 7,26221,58,0.95 [0.51-1.77],0.8704872171525672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTN,Pleiotrophin,26386,58,1.62 [1.05-2.49],0.0280755145192498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTP4A3,Protein tyrosine phosphatase type IVA 3,22791,40,1.20 [0.74-1.94],0.4667868773023557
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,26703,58,1.16 [0.87-1.55],0.3084329837492467
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,26976,58,1.07 [0.82-1.39],0.6311957431834883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,22747,40,1.74 [1.03-2.96],0.0387794513243675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRB,Receptor-type tyrosine-protein phosphatase beta,23456,41,1.80 [0.67-4.82],0.2398982698457591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRC,Receptor-type tyrosine-protein phosphatase C,23449,42,1.43 [0.39-5.20],0.5884061330211637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRF,Receptor-type tyrosine-protein phosphatase F,27215,59,1.07 [0.49-2.35],0.8651898835718033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRH,Receptor-type tyrosine-protein phosphatase H,23331,41,0.94 [0.50-1.79],0.8617248965428513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,23331,41,2.00 [0.73-5.46],0.1758636897490246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRM,Receptor-type tyrosine-protein phosphatase mu,26793,58,0.66 [0.26-1.70],0.393660016792052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,26613,58,1.08 [0.53-2.21],0.8328724852677728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRR,Receptor-type tyrosine-protein phosphatase R,23402,42,1.13 [0.50-2.54],0.7734565380103255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRS,Receptor-type tyrosine-protein phosphatase S,27215,59,1.73 [0.68-4.38],0.2504547535060408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,23456,41,1.05 [0.42-2.62],0.9112177701931364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,22952,38,1.14 [0.69-1.90],0.6105511860737073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTS,6-pyruvoyl tetrahydrobiopterin synthase,26105,58,1.14 [0.77-1.70],0.5152028954285666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTTG1,Securin,23016,42,0.65 [0.29-1.45],0.2936585054033122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTX3,Pentraxin-related protein PTX3,26837,59,0.93 [0.59-1.47],0.7541123439923542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVALB,Parvalbumin alpha,26975,58,1.05 [0.85-1.30],0.6208112053152584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVR,Poliovirus receptor,27122,59,2.78 [1.72-4.52],3.400652883165949e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PXDNL,Peroxidasin-like protein,23323,40,1.29 [0.87-1.90],0.204780957556061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PXN,Paxillin,26221,58,1.43 [0.99-2.05],0.0553639560130675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYDC1,Pyrin domain-containing protein 1,22859,42,1.29 [0.71-2.36],0.4025308564697817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYY,Peptide YY,22720,41,1.07 [0.80-1.45],0.6431719394039852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PZP,Pregnancy zone protein,23501,41,1.18 [0.74-1.88],0.476964633678257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QDPR,Dihydropteridine reductase,26762,57,1.20 [0.71-2.05],0.4986397778518464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QPCT,Glutaminyl-peptide cyclotransferase,26926,59,2.88 [1.51-5.52],0.0013715495064247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QSOX1,Sulfhydryl oxidase 1,23027,39,1.32 [0.84-2.08],0.2237101392619067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB10,Ras-related protein Rab-10,23456,41,1.25 [0.74-2.14],0.4053836104084342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB11FIP3,Rab11 family-interacting protein 3,23456,41,0.98 [0.74-1.29],0.8608537254967361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB27B,Ras-related protein Rab-27B,23456,41,1.12 [0.77-1.63],0.5591700881573729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB2B,Ras-related protein Rab-2B,23323,40,1.17 [0.72-1.90],0.5194533278633608
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB33A,Ras-related protein Rab-33A,22720,41,1.18 [0.76-1.84],0.4668522903625628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB37,Ras-related protein Rab-37,26345,55,1.07 [0.80-1.42],0.6590561286899383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB39B,Ras-related protein Rab-39B,22720,41,0.93 [0.63-1.36],0.7082435400787137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,22691,40,1.20 [0.77-1.88],0.4168855174984371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB44,Ras-related protein Rab-44,23323,40,1.41 [0.89-2.21],0.1403890365551878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB6A,Ras-related protein Rab-6A,26837,59,0.80 [0.49-1.32],0.3906603899086907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB6B,Ras-related protein Rab-6B,26221,58,1.07 [0.67-1.70],0.7851301828522739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABEP1,Rab GTPase-binding effector protein 1,22952,38,1.23 [0.84-1.81],0.2914360219096842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABEPK,Rab9 effector protein with kelch motifs,26244,55,1.27 [0.89-1.81],0.1879098284193986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABGAP1L,Rab GTPase-activating protein 1-like,26345,55,1.07 [0.73-1.59],0.7219036580897797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAC3,Ras-related C3 botulinum toxin substrate 3,22801,38,1.34 [1.00-1.79],0.0464398692523249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAD23B,UV excision repair protein RAD23 homolog B,26244,55,1.27 [0.79-2.02],0.3241546034108721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAD51,DNA repair protein RAD51 homolog 1,23016,42,0.99 [0.56-1.74],0.9718274039335062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RALB,Ras-related protein Ral-B,22791,40,2.11 [0.92-4.85],0.0797701953132999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RALY,RNA-binding protein Raly,23323,40,0.83 [0.42-1.67],0.608346302990274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANBP1,Ran-specific GTPase-activating protein,22859,42,1.48 [0.88-2.48],0.1391164204036313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANBP2,E3 SUMO-protein ligase RanBP2,22691,40,0.81 [0.31-2.10],0.658048601857435
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANGAP1,Ran GTPase-activating protein 1,26244,55,0.69 [0.38-1.26],0.2320534952667194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAP1A,Ras-related protein Rap-1A,22791,40,1.41 [1.10-1.80],0.0061288509944849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAPGEF2,Rap guanine nucleotide exchange factor 2,23016,42,1.07 [0.61-1.86],0.8138126560042911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES1,Retinoic acid receptor responder protein 1,26244,55,0.76 [0.34-1.70],0.500812049994984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES2,Retinoic acid receptor responder protein 2,27021,59,1.63 [1.07-2.48],0.0232447517186754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASA1,Ras GTPase-activating protein 1,26221,58,0.85 [0.41-1.77],0.6650360443057914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,22605,39,1.33 [0.71-2.48],0.377985078227992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASSF2,Ras association domain-containing protein 2,26244,55,1.51 [1.17-1.96],0.0014341605584388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBFOX3,RNA binding protein fox-1 homolog 3,23420,41,2.04 [1.37-3.05],0.0004546085838933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBKS,Ribokinase,26255,58,1.59 [1.04-2.44],0.0324078767485316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM17,Splicing factor 45,23420,41,1.21 [0.83-1.77],0.3265375209706526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM19,Probable RNA-binding protein 19,22720,41,1.54 [1.00-2.37],0.0506430556589061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM25,RNA-binding protein 25,22605,39,1.00 [0.51-1.94],0.9910700204436836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP1,Retinol-binding protein 1,22801,38,1.12 [0.75-1.67],0.5751428278137766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP2,Retinol-binding protein 2,26762,58,1.02 [0.75-1.39],0.8811151670929009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP5,Retinol-binding protein 5,26762,58,1.32 [0.91-1.93],0.1433872970488639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP7,Retinoid-binding protein 7,23331,41,1.43 [0.94-2.16],0.0920987715755891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBPMS,RNA-binding protein with multiple splicing,22791,40,1.14 [0.77-1.71],0.5097481356974404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBPMS2,RNA-binding protein with multiple splicing 2,22859,42,1.09 [0.82-1.46],0.5351319257909877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RCC1,Regulator of chromosome condensation,23323,40,0.92 [0.48-1.73],0.7874728570769659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RCOR1,REST corepressor 1,26386,58,1.13 [0.72-1.75],0.6014215645307709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,22859,42,0.60 [0.14-2.63],0.5003123137551316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REEP4,Receptor expression-enhancing protein 4,23420,41,1.21 [0.76-1.91],0.4203247512789774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1A,Lithostathine-1-alpha,26711,59,1.20 [0.78-1.84],0.4139340182596966
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1B,Lithostathine-1-beta,27215,59,1.20 [0.83-1.74],0.3314821182309826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3A,Regenerating islet-derived protein 3-alpha,27215,59,1.22 [0.86-1.72],0.2610404047910003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3G,Regenerating islet-derived protein 3-gamma,23323,40,0.97 [0.46-2.06],0.9358974617799068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG4,Regenerating islet-derived protein 4,26941,58,2.06 [1.38-3.09],0.0004479797071209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELB,Transcription factor RelB,22791,40,0.79 [0.40-1.55],0.483583164987113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELT,Tumor necrosis factor receptor superfamily member 19L,26892,58,2.36 [1.12-4.98],0.0233650402248783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REN,Renin,26888,57,1.65 [1.31-2.08],2.363968295866856e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REPS1,RalBP1-associated Eps domain-containing protein 1,22791,40,1.12 [0.52-2.40],0.7771529517791099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REST,RE1-silencing transcription factor,22605,39,0.77 [0.30-1.98],0.5869147328522166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,26762,58,0.89 [0.50-1.57],0.6827084544283366
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RETN,Resistin,26820,59,1.49 [0.89-2.49],0.1290896407793304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REXO2,"Oligoribonuclease, mitochondrial",22720,41,0.70 [0.33-1.50],0.3642624325775115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RFC4,Replication factor C subunit 4,23323,40,2.03 [0.60-6.89],0.2556255877941919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGCC,Regulator of cell cycle RGCC,23420,41,1.23 [0.83-1.82],0.2979905087623612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23016,42,0.84 [0.49-1.44],0.5283530938543709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGMA,Repulsive guidance molecule A,27122,59,1.14 [0.54-2.39],0.7272972475713291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGMB,RGM domain family member B,27122,59,1.17 [0.49-2.77],0.7254094745717646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS10,Regulator of G-protein signaling 10,23420,41,1.16 [0.72-1.87],0.5505182624426265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS8,Regulator of G-protein signaling 8,26345,55,0.43 [0.23-0.80],0.0077929586825498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RHOC,Rho-related GTP-binding protein RhoC,26524,58,1.07 [0.87-1.31],0.5175476026291992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RICTOR,Rapamycin-insensitive companion of mTOR,22791,40,1.35 [0.88-2.07],0.1631954827429532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,22952,38,1.26 [0.71-2.23],0.4376176321089897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RILP,Rab-interacting lysosomal protein,27022,59,1.49 [1.04-2.15],0.030945919614529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RILPL2,RILP-like protein 2,23456,41,1.08 [0.80-1.47],0.6118399751888555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,22720,41,0.83 [0.50-1.37],0.4716086303260008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RLN1,Prorelaxin H1,23420,41,0.99 [0.59-1.67],0.972422984000531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RLN2,Prorelaxin H2,22909,37,1.26 [0.96-1.66],0.0996537157622934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE1,Ribonuclease pancreatic,23469,40,1.57 [0.55-4.52],0.401101788815834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE10,Inactive ribonuclease-like protein 10,22859,42,1.18 [0.67-2.07],0.5634853805522657
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE3,Eosinophil cationic protein,26761,57,1.16 [0.97-1.39],0.1059030192082561
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE4,Ribonuclease 4,22688,38,2.03 [0.80-5.17],0.1385395167241433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE6,Ribonuclease K6,23298,40,1.90 [1.09-3.32],0.0233711516369208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASEH2A,Ribonuclease H2 subunit A,23420,41,1.37 [0.86-2.18],0.1795400181276124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASET2,Ribonuclease T2,27087,59,1.86 [0.94-3.70],0.0748728285644464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF149,E3 ubiquitin-protein ligase RNF149,22859,42,1.86 [0.91-3.78],0.0876921164700188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF168,E3 ubiquitin-protein ligase RNF168,22791,40,1.87 [1.13-3.08],0.0144627922296428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF31,E3 ubiquitin-protein ligase RNF31,22791,40,1.67 [0.95-2.94],0.0753899102238357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF4,E3 ubiquitin-protein ligase RNF4,23016,42,1.09 [0.72-1.64],0.6880668943348227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF41,E3 ubiquitin-protein ligase NRDP1,26244,55,1.26 [0.90-1.77],0.1804741282598096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF43,E3 ubiquitin-protein ligase RNF43,23016,42,1.36 [0.96-1.93],0.0862988609268548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF5,E3 ubiquitin-protein ligase RNF5,22859,42,0.84 [0.56-1.25],0.3909938043017245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO1,Roundabout homolog 1,26941,58,2.36 [1.01-5.51],0.0468695240278292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO2,Roundabout homolog 2,27122,59,1.39 [0.53-3.67],0.5006534779878811
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO4,Roundabout homolog 4,22859,42,0.75 [0.32-1.78],0.5185660589846917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,26888,57,1.14 [0.55-2.37],0.7329119182314512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RP2,Protein XRP2,26762,58,1.65 [1.00-2.73],0.0503053405276117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPA2,Replication protein A 32 kDa subunit,22791,40,2.01 [1.04-3.89],0.0370538861294616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPE,Ribulose-phosphate 3-epimerase,23016,42,1.12 [0.75-1.68],0.5897791459277544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPGR,X-linked retinitis pigmentosa GTPase regulator,22801,38,1.04 [0.51-2.13],0.9166251040853448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPL14,60S ribosomal protein L14,22859,42,1.07 [0.52-2.20],0.8559335106245838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPS10,40S ribosomal protein S10,22720,41,0.93 [0.45-1.93],0.8552346860368663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRAS,Ras-related protein R-Ras,22801,38,0.99 [0.78-1.26],0.9253191049859668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRM2,Ribonucleoside-diphosphate reductase subunit M2,26244,55,1.17 [0.82-1.68],0.3917282501399337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,26244,55,1.20 [0.85-1.70],0.2999618215463641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRP15,RRP15-like protein,22691,40,1.06 [0.77-1.46],0.7123571060591624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO1,R-spondin-1,26703,58,2.20 [1.37-3.53],0.0011107950445566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO3,R-spondin-3,27107,59,2.62 [1.37-5.01],0.0035167344598858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTBDN,Retbindin,26762,58,1.35 [0.62-2.93],0.4513277842662044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTKN2,Rhotekin-2,22720,41,1.38 [0.97-1.95],0.0702098060918303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",23420,41,1.15 [0.83-1.59],0.3947551625858881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTN4R,Reticulon-4 receptor,27107,59,1.19 [0.62-2.26],0.6039384316529806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RUVBL1,RuvB-like 1,26244,55,1.13 [0.93-1.37],0.2351270499070643
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RWDD1,RWD domain-containing protein 1,27122,59,1.25 [0.88-1.79],0.209050333708191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RYR1,Ryanodine receptor 1,22720,41,0.49 [0.16-1.47],0.2021047776888497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A11,Protein S100-A11,26665,57,1.53 [1.09-2.15],0.0138028650263192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A12,Protein S100-A12,26521,58,1.34 [1.01-1.80],0.0448790622902049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A13,Protein S100-A13,22791,40,1.48 [0.71-3.08],0.289557396397335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A14,Protein S100-A14,23420,41,0.88 [0.50-1.52],0.6390917208359117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A16,Protein S100-A16,26181,58,1.00 [0.68-1.45],0.990525937101493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A3,Protein S100-A3,23323,40,1.52 [1.04-2.22],0.0324082343068691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A4,Protein S100-A4,26973,57,1.52 [1.00-2.31],0.0475817597707257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100G,Protein S100-G,23420,41,0.56 [0.27-1.17],0.1237038130681864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100P,Protein S100-P,26386,58,1.28 [0.89-1.83],0.1778821648891513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAA4,Serum amyloid A-4 protein,23501,41,1.23 [0.60-2.53],0.5769417112990415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAFB2,Scaffold attachment factor B2,23420,41,0.82 [0.27-2.53],0.7294954387557455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAG,S-arrestin,22691,40,1.28 [0.79-2.07],0.311518729042538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAMD9L,Sterile alpha motif domain-containing protein 9-like,26837,59,1.18 [0.86-1.61],0.2987715737804136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAP18,Histone deacetylase complex subunit SAP18,23016,42,0.91 [0.59-1.38],0.6529884651217333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SARG,Specifically androgen-regulated gene protein,23368,41,1.03 [0.79-1.36],0.8156803079460153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SART1,U4/U6.U5 tri-snRNP-associated protein 1,22720,41,1.68 [1.10-2.56],0.0163706114284585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAT1,Diamine acetyltransferase 1,22720,41,1.10 [0.64-1.90],0.7226760163384607
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAT2,Thialysine N-epsilon-acetyltransferase,23016,42,1.09 [0.72-1.64],0.6904891805086739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SATB1,DNA-binding protein SATB1,23420,41,1.28 [0.52-3.15],0.5868306884811878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SBSN,Suprabasin,23403,42,0.51 [0.21-1.25],0.1415384015469579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCAMP3,Secretory carrier-associated membrane protein 3,26762,58,1.22 [0.94-1.59],0.1342754664738685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARA5,Scavenger receptor class A member 5,27122,59,1.42 [0.66-3.07],0.3652898599645587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB1,Scavenger receptor class B member 1,26221,58,1.07 [0.73-1.56],0.7283545149541926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB2,Lysosome membrane protein 2,26205,57,2.70 [1.53-4.76],0.0006281776394885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF1,Scavenger receptor class F member 1,27215,59,1.44 [0.85-2.44],0.1767319775830751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF2,Scavenger receptor class F member 2,27122,59,2.41 [1.15-5.08],0.0203203501967071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG2,Secretogranin-2,26974,59,1.25 [0.62-2.52],0.5282822422848454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG3,Secretogranin-3,26941,58,0.63 [0.32-1.24],0.1812702235351837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB1A1,Uteroglobin,26937,58,0.75 [0.51-1.11],0.151289409276546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB2A2,Mammaglobin-A,22720,41,1.03 [0.41-2.59],0.9423311083447852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB3A1,Secretoglobin family 3A member 1,22952,38,0.61 [0.18-2.04],0.4173328839044457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB3A2,Secretoglobin family 3A member 2,26976,58,1.18 [0.96-1.43],0.1107195361852366
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGN,Secretagogin,26345,55,0.80 [0.46-1.38],0.4193237996759087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCIN,Adseverin,22691,40,1.27 [0.89-1.81],0.1941043121359019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCLY,Selenocysteine lyase,27022,59,1.17 [0.73-1.87],0.5107721171843461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN2A,Sodium channel protein type 2 subunit alpha,22691,40,0.83 [0.41-1.66],0.5950680360005367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN2B,Sodium channel subunit beta-2,22801,38,0.64 [0.20-2.04],0.4461869842588137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN3A,Sodium channel protein type 3 subunit alpha,22801,38,0.71 [0.27-1.88],0.4911698203521041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN3B,Sodium channel subunit beta-3,22691,40,0.71 [0.33-1.53],0.3832311879922301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN4B,Sodium channel subunit beta-4,22859,42,1.03 [0.51-2.05],0.9422107520398216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCP2,Non-specific lipid-transfer protein,26244,55,0.98 [0.70-1.37],0.8942837266413948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCPEP1,Retinoid-inducible serine carboxypeptidase,22765,42,1.42 [0.80-2.52],0.2365372196089206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRG1,Scrapie-responsive protein 1,23456,41,1.80 [0.66-4.91],0.2498119386136151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRIB,Protein scribble homolog,22859,42,1.19 [0.92-1.55],0.1913775029388522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRN1,Secernin-1,26837,59,1.19 [0.80-1.77],0.3968836247579377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCT,Secretin,22801,38,0.58 [0.29-1.14],0.1142159549651862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDC1,Syndecan-1,26888,57,1.19 [0.66-2.14],0.5596670863828392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDC4,Syndecan-4,26888,57,1.06 [0.64-1.78],0.8130092436648914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDCCAG8,Serologically defined colon cancer antigen 8,23323,40,1.13 [0.87-1.48],0.3509287277376518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDHB,Succinate dehydrogenase,23331,41,1.40 [0.99-1.97],0.0561556566426929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDK2,Protein sidekick-2,22952,38,0.43 [0.18-1.02],0.0546679788632801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEC31A,Protein transport protein Sec31A,22859,42,1.01 [0.69-1.49],0.9551422304666184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEL1L,Protein sel-1 homolog 1,22859,42,1.26 [0.60-2.64],0.5465741125626932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELE,E-selectin,27215,59,1.26 [0.80-1.99],0.321566270365747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELENOP,Selenoprotein P,23501,41,0.72 [0.37-1.41],0.3398592263799713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELL,L-selectin,23501,41,1.44 [0.40-5.15],0.574332813171125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELP,P-selectin,26974,59,1.32 [0.89-1.94],0.1678092877397958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELPLG,P-selectin glycoprotein ligand 1,26837,59,0.48 [0.25-0.90],0.023293914619959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA3F,Semaphorin-3F,26888,57,2.18 [0.91-5.19],0.0795193227565886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA3G,Semaphorin-3G,22952,38,1.13 [0.56-2.29],0.7285337606956596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4C,Semaphorin-4C,26762,58,2.39 [1.70-3.37],5.789856289498485e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4D,Semaphorin-4D,27122,59,1.43 [0.66-3.11],0.36986974618299
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA6C,Semaphorin-6C,22791,40,1.91 [0.94-3.87],0.0741630071994685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA7A,Semaphorin-7A,27129,59,1.90 [0.97-3.72],0.0597415439956415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN3,Neuronal-specific septin-3,23420,41,1.25 [0.87-1.79],0.2293357502340069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN7,Septin-7,23016,42,1.42 [1.03-1.97],0.0312908256871753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN8,Septin-8,23355,42,1.91 [0.95-3.84],0.0696033420716897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN9,Septin-9,26762,58,0.88 [0.38-2.04],0.7653649094063817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA1,Alpha-1-antitrypsin,23053,41,22.09 [2.84-171.97],0.0031149552457482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA11,Serpin A11,27215,59,2.58 [1.43-4.64],0.0015858915558849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA12,Serpin A12,26097,55,1.01 [0.82-1.26],0.8996979835685481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA3,Alpha-1-antichymotrypsin,23410,41,4.82 [0.90-25.79],0.0659383554073454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA4,Kallistatin,23064,40,3.06 [0.90-10.47],0.0741481948931211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA5,Plasma serine protease inhibitor,23158,41,1.29 [0.55-3.00],0.5585287494532714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA6,Corticosteroid-binding globulin,23501,41,2.18 [0.38-12.70],0.3851266850910925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA7,Thyroxine-binding globulin,23501,41,2.22 [0.50-9.91],0.2942815880076893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA9,Serpin A9,26621,58,1.06 [0.76-1.46],0.7433618169681595
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB1,Leukocyte elastase inhibitor,26811,58,1.22 [0.95-1.56],0.1151370442809806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB5,Serpin B5,26386,58,0.75 [0.51-1.10],0.1459880346735399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB6,Serpin B6,27037,59,1.28 [0.87-1.89],0.2032566828379571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB8,Serpin B8,27167,58,1.45 [1.10-1.90],0.0084629857939078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB9,Serpin B9,26703,58,1.31 [0.66-2.61],0.4407874842996431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINC1,Antithrombin-III,23450,41,5.58 [0.81-38.36],0.080400032136367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPIND1,Heparin cofactor 2,23450,41,2.25 [0.77-6.59],0.1380149983676597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINE1,Plasminogen activator inhibitor 1,27215,59,1.18 [0.83-1.67],0.3563793406626819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINE2,Glia-derived nexin,23456,41,1.11 [0.71-1.74],0.6497192312674112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINF1,Pigment epithelium-derived factor,23145,41,1.58 [0.53-4.68],0.4075691329811614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINF2,Alpha-2-antiplasmin,23055,41,6.71 [1.02-44.16],0.0478284286595816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPING1,Plasma protease C1 inhibitor,23450,41,5.22 [1.09-24.92],0.0383735529217662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINH1,Serpin H1,23016,42,1.02 [0.82-1.29],0.8359191526403114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINI1,Neuroserpin,22904,38,1.05 [0.40-2.79],0.9180607595299356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINI2,Serpin I2,23331,41,0.83 [0.48-1.43],0.4948972870757375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,26221,58,1.14 [0.81-1.62],0.4569706136657958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SETMAR,Histone-lysine N-methyltransferase SETMAR,26624,58,0.96 [0.43-2.15],0.91803740919362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6,Seizure protein 6 homolog,22801,38,1.21 [0.46-3.19],0.6990951183051606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6L,Seizure 6-like protein,26973,57,0.71 [0.30-1.66],0.4249291070991883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6L2,Seizure 6-like protein 2,26762,58,1.91 [0.75-4.92],0.1770488938672901
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SF3B4,Splicing factor 3B subunit 4,26762,58,1.09 [0.80-1.48],0.5966402528300079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP1,Secreted frizzled-related protein 1,26622,58,2.12 [1.51-2.98],1.630440216448846e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP4,Secreted frizzled-related protein 4,22952,38,0.56 [0.26-1.18],0.127126673324479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA1,Pulmonary surfactant-associated protein A1,26244,55,1.22 [0.87-1.70],0.2520175074341294
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA2,Pulmonary surfactant-associated protein A2,26244,55,1.57 [1.06-2.32],0.0236133319262182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPD,Pulmonary surfactant-associated protein D,26888,57,1.20 [0.85-1.70],0.3026566061723154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SGSH,N-sulphoglucosamine sulphohydrolase,23055,41,1.27 [0.79-2.06],0.3258712989073323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH2B3,SH2B adapter protein 3,26244,55,1.11 [0.87-1.42],0.417137937549381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH2D1A,SH2 domain-containing protein 1A,26837,59,1.07 [0.73-1.58],0.7217597530383038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,22691,40,1.45 [1.05-2.02],0.0262257524316505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3BP1,SH3 domain-binding protein 1,23331,41,1.13 [0.63-2.03],0.6744144894792654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3GL3,Endophilin-A3,22893,42,1.46 [1.06-2.02],0.0207506345556592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3GLB2,Endophilin-B2,23402,42,1.48 [0.97-2.26],0.0661925089538404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHBG,Sex hormone-binding globulin,23469,40,1.09 [0.62-1.93],0.766701519475005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHC1,SHC-transforming protein 1,22605,39,1.20 [0.96-1.49],0.1120592966720014
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHD,SH2 domain-containing adapter protein D,22671,41,0.74 [0.46-1.20],0.226807688876229
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHH,Sonic hedgehog protein,22791,40,1.32 [0.73-2.37],0.3535766269001056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHISA5,Protein shisa-5,23449,42,2.72 [1.41-5.26],0.0028860573661453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHMT1,"Serine hydroxymethyltransferase, cytosolic",26976,58,1.09 [0.84-1.43],0.5138117740825332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHPK,Sedoheptulokinase,23016,42,0.94 [0.45-1.96],0.8768891456005097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIAE,Sialate O-acetylesterase,26932,57,1.49 [0.92-2.42],0.1054903392674727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC1,Sialoadhesin,27019,58,1.63 [0.97-2.73],0.0629517549011452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC10,Sialic acid-binding Ig-like lectin 10,26837,59,2.10 [1.14-3.90],0.0179095646101368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC15,Sialic acid-binding Ig-like lectin 15,26221,58,0.89 [0.64-1.23],0.4790368184964799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC5,Sialic acid-binding Ig-like lectin 5,26892,58,1.17 [0.93-1.49],0.1786291441282707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC6,Sialic acid-binding Ig-like lectin 6,27107,59,0.89 [0.45-1.76],0.7369980208452106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC7,Sialic acid-binding Ig-like lectin 7,26888,57,1.46 [0.63-3.38],0.376204292753717
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC8,Sialic acid-binding Ig-like lectin 8,22859,42,2.34 [1.26-4.36],0.0073943628569877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC9,Sialic acid-binding Ig-like lectin 9,27070,59,2.26 [1.01-5.02],0.0464243866873463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIL1,Nucleotide exchange factor SIL1,22859,42,1.27 [0.63-2.58],0.5015166046580757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,26956,59,1.47 [0.94-2.30],0.0911423852625392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRPB1,Signal-regulatory protein beta-1,26852,58,1.40 [0.85-2.31],0.1822035168929747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT1,NAD-dependent protein deacetylase sirtuin-1,22791,40,1.24 [0.95-1.63],0.1184850225338573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT2,NAD-dependent protein deacetylase sirtuin-2,26762,58,1.31 [1.01-1.70],0.0453710192004568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",26221,58,0.76 [0.47-1.24],0.2729078432336452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIT1,Signaling threshold-regulating transmembrane adapter 1,26345,55,1.06 [0.69-1.61],0.7953642995795308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKAP1,Src kinase-associated phosphoprotein 1,26653,58,1.05 [0.77-1.42],0.7711336054362976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKAP2,Src kinase-associated phosphoprotein 2,27019,58,1.02 [0.82-1.28],0.8381923654570159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKIV2L,Helicase SKI2W,22720,41,1.44 [0.84-2.48],0.1837866223743145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLA2,Src-like-adapter 2,23420,41,1.12 [0.84-1.50],0.4337235047587638
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF1,Signaling lymphocytic activation molecule,26345,55,1.27 [0.84-1.92],0.2567916691334571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF6,SLAM family member 6,26244,55,1.22 [0.65-2.29],0.5438468944583741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF7,SLAM family member 7,26837,59,1.53 [1.06-2.22],0.0237467322456171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF8,SLAM family member 8,26244,55,2.29 [1.55-3.39],3.3623399796976815e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC12A2,Solute carrier family 12 member 2,22720,41,0.97 [0.33-2.82],0.9571748541304672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC13A1,Solute carrier family 13 member 1,23323,40,1.03 [0.63-1.66],0.9121143799423108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC16A1,Monocarboxylate transporter 1,26221,58,1.02 [0.70-1.50],0.9157008865462396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC1A4,Neutral amino acid transporter A,22801,38,1.62 [1.13-2.32],0.0093477707497248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC27A4,Long-chain fatty acid transport protein 4,26221,58,1.24 [0.91-1.69],0.1748313881800197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC28A1,Sodium/nucleoside cotransporter 1,22605,39,1.32 [0.90-1.93],0.1496711059259661
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC34A3,Sodium-dependent phosphate transport protein 2C,22605,39,1.47 [0.99-2.18],0.0553022466195961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC39A14,Zinc transporter ZIP14,26221,58,1.58 [0.88-2.85],0.1254231077078179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC39A5,Zinc transporter ZIP5,26837,59,1.28 [0.90-1.80],0.1644740369075302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC44A4,Choline transporter-like protein 4,22801,38,1.08 [0.72-1.62],0.6957631661805399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC4A1,Band 3 anion transport protein,23449,42,1.19 [0.65-2.21],0.5727851011805911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC51B,Organic solute transporter subunit beta,22720,41,1.06 [0.74-1.53],0.7380139245750392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,22952,38,1.19 [0.83-1.71],0.3532683795588602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,23331,41,1.05 [0.59-1.87],0.8614680207804967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",22605,39,1.07 [0.64-1.80],0.7958197807867169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLIT2,Slit homolog 2 protein,26221,58,0.79 [0.48-1.29],0.3434881811465591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK1,SLIT and NTRK-like protein 1,22791,40,1.12 [0.43-2.92],0.814315962219268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK2,SLIT and NTRK-like protein 2,27107,59,1.06 [0.58-1.92],0.8512494880992982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK6,SLIT and NTRK-like protein 6,26386,58,1.03 [0.53-2.04],0.9221658619507288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLK,STE20-like serine/threonine-protein kinase,23016,42,1.27 [0.98-1.66],0.0708604594671554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLMAP,Sarcolemmal membrane-associated protein,23331,41,1.31 [0.94-1.84],0.11544766319956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLURP1,Secreted Ly-6/uPAR-related protein 1,23266,41,0.97 [0.44-2.13],0.9410631517789076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD1,Mothers against decapentaplegic homolog 1,26244,55,1.25 [0.94-1.66],0.1290566869913697
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD2,Mothers against decapentaplegic homolog 2,23323,40,1.20 [0.79-1.82],0.3931183417258177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD3,Mothers against decapentaplegic homolog 3,23323,40,1.30 [0.74-2.29],0.355077867221411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD5,Mothers against decapentaplegic homolog 5,26762,58,0.51 [0.17-1.53],0.2326392906744572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMARCA2,Probable global transcription activator SNF2L2,26221,58,0.90 [0.64-1.27],0.5476882427398552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMC3,Structural maintenance of chromosomes protein 3,22605,39,1.01 [0.59-1.74],0.9611715357856354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMNDC1,Survival of motor neuron-related-splicing factor 30,23331,41,1.47 [1.07-2.01],0.0173589014117912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC1,SPARC-related modular calcium-binding protein 1,27107,59,2.13 [1.10-4.12],0.0248650415326788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC2,SPARC-related modular calcium-binding protein 2,27019,58,1.95 [1.12-3.42],0.0192468370201987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPD1,Sphingomyelin phosphodiesterase,26993,59,1.75 [1.12-2.73],0.0147607657005454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPD3,Sphingomyelin phosphodiesterase 3,22791,40,1.57 [1.14-2.17],0.0063568394474665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,26979,58,1.56 [1.06-2.29],0.0244164484962589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,23323,40,1.00 [0.67-1.48],0.9805342591217988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMS,Spermine synthase,22691,40,1.19 [0.77-1.82],0.4325963649972584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMTN,Smoothelin,23360,42,1.18 [0.89-1.58],0.2481337390983252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP23,Synaptosomal-associated protein 23,26888,57,0.96 [0.74-1.26],0.784374398411727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP25,Synaptosomal-associated protein 25,22691,40,1.84 [1.01-3.35],0.0456145650234534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP29,Synaptosomal-associated protein 29,26973,57,1.18 [0.91-1.52],0.2159022214136177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAPIN,SNARE-associated protein Snapin,23420,41,1.15 [0.69-1.92],0.6003111163690038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCA,Alpha-synuclein,22952,38,1.14 [0.87-1.50],0.3460798745215934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCG,Gamma-synuclein,26703,58,1.70 [1.20-2.42],0.002903225609523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",22859,42,0.90 [0.36-2.23],0.8226777937845089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNRPB2,U2 small nuclear ribonucleoprotein B'',23402,42,1.43 [0.96-2.13],0.0747691495154841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNU13,NHP2-like protein 1,22720,41,0.86 [0.49-1.49],0.5823579258497203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX15,Sorting nexin-15,22952,38,1.52 [0.88-2.61],0.1317506481622356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX18,Sorting nexin-18,23331,41,1.09 [0.56-2.11],0.7993216116991166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX2,Sorting nexin-2,23323,40,1.09 [0.76-1.56],0.6540473568387846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX5,Sorting nexin-5,22859,42,0.91 [0.33-2.52],0.8548289063558747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX9,Sorting nexin-9,26888,57,1.04 [0.74-1.47],0.8044657764047081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD1,Superoxide dismutase [Cu-Zn],26323,58,1.36 [0.87-2.14],0.1802609822765489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD2,"Superoxide dismutase [Mn], mitochondrial",26892,58,1.89 [1.15-3.13],0.0125644419365763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD3,Extracellular superoxide dismutase,23469,40,0.44 [0.23-0.85],0.0148256019721524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORBS1,Sorbin and SH3 domain-containing protein 1,23420,41,1.46 [0.89-2.41],0.1363649402514445
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORCS2,VPS10 domain-containing receptor SorCS2,26244,55,1.34 [0.70-2.56],0.3768043602488743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORD,Sorbitol dehydrogenase,26978,58,1.20 [0.85-1.71],0.2981965259188074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORT1,Sortilin,26845,57,1.16 [0.61-2.19],0.6513508446793053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOST,Sclerostin,26845,57,1.12 [0.61-2.03],0.7179395101414198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,22801,38,1.18 [0.73-1.93],0.4998246786634452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOX2,Transcription factor SOX-2,23381,41,0.74 [0.38-1.42],0.3672202308959024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOX9,Transcription factor SOX-9,22801,38,1.05 [0.33-3.29],0.9374018896456516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,23420,41,0.65 [0.21-2.06],0.4682303372161759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPAG1,Sperm-associated antigen 1,23420,41,1.04 [0.62-1.74],0.8726493569422129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPARC,SPARC,26973,57,0.96 [0.69-1.33],0.8202900674007849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPARCL1,SPARC-like protein 1,26889,59,0.53 [0.23-1.23],0.1403321373811123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPART,Spartin,22952,38,1.27 [0.86-1.88],0.2369680366999411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPESP1,Sperm equatorial segment protein 1,23456,41,0.57 [0.19-1.71],0.3158343826957194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK1,Serine protease inhibitor Kazal-type 1,26892,58,1.42 [0.88-2.30],0.1510964661513487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK2,Serine protease inhibitor Kazal-type 2,22952,38,1.78 [0.86-3.69],0.1201081004476243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK4,Serine protease inhibitor Kazal-type 4,26837,59,1.16 [0.84-1.61],0.3704540929748877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK5,Serine protease inhibitor Kazal-type 5,26892,58,0.64 [0.31-1.33],0.2328881384230221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK6,Serine protease inhibitor Kazal-type 6,27107,59,1.46 [0.93-2.27],0.0965924425020192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK8,Serine protease inhibitor Kazal-type 8,22720,41,1.41 [0.85-2.35],0.1819066408680992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT1,Kunitz-type protease inhibitor 1,26811,57,2.48 [1.09-5.67],0.0305688215436451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT2,Kunitz-type protease inhibitor 2,27019,58,1.27 [0.72-2.26],0.4047069181950498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT3,Kunitz-type protease inhibitor 3,23331,41,1.17 [0.90-1.50],0.2354405599383842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPOCK1,Testican-1,26703,58,0.94 [0.37-2.35],0.8888435518070787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON1,Spondin-1,26941,58,2.29 [1.43-3.67],0.0005500849588517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON2,Spondin-2,26761,57,3.45 [1.90-6.28],4.813641267023224e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPP1,Osteopontin,27170,59,1.35 [0.84-2.18],0.2190456167435513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",22791,40,1.60 [0.90-2.84],0.1067239162469675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRING1,SREBP regulating gene protein,22605,39,0.98 [0.56-1.70],0.92977645395485
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRR1B,Cornifin-B,23016,42,1.01 [0.70-1.45],0.958970349497192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRR3,Small proline-rich protein 3,23402,42,1.14 [0.77-1.69],0.5190708432737212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRY2,Protein sprouty homolog 2,26345,55,1.04 [0.81-1.35],0.7528449854576257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",22691,40,0.92 [0.36-2.35],0.8570978401182179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPTLC1,Serine palmitoyltransferase 1,23402,42,1.60 [0.94-2.72],0.0801467945198251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRC,Proto-oncogene tyrosine-protein kinase Src,26928,57,1.07 [0.88-1.30],0.5220130291074119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRP14,Signal recognition particle 14 kDa protein,26762,58,1.31 [0.92-1.86],0.1335979043608615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPK2,SRSF protein kinase 2,26837,59,1.11 [0.85-1.45],0.4300509938192783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPX,Sushi repeat-containing protein SRPX,23456,41,2.26 [0.93-5.50],0.0715541853150308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSB,Lupus La protein,26221,58,1.22 [0.88-1.69],0.2372468368961285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",22791,40,1.43 [0.73-2.78],0.2939206573162784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,26845,57,1.16 [0.94-1.44],0.1667810843476235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,26974,59,1.02 [0.59-1.76],0.952226456606058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSH3,Protein phosphatase Slingshot homolog 3,22605,39,1.52 [0.64-3.58],0.3436738875066172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSNA1,Sjoegren syndrome nuclear autoantigen 1,23331,41,1.43 [0.84-2.42],0.1873258820179143
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST13,Hsc70-interacting protein,22952,38,1.33 [0.78-2.27],0.3018107763203785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",26762,58,0.69 [0.37-1.31],0.2566969750980404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",27215,59,2.85 [1.39-5.85],0.0043477745599121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",22791,40,1.90 [1.37-2.62],0.0001047000597401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAB2,Stabilin-2,23449,42,2.77 [1.23-6.20],0.0134157667734732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAM,Signal transducing adapter molecule 1,23323,40,1.43 [0.72-2.85],0.3056409857315421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAMBP,STAM-binding protein,26653,58,1.25 [0.88-1.79],0.213126246838835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAT2,Signal transducer and activator of transcription 2,22791,40,1.44 [0.99-2.10],0.0589528619024025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAT5B,Signal transducer and activator of transcription 5B,26762,58,1.07 [0.90-1.26],0.4537543564825875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,22605,39,1.12 [0.73-1.72],0.5915750495633798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC1,Stanniocalcin-1,27122,59,1.70 [1.03-2.78],0.0360720838908998
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC2,Stanniocalcin-2,26854,58,1.11 [0.43-2.82],0.8317249566482927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STEAP4,Metalloreductase STEAP4,22691,40,0.67 [0.38-1.16],0.1534282251310401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STIP1,Stress-induced-phosphoprotein 1,26853,58,1.34 [0.95-1.87],0.0907516290300508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK11,Serine/threonine-protein kinase STK11,26386,58,1.18 [0.87-1.62],0.2908446402802735
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK24,Serine/threonine-protein kinase 24,26221,58,1.21 [0.84-1.76],0.3067924827339762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK4,Serine/threonine-protein kinase 4,26888,57,0.96 [0.73-1.26],0.7623718613459387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STOML2,"Stomatin-like protein 2, mitochondrial",22605,39,1.03 [0.74-1.44],0.8585765301235478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX16,Syntaxin-16,26244,55,1.45 [1.05-2.01],0.0254907689330806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX1B,Syntaxin-1B,22801,38,0.98 [0.46-2.09],0.962012319671798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX3,Syntaxin-3,23402,42,1.10 [0.55-2.20],0.7890877407620271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX4,Syntaxin-4,26762,58,1.40 [1.03-1.90],0.0328640718069076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX5,Syntaxin-5,22791,40,1.72 [1.18-2.50],0.0048744616673769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX6,Syntaxin-6,26244,55,1.13 [0.80-1.60],0.4767421495558772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX7,Syntaxin-7,22791,40,1.60 [0.88-2.90],0.1226871763763222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX8,Syntaxin-8,26837,59,1.55 [1.01-2.38],0.0436435814659753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STXBP1,Syntaxin-binding protein 1,23420,41,1.04 [0.71-1.54],0.8362808573437222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STXBP3,Syntaxin-binding protein 3,26244,55,1.64 [1.06-2.53],0.0248815395616139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUGP1,SURP and G-patch domain-containing protein 1,23331,41,1.80 [0.97-3.33],0.0630881383475108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUGT1,Protein SGT1 homolog,26244,55,1.23 [0.91-1.65],0.1811118318019187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT1A1,Sulfotransferase 1A1,27122,59,1.05 [0.88-1.26],0.5982746367190559
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT2A1,Bile salt sulfotransferase,26837,59,1.45 [1.05-1.99],0.0224004839184909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUMF1,Formylglycine-generating enzyme,22791,40,1.13 [0.78-1.64],0.5106160150966652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,27122,59,1.23 [0.79-1.94],0.3625304168061473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUOX,"Sulfite oxidase, mitochondrial",23420,41,1.15 [0.74-1.80],0.5379365550596356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD1,Sushi domain-containing protein 1,26386,58,1.30 [0.80-2.12],0.2912383899533853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD2,Sushi domain-containing protein 2,26892,58,1.84 [0.93-3.64],0.0805865727260889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD4,Sushi domain-containing protein 4,23323,40,1.09 [0.56-2.13],0.7947611564646686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD5,Sushi domain-containing protein 5,22822,37,0.88 [0.35-2.23],0.7896880081081814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SV2A,Synaptic vesicle glycoprotein 2A,22801,38,1.09 [0.67-1.77],0.7310273485612797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SWAP70,Switch-associated protein 70,23331,41,1.30 [0.61-2.79],0.5005704230856131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYAP1,Synapse-associated protein 1,22952,38,1.15 [0.67-1.97],0.6026352012969767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,22691,40,1.29 [0.85-1.94],0.2322810843279905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYT1,Synaptotagmin-1,23402,42,1.02 [0.48-2.17],0.966758498359774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYTL4,Synaptotagmin-like protein 4,23456,41,1.20 [0.82-1.76],0.344800059249148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23016,42,1.04 [0.79-1.38],0.7643572632768683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACC3,Transforming acidic coiled-coil-containing protein 3,26762,58,1.06 [0.87-1.29],0.5837575137171764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACSTD2,Tumor-associated calcium signal transducer 2,23824,51,1.46 [0.75-2.87],0.2691481357722064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TADA3,Transcriptional adapter 3,23323,40,1.00 [0.46-2.17],0.9969216547362926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAFA5,Chemokine-like protein TAFA-5,26762,58,2.38 [1.34-4.20],0.0029209953070637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAGLN3,Transgelin-3,22605,39,1.26 [0.86-1.85],0.2290308969893317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TALDO1,Transaldolase,23360,42,1.53 [0.83-2.82],0.177571490127775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TANK,TRAF family member-associated NF-kappa-B activator,26345,55,1.05 [0.74-1.49],0.8030879063356878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAP1,Antigen peptide transporter 1,23016,42,0.92 [0.54-1.57],0.7711937886444746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARBP2,RISC-loading complex subunit TARBP2,26221,58,1.07 [0.80-1.44],0.6392146740864778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",22801,38,0.85 [0.54-1.35],0.4982426887275737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",23323,40,1.02 [0.46-2.26],0.97062035086553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAX1BP1,Tax1-binding protein 1,23402,42,1.46 [0.97-2.19],0.0684496730404284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D17,TBC1 domain family member 17,26221,58,1.37 [0.92-2.03],0.1192376139972052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D23,TBC1 domain family member 23,26762,58,1.06 [0.82-1.37],0.6527148850979096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D5,TBC1 domain family member 5,26837,59,1.10 [0.83-1.45],0.5018594441537894
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCA,Tubulin-specific chaperone A,22952,38,1.16 [0.81-1.65],0.4106805019311246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCB,Tubulin-folding cofactor B,26703,58,1.09 [0.86-1.38],0.4825393250937906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCC,Tubulin-specific chaperone C,26703,58,1.18 [0.89-1.57],0.2568939516815802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBL1X,F-box-like/WD repeat-containing protein TBL1X,26244,55,1.18 [0.89-1.57],0.2533097698095601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBR1,T-box brain protein 1,22801,38,0.68 [0.29-1.60],0.3803928143939956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1A,T-cell leukemia/lymphoma protein 1A,26659,58,0.94 [0.74-1.20],0.6434075508870709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1B,T-cell leukemia/lymphoma protein 1B,26386,58,0.96 [0.71-1.30],0.7924209223600909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN1,Transcobalamin-1,22991,39,1.05 [0.42-2.60],0.9172311323122369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN2,Transcobalamin-2,27170,59,2.24 [1.38-3.64],0.0011674593154228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCOF1,Treacle protein,23456,41,1.56 [0.74-3.29],0.2420097550963487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCP11,T-complex protein 11 homolog,23016,42,0.78 [0.41-1.49],0.4542365748557418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCTN3,Tectonic-3,23456,41,2.01 [0.72-5.60],0.1811505064429681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDGF1,Teratocarcinoma-derived growth factor 1,26221,58,1.00 [0.85-1.17],0.9559262450513012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDO2,"Tryptophan 2,3-dioxygenase",22801,38,1.16 [0.57-2.37],0.6839397839663727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDP1,Tyrosyl-DNA phosphodiesterase 1,23323,40,1.18 [0.80-1.73],0.4039968729398494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDRKH,Tudor and KH domain-containing protein,26221,58,1.17 [0.90-1.53],0.2471541249664365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEF,Thyrotroph embryonic factor,22720,41,1.22 [0.66-2.26],0.5348361315605875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEK,Angiopoietin-1 receptor,26973,57,1.15 [0.39-3.41],0.7949342366631501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TERF1,Telomeric repeat-binding factor 1,22791,40,1.22 [0.47-3.15],0.6850457705356919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TET2,Methylcytosine dioxygenase TET2,22972,42,0.87 [0.62-1.24],0.4468175120881417
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX101,Testis-expressed protein 101,22801,38,0.73 [0.32-1.64],0.4434555652821003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX33,Testis-expressed protein 33,23016,42,0.94 [0.44-2.04],0.881773022768857
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TF,Serotransferrin,23501,41,2.29 [0.58-9.11],0.2400454905049521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFAP2A,Transcription factor AP-2-alpha,22691,40,1.04 [0.62-1.74],0.8757919319199049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF1,Trefoil factor 1,26762,57,1.18 [0.91-1.54],0.2224630129522899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF2,Trefoil factor 2,26976,58,1.42 [0.97-2.08],0.0698894303537776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF3,Trefoil factor 3,26843,59,1.49 [1.02-2.18],0.0409946998135661
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFPI,Tissue factor pathway inhibitor,26796,59,1.18 [0.56-2.48],0.6677727339534787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFPI2,Tissue factor pathway inhibitor 2,26885,56,1.50 [1.04-2.15],0.0290346410490893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFRC,Transferrin receptor protein 1,26982,59,1.43 [0.79-2.58],0.2357021247029885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TG,Thyroglobulin,23323,40,1.12 [0.89-1.41],0.3211901383669931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFA,Protransforming growth factor alpha,26837,59,1.60 [1.04-2.48],0.0335181526268357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFB1,Transforming growth factor beta-1 proprotein,27123,58,2.06 [1.19-3.56],0.0095877066125361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFB2,Transforming growth factor beta-2 proprotein,23323,40,1.23 [0.73-2.06],0.4346725685606301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBI,Transforming growth factor-beta-induced protein ig-h3,26707,59,1.50 [0.66-3.45],0.3359336419891746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR1,TGF-beta receptor type-1,22791,40,1.65 [0.56-4.90],0.3673022320514891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR2,TGF-beta receptor type-2,26973,57,1.74 [0.92-3.29],0.0885410295020177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR3,Transforming growth factor beta receptor type 3,27215,59,0.97 [0.48-1.93],0.9213272099234404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGM2,Protein-glutamine gamma-glutamyltransferase 2,26845,57,1.39 [1.03-1.87],0.0302773938816136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGOLN2,Trans-Golgi network integral membrane protein 2,23469,40,0.44 [0.14-1.34],0.1474584741298859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THAP12,52 kDa repressor of the inhibitor of the protein kinase,22564,39,1.10 [0.81-1.49],0.5587038232725656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBD,Thrombomodulin,26888,57,1.16 [0.51-2.66],0.7210259095799165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS2,Thrombospondin-2,26892,58,1.45 [0.81-2.59],0.2059249024903826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS4,Thrombospondin-4,26882,59,1.54 [0.93-2.55],0.0952085766164122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THOP1,Thimet oligopeptidase,26763,57,2.04 [1.04-4.00],0.0386613819739017
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THPO,Thrombopoietin,26386,58,1.18 [0.65-2.12],0.5902070788728899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THRAP3,Thyroid hormone receptor-associated protein 3,22720,41,0.98 [0.75-1.28],0.8870428181261332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THSD1,Thrombospondin type-1 domain-containing protein 1,22606,40,1.29 [0.56-2.98],0.5516425198235582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THTPA,Thiamine-triphosphatase,23289,40,1.00 [0.71-1.41],0.9950695351829628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THY1,Thy-1 membrane glycoprotein,27122,59,2.41 [1.15-5.07],0.0203903006213174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIA1,Nucleolysin TIA-1 isoform p40,26087,56,1.07 [0.88-1.30],0.4881451415772901
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIE1,Tyrosine-protein kinase receptor Tie-1,27215,59,0.84 [0.51-1.40],0.5080500677807389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",26171,58,1.26 [0.79-2.00],0.3392031504697269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23016,42,1.19 [0.58-2.47],0.6359770240567872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,26974,59,1.16 [0.69-1.94],0.5811331173642519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,23456,41,1.10 [0.54-2.26],0.794707011641604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,23402,42,0.95 [0.67-1.34],0.752571497736157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP1,Metalloproteinase inhibitor 1,26567,59,2.91 [1.58-5.35],0.0005952148616861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP2,Metalloproteinase inhibitor 2,23456,41,0.99 [0.30-3.27],0.9861978036640904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP3,Metalloproteinase inhibitor 3,27019,58,1.09 [0.92-1.29],0.295875131350291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP4,Metalloproteinase inhibitor 4,26892,58,1.09 [0.63-1.89],0.7616668367068641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TINAGL1,Tubulointerstitial nephritis antigen-like,26796,57,3.45 [1.24-9.57],0.0175431966500403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TJAP1,Tight junction-associated protein 1,26973,57,1.08 [0.82-1.43],0.5870345128619978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TJP3,Tight junction protein ZO-3,22691,40,0.62 [0.26-1.48],0.2866241276606632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TK1,"Thymidine kinase, cytosolic",23016,42,1.25 [0.71-2.22],0.4430572455737405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR1,Toll-like receptor 1,22791,40,2.47 [1.06-5.73],0.0356442493627244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR2,Toll-like receptor 2,23016,42,0.69 [0.19-2.49],0.5730197303925721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR3,Toll-like receptor 3,27167,58,0.77 [0.54-1.10],0.152682344378272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR4,Toll-like receptor 4,22791,40,1.18 [0.42-3.33],0.7577615626319057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,22801,38,0.98 [0.54-1.77],0.9449987988338135
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED1,Transmembrane emp24 domain-containing protein 1,23016,42,1.00 [0.59-1.68],0.9940549921662404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED10,Transmembrane emp24 domain-containing protein 10,22720,41,0.89 [0.43-1.84],0.7500688998038236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED4,Transmembrane emp24 domain-containing protein 4,22720,41,0.84 [0.46-1.56],0.586228684551696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED8,Protein TMED8,23331,41,1.04 [0.78-1.39],0.7811201125754238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM106A,Transmembrane protein 106A,23323,40,0.96 [0.63-1.48],0.8623573310974496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM132A,Transmembrane protein 132A,22859,42,1.36 [0.88-2.11],0.171795178103406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM25,Transmembrane protein 25,23420,41,0.73 [0.34-1.54],0.4018515105946829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMOD4,Tropomodulin-4,22605,39,1.33 [0.67-2.63],0.4079213710658593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS11B,Transmembrane protease serine 11B,22691,40,1.26 [0.92-1.72],0.1540545546580159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS11D,Transmembrane protease serine 11D,23355,42,1.28 [0.65-2.53],0.4800002295683838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS15,Enteropeptidase,26762,58,1.07 [0.83-1.38],0.5959462387407377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS5,Transmembrane protease serine 5,26576,58,1.42 [0.76-2.65],0.2661708749182619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMSB10,Thymosin beta-10,26892,58,1.47 [1.09-2.00],0.0127594582692871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNC,Tenascin,26974,59,1.34 [0.84-2.14],0.215317618800702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNF,Tumor necrosis factor,26344,58,1.32 [0.85-2.05],0.2124800354094482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,23331,41,1.63 [0.99-2.70],0.0567204267183923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,26345,55,0.86 [0.44-1.67],0.6581934137694323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,22952,38,1.22 [0.76-1.95],0.4089904870885769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,26703,58,2.26 [1.53-3.36],4.684107654323577e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,26703,58,1.45 [1.11-1.90],0.006286872789504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,26943,58,1.38 [0.85-2.24],0.1909222227361452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,27167,58,1.66 [0.95-2.89],0.0735373963330721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,26892,58,2.87 [1.44-5.70],0.0027401442088966
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,26973,57,2.18 [1.19-3.98],0.0115333900277123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,26941,58,2.15 [1.38-3.34],0.0006492037198655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,26345,55,1.02 [0.57-1.82],0.9475333112563628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,26941,58,2.35 [1.17-4.72],0.0165762461564045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,22952,38,1.45 [0.69-3.06],0.3289555235742206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,27107,59,2.02 [1.06-3.83],0.0323878227876316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,26892,58,2.65 [1.38-5.11],0.003534549742214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,26892,58,1.55 [1.06-2.28],0.0239886695326856
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,27122,59,1.29 [0.57-2.95],0.5389797590887851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,27123,58,1.62 [0.93-2.81],0.0888002684122811
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,26703,58,1.48 [1.04-2.10],0.02917083453913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,27122,59,1.59 [1.02-2.49],0.0411841321338442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,26703,58,1.47 [0.89-2.42],0.1347236790449929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF10,Tumor necrosis factor ligand superfamily member 10,27167,58,0.55 [0.22-1.34],0.1865336624680062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF11,Tumor necrosis factor ligand superfamily member 11,26837,59,0.79 [0.54-1.16],0.2345539725364906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF12,Tumor necrosis factor ligand superfamily member 12,27167,58,1.77 [0.80-3.90],0.1555125870135612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13,Tumor necrosis factor ligand superfamily member 13,27019,58,2.33 [0.99-5.45],0.0513793496092043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,27170,59,2.14 [1.23-3.75],0.007412462606716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF14,Tumor necrosis factor ligand superfamily member 14,26703,58,1.43 [0.98-2.10],0.0637349961218461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF8,Tumor necrosis factor ligand superfamily member 8,23449,42,1.18 [0.53-2.67],0.6847960136088416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNIP1,TNFAIP3-interacting protein 1,23402,42,1.22 [0.89-1.68],0.2228026343616476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNN,Tenascin-N,23449,42,1.29 [0.66-2.49],0.4547746889095878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNNI3,"Troponin I, cardiac muscle",26386,58,1.07 [0.80-1.42],0.6631203200065288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNPO1,Transportin-1,23016,42,1.19 [0.52-2.70],0.68420031765583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNR,Tenascin-R,26703,58,0.50 [0.30-0.84],0.0090237535047367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNXB,Tenascin-X,26892,58,0.69 [0.27-1.72],0.4224922173021285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,23456,41,1.17 [0.81-1.68],0.4029152432148135
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP1,DNA topoisomerase 1,23331,41,1.00 [0.75-1.34],0.998826600025744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP1MT,"DNA topoisomerase I, mitochondrial",22605,39,1.20 [0.69-2.07],0.5207827169660768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP2B,DNA topoisomerase 2-beta,22791,40,1.23 [0.86-1.77],0.2510639316913958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOR1AIP1,Torsin-1A-interacting protein 1,22859,42,0.98 [0.55-1.74],0.9386734294764012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53,Cellular tumor antigen p53,26244,55,0.78 [0.43-1.39],0.3924930656509944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53BP1,TP53-binding protein 1,22791,40,1.26 [0.90-1.75],0.1745857118648731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53I3,Quinone oxidoreductase PIG3,22454,36,1.77 [1.02-3.09],0.0431644509636166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53INP1,Tumor protein p53-inducible nuclear protein 1,26386,58,0.34 [0.11-1.02],0.053991686886296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP73,Tumor protein p73,22801,38,0.48 [0.19-1.18],0.1102178595304121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPBGL,Trophoblast glycoprotein-like,22801,38,0.70 [0.29-1.66],0.4152837978888954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPD52L2,Tumor protein D54,22952,38,1.07 [0.80-1.43],0.656507286103948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPK1,Thiamin pyrophosphokinase 1,23456,41,0.90 [0.30-2.70],0.8527357473834677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPM3,Tropomyosin alpha-3 chain,22720,41,0.69 [0.30-1.58],0.380393756650133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPMT,Thiopurine S-methyltransferase,26244,55,1.27 [0.95-1.70],0.1058192124943137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPP1,Tripeptidyl-peptidase 1,26723,58,1.70 [1.16-2.49],0.0065817024617229
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPPP2,Tubulin polymerization-promoting protein family member 2,23016,42,1.09 [0.78-1.51],0.6225354121892783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPPP3,Tubulin polymerization-promoting protein family member 3,26221,58,1.25 [0.78-1.99],0.3502784694475461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPR,Nucleoprotein TPR,22720,41,1.38 [0.93-2.05],0.1123621593678424
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPRKB,EKC/KEOPS complex subunit TPRKB,22605,39,0.78 [0.43-1.43],0.4203704728770817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSAB1,Tryptase alpha/beta-1,27120,58,2.09 [1.33-3.28],0.0013618603798641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSD1,Tryptase delta,23420,41,1.52 [0.91-2.56],0.1126341859450916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSG1,Tryptase gamma,22791,40,2.13 [0.96-4.70],0.0620643241979873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPT1,Translationally-controlled tumor protein,26345,55,1.03 [0.72-1.48],0.8681353503028248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF2,TNF receptor-associated factor 2,26837,59,1.02 [0.74-1.41],0.9154854878128856
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF3,"TNF receptor-associated factor 3, Isoform 2",22791,40,1.53 [0.93-2.50],0.0920466549150159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,22720,41,1.03 [0.56-1.91],0.9134315171439592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23016,42,1.21 [0.91-1.60],0.1834491506994258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREH,Trehalase,23449,42,1.06 [0.71-1.58],0.7698863608613816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREM2,Triggering receptor expressed on myeloid cells 2,26892,58,1.30 [0.84-2.00],0.236713179547501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREML1,Trem-like transcript 1 protein,23469,40,1.13 [0.65-1.97],0.6696596570881976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREML2,Trem-like transcript 2 protein,26892,58,1.45 [0.73-2.86],0.2870967015860588
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIAP1,TP53-regulated inhibitor of apoptosis 1,27107,59,1.41 [0.99-2.00],0.0578970391025248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM21,E3 ubiquitin-protein ligase TRIM21,26837,59,0.98 [0.74-1.29],0.8615026907444866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM24,Transcription intermediary factor 1-alpha,22970,42,1.00 [0.63-1.58],0.9838677206054204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,23331,41,1.10 [0.83-1.44],0.5133747672664177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM26,Tripartite motif-containing protein 26,22605,39,1.02 [0.60-1.75],0.9317831011990338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM40,E3 ubiquitin ligase TRIM40,22801,38,1.04 [0.68-1.61],0.8526024864712027
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM5,Tripartite motif-containing protein 5,26837,59,0.87 [0.67-1.14],0.3220377939827756
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM58,E3 ubiquitin-protein ligase TRIM58,23323,40,1.14 [0.81-1.60],0.4598981604746419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRPV3,Transient receptor potential cation channel subfamily V member 3,22720,41,1.33 [0.83-2.12],0.2337494877668377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSC1,Hamartin,22791,40,1.31 [0.97-1.78],0.0791783753704406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSC22D1,TSC22 domain family protein 1,23420,41,1.07 [0.70-1.63],0.7717334246956518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSHB,Thyrotropin subunit beta,26888,57,0.97 [0.74-1.28],0.8488576396839932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSLP,Thymic stromal lymphopoietin,26386,58,1.22 [0.92-1.63],0.1700348316732563
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSNAX,Translin-associated protein X,22720,41,1.33 [0.64-2.77],0.4443332473812803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN1,Tetraspanin-1,26386,58,0.68 [0.26-1.76],0.4250349508991453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN15,Tetraspanin-15,22720,41,0.81 [0.41-1.58],0.5347796815836217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN7,Tetraspanin-7,22691,40,1.13 [0.83-1.52],0.436683357480751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN8,Tetraspanin-8,23331,41,1.16 [0.88-1.53],0.2917082482324307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPYL1,Testis-specific Y-encoded-like protein 1,22791,40,1.48 [0.76-2.90],0.2457667709692642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TST,Thiosulfate sulfurtransferase,26176,58,1.23 [0.91-1.66],0.1842635435465108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTF2,Transcription termination factor 2,22801,38,1.02 [0.54-1.93],0.9462081746561384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTN,Titin,22720,41,1.07 [0.69-1.65],0.7550610654466001
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTR,Transthyretin,23245,41,0.72 [0.22-2.33],0.5842892436161797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TUBB3,Tubulin beta-3 chain,22691,40,0.95 [0.31-2.87],0.9213306452728284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TWF2,Twinfilin-2,23449,42,1.06 [0.75-1.51],0.7458240540255583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXK,Tyrosine-protein kinase TXK,23016,42,0.66 [0.38-1.15],0.1395090901150636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXLNA,Alpha-taxilin,26703,58,1.06 [0.82-1.39],0.6402524597213661
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXN,Thioredoxin,23079,39,1.76 [1.19-2.61],0.0050214926478934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC15,Thioredoxin domain-containing protein 15,26973,57,1.23 [0.53-2.85],0.6255901556679038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC5,Thioredoxin domain-containing protein 5,27122,59,1.30 [0.93-1.81],0.1188278081640317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC9,Thioredoxin domain-containing protein 9,23402,42,1.12 [0.65-1.91],0.6918366421318056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNL1,Thioredoxin-like protein 1,22644,40,0.98 [0.70-1.36],0.8877114486471598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",26892,58,1.51 [0.93-2.44],0.0925557298576428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYMP,Thymidine phosphorylase,26712,57,1.19 [0.83-1.68],0.3420555107324741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYRO3,Tyrosine-protein kinase receptor TYRO3,26888,57,1.28 [0.56-2.94],0.5554335300227493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",22791,40,0.92 [0.58-1.47],0.7330029289676094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBAC1,Ubiquitin-associated domain-containing protein 1,26762,58,1.94 [1.03-3.64],0.0409693656165363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2B,Ubiquitin-conjugating enzyme E2 B,23323,40,1.61 [0.70-3.69],0.2599981712429079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,23456,41,1.64 [1.04-2.60],0.03323807848949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,22791,40,1.61 [1.11-2.32],0.0110726135297747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBQLN3,Ubiquilin-3,22720,41,1.39 [0.89-2.18],0.15213763894912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBXN1,UBX domain-containing protein 1,22952,38,1.16 [0.75-1.80],0.5092436394443177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,23331,41,1.05 [0.85-1.30],0.6496263140240236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UGDH,UDP-glucose 6-dehydrogenase,22720,41,0.92 [0.65-1.31],0.6595636682136912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UHRF2,E3 ubiquitin-protein ligase UHRF2,22720,41,1.12 [0.49-2.55],0.7834204498726549
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ULBP2,UL16-binding protein 2,26703,58,1.87 [1.07-3.27],0.0290000256088891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UMOD,Uromodulin,27136,59,1.43 [0.91-2.24],0.1168802834340938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNC5D,Netrin receptor UNC5D,22791,40,1.99 [0.96-4.13],0.0636738181025972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNC79,Protein unc-79 homolog,22605,39,1.05 [0.61-1.80],0.8710490734204468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNG,Uracil-DNA glycosylase,23323,40,1.13 [0.48-2.66],0.7785693324770845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPB1,Beta-ureidopropionase,23456,41,1.25 [0.92-1.70],0.1547838845357933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPK3A,Uroplakin-3a,22691,40,1.14 [0.64-2.03],0.6473168857345194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPK3BL1,Uroplakin-3b-like protein 1,22976,42,0.79 [0.40-1.57],0.5063160252195453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UROD,Uroporphyrinogen decarboxylase,22952,38,0.92 [0.59-1.43],0.7031545302557924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UROS,Uroporphyrinogen-III synthase,22801,38,0.85 [0.52-1.40],0.5307059033437906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USO1,General vesicular transport factor p115,26762,58,1.13 [0.87-1.46],0.3576009696870682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP25,Ubiquitin carboxyl-terminal hydrolase 25,23323,40,1.26 [0.83-1.90],0.2790662117486231
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP28,Ubiquitin carboxyl-terminal hydrolase 28,23402,42,1.93 [1.22-3.05],0.0050599912777264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP47,Ubiquitin carboxyl-terminal hydrolase 47,22720,41,0.98 [0.68-1.41],0.914030640763913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP8,Ubiquitin carboxyl-terminal hydrolase 8,26386,58,1.11 [0.88-1.41],0.3819729957439605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UXS1,UDP-glucuronic acid decarboxylase 1,26244,55,0.78 [0.49-1.26],0.3135655575500604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAMP5,Vesicle-associated membrane protein 5,26386,58,1.34 [0.99-1.81],0.057271459295526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAMP8,Vesicle-associated membrane protein 8,22791,40,1.39 [1.00-1.94],0.0497294809624772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASH1,Tubulinyl-Tyr carboxypeptidase 1,26837,59,1.13 [0.86-1.49],0.3798867515276388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASN,Vasorin,26444,59,1.08 [0.46-2.51],0.8659258108398246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASP,Vasodilator-stimulated phosphoprotein,23469,40,1.02 [0.67-1.53],0.9435529031657371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,26762,58,0.56 [0.17-1.86],0.3467574808630639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAV3,Guanine nucleotide exchange factor VAV3,22691,40,1.12 [0.82-1.51],0.4806043766317237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAM1,Vascular cell adhesion protein 1,26928,59,1.78 [0.79-3.99],0.1635362371107528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAN,Versican core protein,27122,59,1.22 [0.58-2.58],0.6050511108798751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCPKMT,Protein-lysine methyltransferase METTL21D,22605,39,0.63 [0.37-1.07],0.086451737497965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFA,Vascular endothelial growth factor A,27075,58,1.43 [1.00-2.05],0.0522934484256766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFB,Vascular endothelial growth factor B,22791,40,5.71 [2.33-14.00],0.0001375914850675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFC,Vascular endothelial growth factor C,26973,57,1.28 [0.85-1.94],0.236283836059375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFD,Vascular endothelial growth factor D,27116,58,1.87 [0.95-3.71],0.0713434140027488
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VGF,Neurosecretory protein VGF,23420,41,0.90 [0.34-2.38],0.8395135527664757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIM,Vimentin,26386,58,1.01 [0.82-1.24],0.9287547815210884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIPR1,Vasoactive intestinal polypeptide receptor 1,22859,42,0.45 [0.12-1.67],0.2347731608540107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIT,Vitrin,23456,41,0.98 [0.44-2.21],0.9700801535767024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VMO1,Vitelline membrane outer layer protein 1 homolog,26762,58,1.05 [0.75-1.48],0.7655709268744073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN1,Pantetheinase,23469,40,1.03 [0.68-1.57],0.8783379840934545
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN2,Vascular non-inflammatory molecule 2,26762,58,2.26 [1.26-4.03],0.0058759487504451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS28,Vacuolar protein sorting-associated protein 28 homolog,23016,42,1.09 [0.71-1.68],0.6961398712166822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS37A,Vacuolar protein sorting-associated protein 37A,26762,58,1.04 [0.78-1.39],0.7825449663226767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS4B,Vacuolar protein sorting-associated protein 4B,23323,40,1.22 [0.89-1.67],0.2122250604619955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS53,Vacuolar protein sorting-associated protein 53 homolog,26762,58,1.14 [0.85-1.53],0.3943554989645704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG10,V-set and immunoglobulin domain-containing protein 10,23323,40,1.39 [0.72-2.69],0.3288735830745052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,22720,41,1.28 [0.55-3.02],0.5668827108434574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG2,V-set and immunoglobulin domain-containing protein 2,23323,40,1.97 [1.35-2.87],0.0004027223875629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG4,V-set and immunoglobulin domain-containing protein 4,26854,58,1.65 [0.98-2.80],0.0614744937644907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,26847,57,1.16 [0.81-1.66],0.4255673103525413
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSNL1,Visinin-like protein 1,23402,42,1.23 [0.59-2.59],0.5795494452163996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM1,V-set and transmembrane domain-containing protein 1,26221,58,1.46 [0.95-2.26],0.0873278868215524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM2B,V-set and transmembrane domain-containing protein 2B,23016,42,1.05 [0.53-2.05],0.897110322884242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,26386,58,0.62 [0.39-0.97],0.0366034932022038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,27122,59,1.19 [0.88-1.63],0.2630580190847207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTCN1,V-set domain-containing T-cell activation inhibitor 1,26244,55,0.48 [0.22-1.06],0.0693447495722654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,22952,38,1.49 [0.92-2.40],0.1038998430216327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWA1,von Willebrand factor A domain-containing protein 1,27059,59,1.17 [0.67-2.04],0.5742222239601501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWA5A,von Willebrand factor A domain-containing protein 5A,22605,39,1.09 [0.77-1.55],0.6144730119140451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWC2,Brorin,26612,58,1.73 [0.96-3.10],0.0668644933881443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWC2L,von Willebrand factor C domain-containing protein 2-like,23420,41,1.13 [0.65-1.98],0.6587965807756858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWF,von Willebrand factor,27215,59,1.13 [0.82-1.55],0.4459057868134344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WARS,"Tryptophan--tRNA ligase, cytoplasmic",26892,58,1.83 [1.02-3.29],0.0444374718729869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WAS,Wiskott-Aldrich syndrome protein,26345,55,1.02 [0.72-1.45],0.8941851912058498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASF1,Wiskott-Aldrich syndrome protein family member 1,26386,58,1.09 [0.85-1.39],0.5199790421090194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASF3,Wiskott-Aldrich syndrome protein family member 3,26221,58,1.31 [1.00-1.72],0.0540728699448398
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASHC3,WASH complex subunit 3,23402,42,1.22 [0.84-1.75],0.2930745782662997
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASL,Neural Wiskott-Aldrich syndrome protein,22791,40,1.02 [0.63-1.65],0.9267868717835692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WDR46,WD repeat-containing protein 46,23323,40,1.45 [0.77-2.73],0.2533232688200994
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC1,WAP four-disulfide core domain protein 1,22862,39,1.05 [0.61-1.80],0.8566488707524493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC12,WAP four-disulfide core domain protein 12,27072,59,0.96 [0.67-1.36],0.8080094598134828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC2,WAP four-disulfide core domain protein 2,25492,54,2.36 [1.46-3.83],0.0004773025978668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",26624,58,0.77 [0.43-1.36],0.3687086774736212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",26941,58,0.93 [0.48-1.80],0.8341123192290236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WIF1,Wnt inhibitory factor 1,27107,59,1.81 [0.94-3.50],0.0772547301281508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WNT9A,Protein Wnt-9a,26345,55,1.94 [1.04-3.62],0.0374688207428598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,26703,58,1.21 [0.79-1.84],0.3817443021108548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XCL1,Lymphotactin,27107,59,1.43 [1.04-1.96],0.0283496159967356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XG,Glycoprotein Xg,27080,59,2.01 [1.12-3.61],0.020031301779558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XIAP,E3 ubiquitin-protein ligase XIAP,22791,40,1.31 [0.79-2.17],0.2965126289010175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XPNPEP2,Xaa-Pro aminopeptidase 2,26973,57,0.68 [0.53-0.89],0.0041765131291281
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XRCC4,DNA repair protein XRCC4,26221,58,1.39 [0.80-2.40],0.239371064132791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YAP1,Transcriptional coactivator YAP1,23402,42,2.70 [1.10-6.64],0.0302103584564573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",23331,41,1.01 [0.83-1.24],0.9196413160767224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YES1,Tyrosine-protein kinase Yes,26762,58,1.01 [0.83-1.24],0.8971860010250717
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YJU2,Splicing factor YJU2,23323,40,1.25 [0.53-2.95],0.6157471760422724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YOD1,Ubiquitin thioesterase OTU1,22720,41,1.62 [1.04-2.53],0.0313286458328992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YTHDF3,YTH domain-containing family protein 3,26345,55,1.02 [0.77-1.35],0.8789287665197142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YWHAQ,14-3-3 protein theta,22952,38,1.15 [0.76-1.73],0.519660280300318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YY1,Transcriptional repressor protein YY1,22791,40,1.44 [0.55-3.82],0.4578162242100088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBP1,Z-DNA-binding protein 1,22791,40,1.64 [0.98-2.74],0.0603254715822333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBTB16,Zinc finger and BTB domain-containing protein 16,26244,55,1.26 [0.92-1.74],0.1517151520751972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBTB17,Zinc finger and BTB domain-containing protein 17,26386,58,1.58 [1.06-2.35],0.0255536143877047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZCCHC8,Zinc finger CCHC domain-containing protein 8,22720,41,1.08 [0.70-1.66],0.7212989501695078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZFYVE19,Abscission/NoCut checkpoint regulator,23331,41,1.03 [0.74-1.43],0.8749329596265327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZHX2,Zinc fingers and homeoboxes protein 2,23402,42,1.42 [0.74-2.70],0.2883088810961519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF174,Zinc finger protein 174,22791,40,1.16 [0.57-2.38],0.684891178901061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF75D,Zinc finger protein 75D,23016,42,0.86 [0.50-1.46],0.5657562543746752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF830,Zinc finger protein 830,23323,40,1.14 [0.80-1.62],0.4719670299771191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNRD2,Protein ZNRD2,23331,41,1.24 [0.82-1.85],0.3084305645146934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,23323,40,1.59 [1.02-2.47],0.0397624444989186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZP3,Zona pellucida sperm-binding protein 3,22859,42,1.04 [0.93-1.17],0.4733735640119807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZP4,Zona pellucida sperm-binding protein 4,22605,39,0.60 [0.19-1.94],0.3928869365714614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZPR1,Zinc finger protein ZPR1,22691,40,1.07 [0.80-1.42],0.6602263834038795
